<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Multiple sclerosis,2003,2004,2006,2007,April 1,August 13,Digital object identifier,February 1,February 9,January 1" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Multiple_sclerosis&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Multiple_sclerosis&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Multiple sclerosis - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Multiple_sclerosis";
		var wgTitle = "Multiple sclerosis";
		var wgAction = "view";
		var wgArticleId = "50603";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281888849;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Multiple_sclerosis skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Multiple sclerosis</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Multiple sclerosis</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_G" title="ICD-10 Chapter G" class="mw-redirect">G</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gg35.htm+g35" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gg35.htm+g35" rel="nofollow">35.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=340" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=340" rel="nofollow">340</a></td>
</tr>
<tr>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=126200" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=126200" rel="nofollow">126200</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb8412.htm" class="external text" title="http://www.diseasesdatabase.com/ddb8412.htm" rel="nofollow">8412</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000737.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000737.htm" rel="nofollow">000737</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/neuro/topic228.htm" class="external text" title="http://www.emedicine.com/neuro/topic228.htm" rel="nofollow">neuro/228</a>&#160; <a href="http://www.emedicine.com/oph/topic179.htm#" class="external text" title="http://www.emedicine.com/oph/topic179.htm#" rel="nofollow">oph/179</a> <a href="http://www.emedicine.com/emerg/topic321.htm#" class="external text" title="http://www.emedicine.com/emerg/topic321.htm#" rel="nofollow">emerg/321</a> <a href="http://www.emedicine.com/pmr/topic82.htm#" class="external text" title="http://www.emedicine.com/pmr/topic82.htm#" rel="nofollow">pmr/82</a> <a href="http://www.emedicine.com/radio/topic461.htm#" class="external text" title="http://www.emedicine.com/radio/topic461.htm#" rel="nofollow">radio/461</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D009103" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D009103" rel="nofollow">D009103</a></td>
</tr>
</table>
<p><b>Multiple sclerosis</b> (abbreviated MS, also known as <i>disseminated sclerosis</i> or <i>encephalomyelitis disseminata</i>) is an <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune condition</a> in which the immune system attacks the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a>, leading to <a href="/wiki/Demyelinating_disease" title="Demyelinating disease">demyelination</a>.<sup id="cite_ref-pmid11955556_0-0" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> Disease onset usually occurs in young adults, and it is more common in females.<sup id="cite_ref-pmid18637953_1-0" class="reference"><a href="#cite_note-pmid18637953-1" title=""><span>[</span>2<span>]</span></a></sup> It has a <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> that ranges between 2 and 150 per 100,000.<sup id="cite_ref-pmid11603614_2-0" class="reference"><a href="#cite_note-pmid11603614-2" title=""><span>[</span>3<span>]</span></a></sup> MS was first described in 1868 by <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>.<sup id="cite_ref-Charcot1_3-0" class="reference"><a href="#cite_note-Charcot1-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>MS affects the ability of nerve cells in the brain and spinal cord to communicate with each other. Nerve cells communicate by sending electrical signals called <a href="/wiki/Action_potential" title="Action potential">action potentials</a> down long fibers called <a href="/wiki/Axon" title="Axon">axons</a>, which are wrapped in an insulating substance called <a href="/wiki/Myelin" title="Myelin">myelin</a>. In MS, the body's own immune system attacks and damages the myelin. When myelin is lost, the axons can no longer effectively conduct signals.<sup id="cite_ref-pmid11955556_0-1" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> The name <i>multiple sclerosis</i> refers to scars (scleroses – better known as plaques or lesions) in the <a href="/wiki/White_matter" title="White matter">white matter</a> of the brain and spinal cord, which is mainly composed of myelin.<sup id="cite_ref-Charcot1_3-1" class="reference"><a href="#cite_note-Charcot1-3" title=""><span>[</span>4<span>]</span></a></sup> Although much is known about the mechanisms involved in the disease process, the cause remains unknown. Theories include <a href="/wiki/Genetics" title="Genetics">genetics</a> or <a href="/wiki/Infection" title="Infection">infections</a>. Different environmental <a href="/wiki/Risk_factor" title="Risk factor">risk factors</a> have also been found.<sup id="cite_ref-pmid17444504_4-0" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid11955556_0-2" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Almost any neurological <a href="/wiki/Symptom" title="Symptom">symptom</a> can appear with the disease, and often progresses to <a href="/wiki/Physical" title="Physical">physical</a> and <a href="/wiki/Cognitive" title="Cognitive" class="mw-redirect">cognitive</a> <a href="/wiki/Disability" title="Disability">disability</a>.<sup id="cite_ref-pmid11955556_0-3" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> MS takes several forms, with new symptoms occurring either in discrete attacks (relapsing forms) or slowly accumulating over time (progressive forms).<sup id="cite_ref-pmid8780061_5-0" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup> Between attacks, symptoms may go away completely, but permanent neurological problems often occur, especially as the disease advances.<sup id="cite_ref-pmid8780061_5-1" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>There is no known cure for MS. Treatments attempt to return function after an attack, prevent new attacks, and prevent disability.<sup id="cite_ref-pmid11955556_0-4" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> MS medications can have adverse effects or be poorly tolerated, and many patients pursue alternative treatments, despite the lack of supporting scientific study. The <a href="/wiki/Prognosis" title="Prognosis">prognosis</a> is difficult to predict; it depends on the subtype of the disease, the individual patient's disease characteristics, the initial symptoms and the degree of disability the person experiences as time advances.<sup id="cite_ref-pmid8017890_6-0" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Life_expectancy" title="Life expectancy">Life expectancy</a> of patients is nearly the same as that of the unaffected population.<sup id="cite_ref-pmid8017890_6-1" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1"><a href="#Disease_subtypes"><span class="tocnumber">2</span> <span class="toctext">Disease subtypes</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2"><a href="#MS_as_an_autoimmunological_disease"><span class="tocnumber">4.1</span> <span class="toctext">MS as an autoimmunological disease</span></a></li>
<li class="toclevel-2"><a href="#Lesions"><span class="tocnumber">4.2</span> <span class="toctext">Lesions</span></a></li>
<li class="toclevel-2"><a href="#Inflammation"><span class="tocnumber">4.3</span> <span class="toctext">Inflammation</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">5</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#Causes"><span class="tocnumber">6</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2"><a href="#Genetic_factors"><span class="tocnumber">6.1</span> <span class="toctext">Genetic factors</span></a></li>
<li class="toclevel-2"><a href="#Infectious_cause"><span class="tocnumber">6.2</span> <span class="toctext">Infectious cause</span></a></li>
<li class="toclevel-2"><a href="#Non-infectious_environmental_risk_factors"><span class="tocnumber">6.3</span> <span class="toctext">Non-infectious environmental risk factors</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Management_of_acute_attacks"><span class="tocnumber">7.1</span> <span class="toctext">Management of acute attacks</span></a></li>
<li class="toclevel-2"><a href="#Disease-modifying_treatments"><span class="tocnumber">7.2</span> <span class="toctext">Disease-modifying treatments</span></a></li>
<li class="toclevel-2"><a href="#Management_of_the_effects_of_MS"><span class="tocnumber">7.3</span> <span class="toctext">Management of the effects of MS</span></a></li>
<li class="toclevel-2"><a href="#Alternative_treatments"><span class="tocnumber">7.4</span> <span class="toctext">Alternative treatments</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2"><a href="#Medical_discovery"><span class="tocnumber">9.1</span> <span class="toctext">Medical discovery</span></a></li>
<li class="toclevel-2"><a href="#Historical_cases"><span class="tocnumber">9.2</span> <span class="toctext">Historical cases</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Research_directions"><span class="tocnumber">10</span> <span class="toctext">Research directions</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">11</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Further_reading"><span class="tocnumber">13</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Multiple_sclerosis_signs_and_symptoms" title="Multiple sclerosis signs and symptoms">Multiple sclerosis signs and symptoms</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="/wiki/File:Symptoms_of_multiple_sclerosis.png" class="image" title="Main symptoms of multiple sclerosis."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a3/Symptoms_of_multiple_sclerosis.png/250px-Symptoms_of_multiple_sclerosis.png" width="250" height="383" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Symptoms_of_multiple_sclerosis.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Main symptoms of multiple sclerosis.</div>
</div>
</div>
<p>Symptoms of MS usually appear in episodic acute periods of worsening (<a href="/wiki/Relapse" title="Relapse">relapses</a>, exacerbations, bouts or attacks), in a gradually-progressive deterioration of neurologic function, or in a combination of both.<sup id="cite_ref-pmid8780061_5-2" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>The most common presentation of MS is the <i><a href="/wiki/Clinically_isolated_syndrome" title="Clinically isolated syndrome">clinically isolated syndrome</a></i> (CIS). In CIS, a patient has an attack suggestive of <a href="/wiki/Demyelination" title="Demyelination" class="mw-redirect">demyelination</a>, but does not fulfill the criteria for multiple sclerosis.<sup id="cite_ref-pmid15847841_7-0" class="reference"><a href="#cite_note-pmid15847841-7" title=""><span>[</span>8<span>]</span></a></sup> Only 30 to 70% of persons experiencing CIS later develop MS.<sup id="cite_ref-pmid15847841_7-1" class="reference"><a href="#cite_note-pmid15847841-7" title=""><span>[</span>8<span>]</span></a></sup> The disease usually presents with sensorial (46% of cases), visual (33%), cerebellar (30%) and motor (26%) symptoms.<sup id="cite_ref-pmid17952303_8-0" class="reference"><a href="#cite_note-pmid17952303-8" title=""><span>[</span>9<span>]</span></a></sup> Many rare initial symptoms have also been reported, including <a href="/wiki/Aphasia" title="Aphasia">aphasia</a>, <a href="/wiki/Psychosis" title="Psychosis">psychosis</a> and <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>.<sup id="cite_ref-pmid16288423_9-0" class="reference"><a href="#cite_note-pmid16288423-9" title=""><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-pmid16631798_10-0" class="reference"><a href="#cite_note-pmid16631798-10" title=""><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-pmid18677330_11-0" class="reference"><a href="#cite_note-pmid18677330-11" title=""><span>[</span>12<span>]</span></a></sup> Patients first seeking medical attention commonly present with multiple symptoms.<sup id="cite_ref-pmid17952303_8-1" class="reference"><a href="#cite_note-pmid17952303-8" title=""><span>[</span>9<span>]</span></a></sup> The initial signs and symptoms of MS are often transient, mild, and self-limited. These signs and symptoms often do not prompt a person to seek medical attention and are sometimes identified only retrospectively once the diagnosis of MS has been made. Cases of MS are sometimes incidentally identified during neurological examinations performed for other causes. Such cases are referred to as <i>subclinical MS</i>.<sup id="cite_ref-pmid18507677_12-0" class="reference"><a href="#cite_note-pmid18507677-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-pmid18202208_13-0" class="reference"><a href="#cite_note-pmid18202208-13" title=""><span>[</span>14<span>]</span></a></sup></p>
<div class="thumb tleft">
<div class="thumbinner" style="width:142px;"><a href="/wiki/File:Optokinetic_nystagmus.gif" class="image" title="Nystagmus, characterised by involuntary eye movements, is one of many symptoms that can appear with MS"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/b/b6/Optokinetic_nystagmus.gif" width="140" height="70" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Optokinetic_nystagmus.gif" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Pathologic_nystagmus" title="Pathologic nystagmus">Nystagmus</a>, characterised by involuntary eye movements, is one of many symptoms that can appear with MS</div>
</div>
</div>
<p>The person with MS can suffer almost any neurological symptom or sign, including changes in sensation (<a href="/wiki/Hypoesthesia" title="Hypoesthesia">hypoesthesia</a> and <a href="/wiki/Paraesthesia" title="Paraesthesia" class="mw-redirect">paraesthesia</a>), muscle weakness, <a href="/wiki/Muscle_spasms" title="Muscle spasms" class="mw-redirect">muscle spasms</a>, or difficulty in moving;<sup id="cite_ref-pmid11374088_14-0" class="reference"><a href="#cite_note-pmid11374088-14" title=""><span>[</span>15<span>]</span></a></sup> difficulties with coordination and balance (<a href="/wiki/Ataxia" title="Ataxia">ataxia</a>);<sup id="cite_ref-pmid11374088_14-1" class="reference"><a href="#cite_note-pmid11374088-14" title=""><span>[</span>15<span>]</span></a></sup> problems in speech (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>) or swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>),<sup id="cite_ref-pmid9894114_15-0" class="reference"><a href="#cite_note-pmid9894114-15" title=""><span>[</span>16<span>]</span></a></sup> visual problems (<a href="/wiki/Pathologic_nystagmus" title="Pathologic nystagmus">nystagmus</a>, <a href="/wiki/Optic_neuritis" title="Optic neuritis">optic neuritis</a>, or <a href="/wiki/Diplopia" title="Diplopia">diplopia</a>),<sup id="cite_ref-pmid17531862_16-0" class="reference"><a href="#cite_note-pmid17531862-16" title=""><span>[</span>17<span>]</span></a></sup> fatigue, <a href="/wiki/Acute_pain" title="Acute pain" class="mw-redirect">acute</a> or <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>,<sup id="cite_ref-pmid18336059_17-0" class="reference"><a href="#cite_note-pmid18336059-17" title=""><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-pmid16417816_18-0" class="reference"><a href="#cite_note-pmid16417816-18" title=""><span>[</span>19<span>]</span></a></sup> and bladder and bowel difficulties.<sup id="cite_ref-pmid16417816_18-1" class="reference"><a href="#cite_note-pmid16417816-18" title=""><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-pmid9413302_19-0" class="reference"><a href="#cite_note-pmid9413302-19" title=""><span>[</span>20<span>]</span></a></sup> <a href="/wiki/Cognitive" title="Cognitive" class="mw-redirect">Cognitive</a> impairment of varying degrees and emotional symptoms of <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a> or <a href="/wiki/Labile_affect" title="Labile affect">unstable mood</a> are also common.<sup id="cite_ref-pmid12858063_20-0" class="reference"><a href="#cite_note-pmid12858063-20" title=""><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-pmid17101907_21-0" class="reference"><a href="#cite_note-pmid17101907-21" title=""><span>[</span>22<span>]</span></a></sup> The main clinical measure of disability progression and symptom severity is the <a href="/wiki/Expanded_Disability_Status_Scale" title="Expanded Disability Status Scale">Expanded Disability Status Scale</a> or EDSS.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p>Multiple sclerosis relapses are often unpredictable, occurring without warning and without obvious inciting factors. Some attacks, however, are preceded by common triggers. Relapses occur more frequently during spring and summer.<sup id="cite_ref-pmid16804331_23-0" class="reference"><a href="#cite_note-pmid16804331-23" title=""><span>[</span>24<span>]</span></a></sup> Infections such as the common cold, influenza, or <a href="/wiki/Gastroenteritis" title="Gastroenteritis">gastroenteritis</a> increase the risk of relapse.<sup id="cite_ref-pmid11960883_24-0" class="reference"><a href="#cite_note-pmid11960883-24" title=""><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-pmid11960885_25-0" class="reference"><a href="#cite_note-pmid11960885-25" title=""><span>[</span>26<span>]</span></a></sup> <a href="/wiki/Stress_(medicine)" title="Stress (medicine)" class="mw-redirect">Stress</a> may also trigger an attack.<sup id="cite_ref-pmid14500435_26-0" class="reference"><a href="#cite_note-pmid14500435-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid16900759_27-0" class="reference"><a href="#cite_note-pmid16900759-27" title=""><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-pmid16900760_28-0" class="reference"><a href="#cite_note-pmid16900760-28" title=""><span>[</span>29<span>]</span></a></sup> Pregnancy may affect susceptibility to relapse, offering protection during the last trimester, for instance. During the first few months after delivery, however, the risk of relapse is increased. Overall, pregnancy does not seem to influence long-term disability.<sup id="cite_ref-pmid8195822_29-0" class="reference"><a href="#cite_note-pmid8195822-29" title=""><span>[</span>30<span>]</span></a></sup> Many potential triggers have been examined and found not to influence MS relapse rates. There is no evidence that vaccination for influenza, <a href="/wiki/Hepatitis_B" title="Hepatitis B">hepatitis B</a>, <a href="/wiki/Varicella" title="Varicella" class="mw-redirect">varicella</a>, <a href="/wiki/Tetanus" title="Tetanus">tetanus</a>, or <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a> increases risk of relapse.<sup id="cite_ref-pmid11172162_30-0" class="reference"><a href="#cite_note-pmid11172162-30" title=""><span>[</span>31<span>]</span></a></sup> Physical trauma does not trigger relapses.<sup id="cite_ref-pmid11205361_31-0" class="reference"><a href="#cite_note-pmid11205361-31" title=""><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-pmid1895121_32-0" class="reference"><a href="#cite_note-pmid1895121-32" title=""><span>[</span>33<span>]</span></a></sup> Exposure to higher than usual ambient temperatures can exacerbate extant symptoms, an effect known as <a href="/wiki/Uhthoff%27s_phenomenon" title="Uhthoff's phenomenon">Uhthoff's phenomenon</a>.<sup id="cite_ref-pmid10603618_33-0" class="reference"><a href="#cite_note-pmid10603618-33" title=""><span>[</span>34<span>]</span></a></sup> Uhthoff's phenomenon is not, however, an established relapse trigger.<sup id="cite_ref-pmid16804331_23-1" class="reference"><a href="#cite_note-pmid16804331-23" title=""><span>[</span>24<span>]</span></a></sup></p>
<p><a name="Disease_subtypes" id="Disease_subtypes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=2" title="Edit section: Disease subtypes">edit</a>]</span> <span class="mw-headline">Disease subtypes</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:302px;"><a href="/wiki/File:Ms_progression_types.svg" class="image" title="Progression of MS subtypes"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/3/3c/Ms_progression_types.svg/300px-Ms_progression_types.svg.png" width="300" height="322" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ms_progression_types.svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Progression of MS subtypes</div>
</div>
</div>
<p>Several subtypes, or patterns of progression, have been described. Subtypes use the past course of the disease in an attempt to <a href="/wiki/Predict" title="Predict" class="mw-redirect">predict</a> the future course. They are important not only for prognosis but also for therapeutic decisions. In 1996 the United States <a href="/wiki/National_Multiple_Sclerosis_Society" title="National Multiple Sclerosis Society">National Multiple Sclerosis Society</a> standardized four subtype definitions: <i>relapsing remitting</i>, <i>secondary progressive</i>, <i>primary progressive</i> and <i>progressive relapsing</i>.<sup id="cite_ref-pmid8780061_5-3" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>The relapsing-remitting subtype is characterized by unpredictable relapses followed by periods of months to years of relative quiet (<a href="/wiki/Remission_(medicine)" title="Remission (medicine)">remission</a>) with no new signs of disease activity. Deficits suffered during attacks may either resolve or leave <a href="/wiki/Sequelae" title="Sequelae" class="mw-redirect">sequelae</a>. This describes the initial course of 85–90% of individuals with MS.<sup id="cite_ref-pmid8780061_5-4" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup> When deficits always resolve between attacks, this is sometimes referred to as <i><a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> MS</i>.<sup id="cite_ref-pmid18219812_34-0" class="reference"><a href="#cite_note-pmid18219812-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<p>Secondary progressive MS describes those with initial relapsing-remitting MS, who then begin to have progressive neurologic decline between acute attacks without any definite periods of remission.<sup id="cite_ref-pmid8780061_5-5" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup> Occasional relapses and minor remissions may appear.<sup id="cite_ref-pmid8780061_5-6" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup> The median time between disease onset and conversion from relapsing-remitting to secondary progressive MS is 19&#160;years.<sup id="cite_ref-pmid16545751_35-0" class="reference"><a href="#cite_note-pmid16545751-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p>The primary progressive subtype describes the approximately 10–15% of individuals who never have remission after their initial MS symptoms.<sup id="cite_ref-pmid17884680_36-0" class="reference"><a href="#cite_note-pmid17884680-36" title=""><span>[</span>37<span>]</span></a></sup> It is characterized by progression of disability from onset, with no, or only occasional and minor, remissions and improvements.<sup id="cite_ref-pmid8780061_5-7" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup> The age of onset for the primary progressive subtype is later than other subtypes.<sup id="cite_ref-pmid17884680_36-1" class="reference"><a href="#cite_note-pmid17884680-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p>Progressive relapsing MS describes those individuals who, from onset, have a steady neurologic decline but also suffer clear superimposed attacks. This is the least common of all subtypes.<sup id="cite_ref-pmid8780061_5-8" class="reference"><a href="#cite_note-pmid8780061-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>Cases with non-standard behavior have also been described. Sometimes referred to as <a href="/wiki/Borderline_forms_of_multiple_sclerosis" title="Borderline forms of multiple sclerosis" class="mw-redirect">borderline forms of multiple sclerosis</a>,<sup id="cite_ref-pmid11787357_37-0" class="reference"><a href="#cite_note-pmid11787357-37" title=""><span>[</span>38<span>]</span></a></sup> these include <a href="/wiki/Devic%27s_disease" title="Devic's disease" class="mw-redirect">Devic's disease</a>, <a href="/wiki/Balo_concentric_sclerosis" title="Balo concentric sclerosis">Balo concentric sclerosis</a>, <a href="/wiki/Schilder%27s_disease" title="Schilder's disease">Schilder's diffuse sclerosis</a> and <a href="/wiki/Marburg_multiple_sclerosis" title="Marburg multiple sclerosis">Marburg multiple sclerosis</a>.<sup id="cite_ref-pmid15727234_38-0" class="reference"><a href="#cite_note-pmid15727234-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-pmid1343820_39-0" class="reference"><a href="#cite_note-pmid1343820-39" title=""><span>[</span>40<span>]</span></a></sup> Multiple sclerosis also behaves differently in children.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup> There is debate whether these are atypical variants of MS or different diseases.<sup id="cite_ref-pmid9229127_41-0" class="reference"><a href="#cite_note-pmid9229127-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Monthly_multiple_sclerosis_MRI.gif" class="image" title="T1-weighted MRI scans (post-contrast) of the same brain slice at monthly intervals. Bright spots indicate active lesions."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/5/5d/Monthly_multiple_sclerosis_MRI.gif" width="180" height="145" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Monthly_multiple_sclerosis_MRI.gif" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
T1-weighted <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a> scans (post-contrast) of the same brain slice at monthly intervals. Bright spots indicate active lesions.</div>
</div>
</div>
<p>Multiple sclerosis can be difficult to <a href="/wiki/Diagnose" title="Diagnose" class="mw-redirect">diagnose</a> since its signs and symptoms may be similar to many other medical problems.<sup id="cite_ref-pmid11794488_42-0" class="reference"><a href="#cite_note-pmid11794488-42" title=""><span>[</span>43<span>]</span></a></sup> Medical organizations have created diagnostic criteria to ease and standardize the diagnostic process for practicing physicians. Historically, the <a href="/w/index.php?title=Schumacher_criteria&amp;action=edit&amp;redlink=1" class="new" title="Schumacher criteria (page does not exist)">Schumacher</a> and <a href="/w/index.php?title=Poser_criteria&amp;action=edit&amp;redlink=1" class="new" title="Poser criteria (page does not exist)">Poser criteria</a> were both popular.<sup id="cite_ref-pmid15177763_43-0" class="reference"><a href="#cite_note-pmid15177763-43" title=""><span>[</span>44<span>]</span></a></sup> Currently, the <a href="/wiki/McDonald_criteria" title="McDonald criteria">McDonald criteria</a> focus on a demonstration with clinical, laboratory and radiologic data of the dissemination of MS lesions in time and space. A diagnosis cannot be made until other possible conditions have been <a href="/wiki/Differential_diagnosis" title="Differential diagnosis">ruled out</a> and there is evidence of demyelinating events separated <a href="/wiki/Anatomy" title="Anatomy">anatomically</a> and in time.<sup id="cite_ref-pmid11456302_44-0" class="reference"><a href="#cite_note-pmid11456302-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p>Clinical data alone may be sufficient for a diagnosis of MS if an individual has suffered separate episodes of neurologic symptoms characteristic of MS.<sup id="cite_ref-pmid11456302_44-1" class="reference"><a href="#cite_note-pmid11456302-44" title=""><span>[</span>45<span>]</span></a></sup> Since some people seek medical attention after only one attack, other testing may hasten and ease the diagnosis. The most commonly used diagnostic tools are <a href="/wiki/Neuroimaging" title="Neuroimaging">neuroimaging</a>, analysis of <a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a> and <a href="/wiki/Evoked_potential" title="Evoked potential">evoked potentials</a>. <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">Magnetic resonance imaging</a> of the brain and spine shows areas of demyelination (lesions or plaques). <a href="/wiki/Gadolinium" title="Gadolinium">Gadolinium</a> can be administered <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenously</a> as a contrast to highlight active plaques and, by elimination, demonstrate the existence of historical lesions not associated with symptoms at the moment of the evaluation.<sup id="cite_ref-pmid11456302_44-2" class="reference"><a href="#cite_note-pmid11456302-44" title=""><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-pmid18256986_45-0" class="reference"><a href="#cite_note-pmid18256986-45" title=""><span>[</span>46<span>]</span></a></sup> Testing of <a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a> obtained from a <a href="/wiki/Lumbar_puncture" title="Lumbar puncture">lumbar puncture</a> can provide evidence of chronic <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> of the central nervous system. The cerebrospinal fluid is tested for <a href="/wiki/Oligoclonal_band" title="Oligoclonal band">oligoclonal bands</a>, which are an inflammation marker found in 75–85% of people with MS.<sup id="cite_ref-pmid11456302_44-3" class="reference"><a href="#cite_note-pmid11456302-44" title=""><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-pmid16945427_46-0" class="reference"><a href="#cite_note-pmid16945427-46" title=""><span>[</span>47<span>]</span></a></sup> The nervous system of a person with MS often responds less actively to stimulation of the <a href="/wiki/Optic_nerve" title="Optic nerve">optic nerve</a> and <a href="/wiki/Sensory_neuron" title="Sensory neuron">sensory nerves</a> due to demyelination of such pathways. These brain responses can be examined using <a href="/wiki/Visual_evoked_potential" title="Visual evoked potential" class="mw-redirect">visual</a> and sensory evoked potentials.<sup id="cite_ref-pmid10802774_47-0" class="reference"><a href="#cite_note-pmid10802774-47" title=""><span>[</span>48<span>]</span></a></sup></p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=4" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Pathophysiology_of_multiple_sclerosis" title="Pathophysiology of multiple sclerosis">Pathophysiology of multiple sclerosis</a></div>
<table class="infobox">
<caption>Structure of a typical neuron</caption>
<tr>
<th style="background-color:#d0d0d0;">Myelin sheath of a healthy neuron</th>
</tr>
<tr style="text-align: center">
<td>
<div style="position: relative;"><a href="/wiki/File:Neuron-no_labels.png" class="image" title="Neuron-no labels.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/b/ba/Neuron-no_labels.png" width="400" height="215" border="0" /></a>
<div style="position: absolute; text-align: center; left:50px; top: 2px;"><a href="/wiki/Dendrite" title="Dendrite">Dendrite</a></div>
<div style="position: absolute; text-align: center; left:135px; top: 60px;"><a href="/wiki/Soma_(biology)" title="Soma (biology)">Soma</a></div>
<div style="position: absolute; text-align: center; left:139px; top: 166px;"><a href="/wiki/Axon" title="Axon">Axon</a></div>
<div style="position: absolute; text-align: center; left:13px; top: 197px;"><a href="/wiki/Cell_nucleus" title="Cell nucleus">Nucleus</a></div>
<div style="position: absolute; text-align: center; left:226px; top: 38px;"><a href="/wiki/Node_of_Ranvier" title="Node of Ranvier" class="mw-redirect">Node of<br />
Ranvier</a></div>
<div style="position: absolute; text-align: center; left:319px; top: 0px;"><a href="/wiki/Axon_terminals" title="Axon terminals" class="mw-redirect">Axon Terminal</a></div>
<div style="position: absolute; text-align: center; left:306px; top: 161px;"><a href="/wiki/Schwann_cell" title="Schwann cell">Schwann cell</a></div>
<div style="position: absolute; text-align: center; left:220px; top: 187px;"><a href="/wiki/Myelin_sheath" title="Myelin sheath" class="mw-redirect">Myelin sheath</a></div>
</div>
</td>
</tr>
</table>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:MS_Demyelinisation_KB_10x.jpg" class="image" title="Demyelinization in MS. On Klüver-Barrera myelin staining, decoloration in the area of the lesion can be appreciated (Original scale 1:100)."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/e4/MS_Demyelinisation_KB_10x.jpg/180px-MS_Demyelinisation_KB_10x.jpg" width="180" height="134" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:MS_Demyelinisation_KB_10x.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Demyelinization in MS. On Klüver-Barrera myelin staining, decoloration in the area of the lesion can be appreciated (Original scale 1:100).</div>
</div>
</div>
<p><a name="MS_as_an_autoimmunological_disease" id="MS_as_an_autoimmunological_disease"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=5" title="Edit section: MS as an autoimmunological disease">edit</a>]</span> <span class="mw-headline">MS as an autoimmunological disease</span></h3>
<p>MS is currently believed to be an immune-mediated disorder with an initial trigger, which may have a viral etiology,<sup id="cite_ref-pmid11955556_0-5" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> although this concept has been debated for years and some still oppose it. Damage is believed to be caused by the patient's own immune system. The immune system attacks the nervous system, possibly as a result of exposure to a molecule with a similar structure to one of its own.<sup id="cite_ref-pmid11955556_0-6" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p><a name="Lesions" id="Lesions"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=6" title="Edit section: Lesions">edit</a>]</span> <span class="mw-headline">Lesions</span></h3>
<p>The name <i>multiple sclerosis</i> refers to the scars (scleroses – better known as plaques or lesions) that form in the nervous system. MS lesions most commonly involve <a href="/wiki/White_matter" title="White matter">white matter</a> areas close to the <a href="/wiki/Ventricular_system" title="Ventricular system">ventricles</a> of the <a href="/wiki/Cerebellum" title="Cerebellum">cerebellum</a>, <a href="/wiki/Brain_stem" title="Brain stem">brain stem</a>, <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a> and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>; and the <a href="/wiki/Optic_nerve" title="Optic nerve">optic nerve</a>. The function of white matter cells is to carry signals between <a href="/wiki/Grey_matter" title="Grey matter">grey matter</a> areas, where the processing is done, and the rest of the body. The <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">peripheral nervous system</a> is rarely involved.<sup id="cite_ref-pmid11955556_0-7" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>More specifically, MS destroys <a href="/wiki/Oligodendrocyte" title="Oligodendrocyte">oligodendrocytes</a>, the cells responsible for creating and maintaining a fatty layer—known as the <a href="/wiki/Myelin" title="Myelin">myelin</a> sheath—which helps the neurons carry <a href="/wiki/Electricity" title="Electricity">electrical</a> <a href="/wiki/Signal_(biology)" title="Signal (biology)">signals</a>.<sup id="cite_ref-pmid11955556_0-8" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> MS results in a thinning or complete loss of myelin and, as the disease advances, the cutting (transection) of the neuron's extensions or <a href="/wiki/Axons" title="Axons" class="mw-redirect">axons</a>.<sup id="cite_ref-pmid17606882_48-0" class="reference"><a href="#cite_note-pmid17606882-48" title=""><span>[</span>49<span>]</span></a></sup> When the myelin is lost, a neuron can no longer effectively conduct <a href="/wiki/Action_potential" title="Action potential">electrical signals</a>.<sup id="cite_ref-pmid11955556_0-9" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> A repair process, called <a href="/wiki/Remyelination" title="Remyelination">remyelination</a>, takes place in early phases of the disease, but the oligodendrocytes cannot completely rebuild the cell's myelin sheath.<sup id="cite_ref-pmid17531860_49-0" class="reference"><a href="#cite_note-pmid17531860-49" title=""><span>[</span>50<span>]</span></a></sup> Repeated attacks lead to successively fewer effective remyelinations, until a scar-like plaque is built up around the damaged axons.<sup id="cite_ref-pmid17531860_49-1" class="reference"><a href="#cite_note-pmid17531860-49" title=""><span>[</span>50<span>]</span></a></sup> <a href="/wiki/Pathophysiology_of_multiple_sclerosis#Demyelination_patterns" title="Pathophysiology of multiple sclerosis">Four different lesion patterns</a> have been described.<sup id="cite_ref-pmid10852536_50-0" class="reference"><a href="#cite_note-pmid10852536-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<p><a name="Inflammation" id="Inflammation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=7" title="Edit section: Inflammation">edit</a>]</span> <span class="mw-headline">Inflammation</span></h3>
<p>Apart from demyelination, the other pathologic hallmark of the disease is inflammation. According to a strictly immunological explanation of MS, the inflammatory process is caused by <a href="/wiki/T_cell" title="T cell">T cells</a>, a kind of <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocyte</a>. Lymphocytes are cells that play an important role in the body's defenses.<sup id="cite_ref-pmid11955556_0-10" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> In MS, T cells gain entry into the brain via the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier" class="mw-redirect">blood–brain barrier</a>, a <a href="/wiki/Capillary" title="Capillary">capillary</a> system that should prevent entrance of T cells into the nervous system.<sup id="cite_ref-pmid11955556_0-11" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> The blood–brain barrier is normally not permeable to these types of cells, unless triggered by infection or a virus, which decreases the integrity of the <a href="/wiki/Tight_junction" title="Tight junction">tight junctions</a> forming the barrier.<sup id="cite_ref-pmid11955556_0-12" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> When the blood–brain barrier regains its integrity, usually after infection or virus has cleared, the T cells are trapped inside the brain.<sup id="cite_ref-pmid11955556_0-13" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> The T cells recognize myelin as foreign and attack it as if it were an invading virus. This triggers inflammatory processes, stimulating other immune cells and soluble factors like <a href="/wiki/Cytokine" title="Cytokine">cytokines</a> and antibodies. Leaks form in the blood–brain barrier, which in turn cause a number of other damaging effects such as <a href="/wiki/Edema" title="Edema">swelling</a>, activation of <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a>, and more activation of cytokines and other destructive proteins.<sup id="cite_ref-pmid11955556_0-14" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=8" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:MS_Risk.jpg" class="image" title="World map showing that risk (incidence) for MS increases with distance from the equator"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/7/7d/MS_Risk.jpg/180px-MS_Risk.jpg" width="180" height="110" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:MS_Risk.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
World map showing that risk (incidence) for MS increases with distance from the equator</div>
</div>
</div>
<p>Two main measures are used in <a href="/wiki/Epidemiology" title="Epidemiology">epidemiological</a> studies: incidence and prevalence. <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">Incidence</a> is the number of new cases per unit of person–time at risk (usually number of new cases per thousand person–years); while <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> is the total number of cases of the disease in the population at a given time. Prevalence is known to depend not only on incidence, but also on survival rate and migrations of affected people. MS has a prevalence that ranges between 2 and 150 per 100,000 depending on the country or specific population.<sup id="cite_ref-pmid11603614_2-1" class="reference"><a href="#cite_note-pmid11603614-2" title=""><span>[</span>3<span>]</span></a></sup> Studies on populational and geographical patterns of epidemiological measures have been very common in MS,<sup id="cite_ref-pmid8269393_51-0" class="reference"><a href="#cite_note-pmid8269393-51" title=""><span>[</span>52<span>]</span></a></sup> and have led to the proposal of different <a href="/wiki/Etiology" title="Etiology">etiological</a> (causal) theories.<sup id="cite_ref-pmid8269393_51-1" class="reference"><a href="#cite_note-pmid8269393-51" title=""><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-pmid15556803_52-0" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17444504_4-1" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid17492755_53-0" class="reference"><a href="#cite_note-pmid17492755-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p>MS usually appears in adults in their thirties,<sup id="cite_ref-pmid18637953_1-1" class="reference"><a href="#cite_note-pmid18637953-1" title=""><span>[</span>2<span>]</span></a></sup> but it can also appear in children,<sup id="cite_ref-pmid11582940_54-0" class="reference"><a href="#cite_note-pmid11582940-54" title=""><span>[</span>55<span>]</span></a></sup> and the primary progressive subtype is more common in people in their fifties.<sup id="cite_ref-pmid17884680_36-2" class="reference"><a href="#cite_note-pmid17884680-36" title=""><span>[</span>37<span>]</span></a></sup> As with many autoimmune disorders, the disease is more common in women, and the trend may be increasing.<sup id="cite_ref-pmid8269393_51-2" class="reference"><a href="#cite_note-pmid8269393-51" title=""><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-pmid18606967_55-0" class="reference"><a href="#cite_note-pmid18606967-55" title=""><span>[</span>56<span>]</span></a></sup> In children, the sex ratio may reach three females for each male.<sup id="cite_ref-pmid11582940_54-1" class="reference"><a href="#cite_note-pmid11582940-54" title=""><span>[</span>55<span>]</span></a></sup> In people over fifty, MS affects males and females almost equally.<sup id="cite_ref-pmid17884680_36-3" class="reference"><a href="#cite_note-pmid17884680-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:142px;"><a href="/wiki/File:Lapland_Mother_NGM-v31-p556.jpg" class="image" title="Ethnic groups such as the Samis have a reduced risk of MS, probably due to genetic factors."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/83/Lapland_Mother_NGM-v31-p556.jpg/140px-Lapland_Mother_NGM-v31-p556.jpg" width="140" height="200" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Lapland_Mother_NGM-v31-p556.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Ethnic groups such as the Samis have a reduced risk of MS, probably due to genetic factors.</div>
</div>
</div>
<p>There is a north-to-south gradient in the northern hemisphere and a south-to-north gradient in the southern hemisphere, with MS being much less common in people living near the <a href="/wiki/Equator" title="Equator">equator</a>.<sup id="cite_ref-pmid18606967_55-1" class="reference"><a href="#cite_note-pmid18606967-55" title=""><span>[</span>56<span>]</span></a></sup> <a href="/wiki/Climate" title="Climate">Climate</a>, <a href="/wiki/Sunlight" title="Sunlight">sunlight</a> and intake of <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> have been investigated as possible causes of the disease that could explain this latitude gradient.<sup id="cite_ref-pmid17492755_53-1" class="reference"><a href="#cite_note-pmid17492755-53" title=""><span>[</span>54<span>]</span></a></sup> However, there are important exceptions to the north-south pattern such as incidence and prevalence in the <a href="/wiki/Canary_Islands" title="Canary Islands">Canary Islands</a><sup id="cite_ref-pmid15459512_56-0" class="reference"><a href="#cite_note-pmid15459512-56" title=""><span>[</span>57<span>]</span></a></sup> and changes in prevalence rates over time;<sup id="cite_ref-pmid11603620_57-0" class="reference"><a href="#cite_note-pmid11603620-57" title=""><span>[</span>58<span>]</span></a></sup> in general, this trend might be disappearing.<sup id="cite_ref-pmid18606967_55-2" class="reference"><a href="#cite_note-pmid18606967-55" title=""><span>[</span>56<span>]</span></a></sup> This indicates that other factors such as environment or genetics have to be taken into account to explain the origin of MS.<sup id="cite_ref-pmid11603620_57-1" class="reference"><a href="#cite_note-pmid11603620-57" title=""><span>[</span>58<span>]</span></a></sup></p>
<p>Environmental factors during childhood may play an important role in the development of MS later in life. Several studies of migrants show that if migration occurs before the age of fifteen, the migrant acquires the new region's susceptibility to MS. If migration takes place after age fifteen, the migrant retains the susceptibility of his home country.<sup id="cite_ref-pmid15556803_52-1" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup> However, the age–geographical risk for developing multiple sclerosis may span a larger timescale.<sup id="cite_ref-pmid10775541_58-0" class="reference"><a href="#cite_note-pmid10775541-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p>Even in regions where MS is common, some ethnic groups are at low risk of developing the disease, including the <a href="/wiki/Sami_people" title="Sami people">Samis</a>, <a href="/wiki/Turkmen_people" title="Turkmen people">Turkmen</a>, <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Amerindians</a>, Canadian <a href="/wiki/Hutterite" title="Hutterite">Hutterites</a>, Africans, and New Zealand <a href="/wiki/M%C4%81ori" title="Māori">Maoris</a>.<sup id="cite_ref-pmid15556803_52-2" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup> Scotland appears to have one of the highest rates of MS in the world.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup></p>
<p><a name="Causes" id="Causes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=9" title="Edit section: Causes">edit</a>]</span> <span class="mw-headline">Causes</span></h2>
<p>Epidemiological studies of MS have provided hints on possible causes for the disease. Various theories try to combine the known data into plausible explanations, but none has proved definitive. MS likely occurs as a result of some combination of both environmental and genetic factors.</p>
<p><a name="Genetic_factors" id="Genetic_factors"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=10" title="Edit section: Genetic factors">edit</a>]</span> <span class="mw-headline">Genetic factors</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:142px;"><a href="/wiki/File:HLA_complex1.JPG" class="image" title="HLA region of Chromosome&#160;6. Changes in this area increase the probability of suffering MS."><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/4/4f/HLA_complex1.JPG/140px-HLA_complex1.JPG" width="140" height="284" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:HLA_complex1.JPG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
HLA region of Chromosome&#160;6. Changes in this area increase the probability of suffering MS.</div>
</div>
</div>
<p>MS is not considered a <a href="/wiki/Hereditary" title="Hereditary" class="mw-redirect">hereditary</a> disease. However, a number of <a href="/wiki/Genetics" title="Genetics">genetic variations</a> have been shown to increase the risk of developing the disease.<sup id="cite_ref-pmid14747002_60-0" class="reference"><a href="#cite_note-pmid14747002-60" title=""><span>[</span>61<span>]</span></a></sup></p>
<p>The risk of acquiring MS is higher in relatives of a person with the disease than in the general population, especially in the case of <a href="/wiki/Sibling" title="Sibling">siblings</a>, parents, and children.<sup id="cite_ref-pmid11955556_0-15" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup> In the case of monozygotic <a href="/wiki/Twin" title="Twin">twins</a>, concordance occurs only in about 35% of cases, and half-siblings have a lower risk than full siblings, indicating a <a href="/wiki/Quantitative_trait_locus" title="Quantitative trait locus">polygenic</a> origin.<sup id="cite_ref-pmid11955556_0-16" class="reference"><a href="#cite_note-pmid11955556-0" title=""><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid8656905_61-0" class="reference"><a href="#cite_note-pmid8656905-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p>Apart from familial studies, specific <a href="/wiki/Gene" title="Gene">genes</a> have been linked with MS. Differences in the <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">human leukocyte antigen</a> (HLA) system—a group of genes in <a href="/wiki/Chromosome" title="Chromosome">chromosome</a> <a href="/wiki/Chromosome_6_(human)" title="Chromosome 6 (human)">6</a> that serves as the <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> in humans—increase the probability of suffering MS.<sup id="cite_ref-pmid18461312_62-0" class="reference"><a href="#cite_note-pmid18461312-62" title=""><span>[</span>63<span>]</span></a></sup> Two other genes have been shown to be linked to MS. These are the <a href="/wiki/IL-2_receptor" title="IL-2 receptor">IL2RA</a> and the <a href="/wiki/IL-7_receptor" title="IL-7 receptor" class="mw-redirect">IL7RA</a>, subunits of the <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a> for <a href="/wiki/Interleukin_2" title="Interleukin 2">interleukin 2</a> and <a href="/wiki/Interleukin_7" title="Interleukin 7">interleukin 7</a> respectively.<sup id="cite_ref-pmid17660530_63-0" class="reference"><a href="#cite_note-pmid17660530-63" title=""><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-pmid18354419_64-0" class="reference"><a href="#cite_note-pmid18354419-64" title=""><span>[</span>65<span>]</span></a></sup> The HLA complex is involved in antigen presentation, which is crucial to the functioning of the <a href="/wiki/Immune_system" title="Immune system">immune system</a>, while mutations in the IL2 and IL7 receptor genes were already known to be associated with <a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">diabetes</a> and other <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmune</a> conditions, supporting the notion that MS is an autoimmune disease.<sup id="cite_ref-pmid17162361_65-0" class="reference"><a href="#cite_note-pmid17162361-65" title=""><span>[</span>66<span>]</span></a></sup><sup id="cite_ref-pmid18461312_62-1" class="reference"><a href="#cite_note-pmid18461312-62" title=""><span>[</span>63<span>]</span></a></sup><sup id="cite_ref-pmid18779574_66-0" class="reference"><a href="#cite_note-pmid18779574-66" title=""><span>[</span>67<span>]</span></a></sup> The gene encoding kinesin <i><a href="/wiki/KIF1B" title="KIF1B">KIF1B</a></i> is the first neuronal expressed gene demonstrated to enhance the risk for the disease.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67" title=""><span>[</span>68<span>]</span></a></sup> Other studies have linked genes in <a href="/wiki/Chromosome_5_(human)" title="Chromosome 5 (human)">chromosome 5</a> with the disease.<sup id="cite_ref-pmid16099057_68-0" class="reference"><a href="#cite_note-pmid16099057-68" title=""><span>[</span>69<span>]</span></a></sup></p>
<p><a name="Infectious_cause" id="Infectious_cause"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=11" title="Edit section: Infectious cause">edit</a>]</span> <span class="mw-headline">Infectious cause</span></h3>
<p>Genetic susceptibility can explain some of the geographic and epidemiological variations in MS incidence, like the high appearance of the disease among some families or the risk decline with genetic distance, but does not account for other phenomena, such as the changes in risk that occur with migration at an early age.<sup id="cite_ref-pmid17444504_4-2" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>An explanation for this epidemiology finding could be that some kind of infection, produced by a widespread microbe rather than a rare pathogen, is the origin of the disease.<sup id="cite_ref-pmid17444504_4-3" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup> Different hypotheses have elaborated on the mechanism by which this may occur. The <i>hygiene hypothesis</i> proposes that exposure to several infectious agents early in life is protective against MS. MS would be an autoimmune reaction triggered in susceptible individuals by multiple infective <a href="/wiki/Microorganism" title="Microorganism">microorganisms</a>, with risk increasing with age at infection.<sup id="cite_ref-pmid17444504_4-4" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid5910580_69-0" class="reference"><a href="#cite_note-pmid5910580-69" title=""><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-pmid17315205_70-0" class="reference"><a href="#cite_note-pmid17315205-70" title=""><span>[</span>71<span>]</span></a></sup> The <i>prevalence hypothesis</i> proposes that the disease is due to a <a href="/wiki/Pathogen" title="Pathogen">pathogen</a> more common in regions of high MS prevalence. This pathogen is very common, causing in most individuals an <a href="/wiki/Asymptomatic" title="Asymptomatic" class="mw-redirect">asymptomatic</a> persistent infection. Only in a few cases, and after many years since the original infection, does it bring demyelination.<sup id="cite_ref-pmid17444504_4-5" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid8269393_51-3" class="reference"><a href="#cite_note-pmid8269393-51" title=""><span>[</span>52<span>]</span></a></sup> The hygiene hypothesis has received more support than the prevalence hypothesis.<sup id="cite_ref-pmid17444504_4-6" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>Evidence for viruses as a cause includes the presence of oligoclonal bands in the brain and cerebrospinal fluid of most patients, the association of several viruses with human demyelinating <a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">encephalomyelitis</a>, and induction of demyelination in animals through viral infection.<sup id="cite_ref-pmid15721830_71-0" class="reference"><a href="#cite_note-pmid15721830-71" title=""><span>[</span>72<span>]</span></a></sup> <a href="/wiki/Human_herpesvirus" title="Human herpesvirus" class="mw-redirect">Human herpesviruses</a> are a candidate group of viruses linked to MS;<sup id="cite_ref-pmid17686342_72-0" class="reference"><a href="#cite_note-pmid17686342-72" title=""><span>[</span>73<span>]</span></a></sup> <a href="/wiki/Varicella_zoster_virus" title="Varicella zoster virus"><i>Varicella zoster</i> virus</a> has been found at high levels in the cerebrospinal fluid of MS patients,<sup id="cite_ref-pmid18306233_73-0" class="reference"><a href="#cite_note-pmid18306233-73" title=""><span>[</span>74<span>]</span></a></sup> but the most reproduced finding is the reduced risk of having the disease in those who have never been infected by the <a href="/wiki/Epstein-Barr" title="Epstein-Barr" class="mw-redirect">Epstein-Barr</a> virus.<sup id="cite_ref-pmid17444504_4-7" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid17459939_74-0" class="reference"><a href="#cite_note-pmid17459939-74" title=""><span>[</span>75<span>]</span></a></sup> This goes against the hygiene hypothesis, since the non-infected have probably experienced a more hygienic upbringing.<sup id="cite_ref-pmid17444504_4-8" class="reference"><a href="#cite_note-pmid17444504-4" title=""><span>[</span>5<span>]</span></a></sup> Other agents that have also been related with MS are human <a href="/wiki/Endogenous_retrovirus" title="Endogenous retrovirus">endogenous retroviruses</a> and <i><a href="/wiki/Chlamydia_pneumoniae" title="Chlamydia pneumoniae" class="mw-redirect">Chlamydia pneumoniae</a></i>.<sup id="cite_ref-pmid11601494_75-0" class="reference"><a href="#cite_note-pmid11601494-75" title=""><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-pmid16635422_76-0" class="reference"><a href="#cite_note-pmid16635422-76" title=""><span>[</span>77<span>]</span></a></sup><sup id="cite_ref-pmid11342681_77-0" class="reference"><a href="#cite_note-pmid11342681-77" title=""><span>[</span>78<span>]</span></a></sup></p>
<p><a name="Non-infectious_environmental_risk_factors" id="Non-infectious_environmental_risk_factors"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=12" title="Edit section: Non-infectious environmental risk factors">edit</a>]</span> <span class="mw-headline">Non-infectious environmental risk factors</span></h3>
<p>MS is more common in people who live farther from the equator. Decreased sunlight exposure has been linked with a higher risk of MS.<sup id="cite_ref-pmid15556803_52-3" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17646631_78-0" class="reference"><a href="#cite_note-pmid17646631-78" title=""><span>[</span>79<span>]</span></a></sup><sup id="cite_ref-pmid12907484_79-0" class="reference"><a href="#cite_note-pmid12907484-79" title=""><span>[</span>80<span>]</span></a></sup> Decreased <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> production and intake has been the main biological mechanism used to explain the higher risk among those less exposed to sun.<sup id="cite_ref-pmid15556803_52-4" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17492755_53-2" class="reference"><a href="#cite_note-pmid17492755-53" title=""><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-pmid17179460_80-0" class="reference"><a href="#cite_note-pmid17179460-80" title=""><span>[</span>81<span>]</span></a></sup></p>
<p>Severe <a href="/wiki/Stress_(biological)" title="Stress (biological)">stress</a> may also be a risk factor although evidence is weak;<sup id="cite_ref-pmid15556803_52-5" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup> parents who lost a child unexpectedly were more likely to develop MS than parents who had not.<sup id="cite_ref-pmid15007121_81-0" class="reference"><a href="#cite_note-pmid15007121-81" title=""><span>[</span>82<span>]</span></a></sup> <a href="/wiki/Tobacco_smoking" title="Tobacco smoking">Smoking</a> has also been shown to be an independent risk factor for developing MS.<sup id="cite_ref-pmid14581658_82-0" class="reference"><a href="#cite_note-pmid14581658-82" title=""><span>[</span>83<span>]</span></a></sup><sup id="cite_ref-pmid17492755_53-3" class="reference"><a href="#cite_note-pmid17492755-53" title=""><span>[</span>54<span>]</span></a></sup> Association with occupational exposures and <a href="/wiki/Toxin" title="Toxin">toxins</a>—mainly <a href="/wiki/Solvent" title="Solvent">solvents</a>—has been evaluated, but no clear conclusions have been reached.<sup id="cite_ref-pmid15556803_52-6" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup> <a href="/wiki/Vaccin" title="Vaccin" class="mw-redirect">Vaccinations</a> were also considered as causal factors for the disease; however, most studies show no association between MS and vaccines.<sup id="cite_ref-pmid15556803_52-7" class="reference"><a href="#cite_note-pmid15556803-52" title=""><span>[</span>53<span>]</span></a></sup></p>
<p><a href="/wiki/Gout" title="Gout">Gout</a> occurs less than would statistically be expected in people with MS, and low levels of <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> have been found in MS patients as compared to normal individuals. This led to the theory that uric acid, which can protect against <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a> from substances such as <a href="/wiki/Peroxynitrite" title="Peroxynitrite">peroxynitrite</a>, protects against MS, although its exact importance remains unknown.<sup id="cite_ref-pmid16687059_83-0" class="reference"><a href="#cite_note-pmid16687059-83" title=""><span>[</span>84<span>]</span></a></sup><sup id="cite_ref-pmid18219824_84-0" class="reference"><a href="#cite_note-pmid18219824-84" title=""><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-pmid15493114_85-0" class="reference"><a href="#cite_note-pmid15493114-85" title=""><span>[</span>86<span>]</span></a></sup> Several other possible risk factors, such as <a href="/wiki/Diet" title="Diet">diet</a> and <a href="/wiki/Hormone" title="Hormone">hormone</a> intake, have been investigated; however, more evidence is needed to confirm or refute their relation with the disease.<sup id="cite_ref-pmid17492755_53-4" class="reference"><a href="#cite_note-pmid17492755-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p>Although some of these risk factors, including infection, are partly modifiable, only further research—especially clinical trials—will reveal whether their elimination can help prevent MS.<sup id="cite_ref-pmid18256984_86-0" class="reference"><a href="#cite_note-pmid18256984-86" title=""><span>[</span>87<span>]</span></a></sup></p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=13" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Treatment_of_multiple_sclerosis" title="Treatment of multiple sclerosis">Treatment of multiple sclerosis</a></div>
<p>Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS have several <a href="/wiki/Adverse_effect_(medicine)" title="Adverse effect (medicine)" class="mw-redirect">adverse effects</a>. <a href="/wiki/Alternative_medicine" title="Alternative medicine">Alternative treatments</a> are pursued by some patients, despite the shortage of supporting, comparable, replicated scientific study.</p>
<p><a name="Management_of_acute_attacks" id="Management_of_acute_attacks"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=14" title="Edit section: Management of acute attacks">edit</a>]</span> <span class="mw-headline">Management of acute attacks</span></h3>
<p>During symptomatic attacks, administration of high doses of <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous</a> <a href="/wiki/Corticosteroid" title="Corticosteroid">corticosteroids</a>, such as <a href="/wiki/Methylprednisolone" title="Methylprednisolone">methylprednisolone</a>,<sup id="cite_ref-87" class="reference"><a href="#cite_note-87" title=""><span>[</span>88<span>]</span></a></sup><sup id="cite_ref-88" class="reference"><a href="#cite_note-88" title=""><span>[</span>89<span>]</span></a></sup> is the routine therapy for acute relapses. The aim of this kind of treatment is to end the attack sooner and leave fewer lasting deficits in the patient. Although generally effective in the short term for relieving symptoms, corticosteroid treatments do not appear to have a significant impact on long-term recovery.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89" title=""><span>[</span>90<span>]</span></a></sup> Potential side effects include osteoporosis<sup id="cite_ref-90" class="reference"><a href="#cite_note-90" title=""><span>[</span>91<span>]</span></a></sup> and impaired memory, the latter being reversible.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91" title=""><span>[</span>92<span>]</span></a></sup></p>
<p><a name="Disease-modifying_treatments" id="Disease-modifying_treatments"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=15" title="Edit section: Disease-modifying treatments">edit</a>]</span> <span class="mw-headline">Disease-modifying treatments</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Injection_23.JPG" class="image" title="Disease-modifying treatments are expensive and most of these require frequent (up-to-daily) injections. Others require IV infusions at 1–3 month intervals."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/fb/Injection_23.JPG/180px-Injection_23.JPG" width="180" height="135" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Injection_23.JPG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Disease-modifying treatments are expensive and most of these require frequent (up-to-daily) injections. Others require IV infusions at 1–3 month intervals.</div>
</div>
</div>
<p>The earliest clinical presentation of relapsing-remitting MS (RRMS) is the clinically isolated syndrome (CIS). Several studies have shown that treatment with <a href="/wiki/Interferon" title="Interferon">interferons</a> during an initial attack can decrease the chance that a patient will develop clinical MS.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92" title=""><span>[</span>93<span>]</span></a></sup><sup id="cite_ref-93" class="reference"><a href="#cite_note-93" title=""><span>[</span>94<span>]</span></a></sup><sup id="cite_ref-pmid17679016_94-0" class="reference"><a href="#cite_note-pmid17679016-94" title=""><span>[</span>95<span>]</span></a></sup></p>
<p>As of 2007, six disease-modifying treatments have been approved by regulatory agencies of different countries for RRMS. Three are interferons: two formulations of <a href="/wiki/Interferon_beta-1a" title="Interferon beta-1a">interferon beta-1a</a> (trade names <i>Avonex</i>, <i><a href="/wiki/CinnoVex" title="CinnoVex">CinnoVex</a></i>, <i><a href="/wiki/ReciGen" title="ReciGen">ReciGen</a></i> and <i>Rebif</i>) and one of <a href="/wiki/Interferon_beta-1b" title="Interferon beta-1b">interferon beta-1b</a> (U.S. trade name <i>Betaseron</i>, in Europe and Japan <i>Betaferon</i>). A fourth medication is <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">glatiramer acetate</a> (<i>Copaxone</i>). The fifth medication, <a href="/wiki/Mitoxantrone" title="Mitoxantrone">mitoxantrone</a>, is an <a href="/wiki/Immunosuppressant" title="Immunosuppressant">immunosuppressant</a> also used in <a href="/wiki/Chemotherapy" title="Chemotherapy">cancer chemotherapy</a>, approved only in the USA and largely for secondary progressive MS. The sixth is <a href="/wiki/Natalizumab" title="Natalizumab">natalizumab</a> (marketed as <i>Tysabri</i>). All six medications are modestly effective at decreasing the number of attacks and slowing progression to disability, although their efficacy rates differ, and studies of their long-term effects are still lacking.<sup id="cite_ref-pmid17627671_95-0" class="reference"><a href="#cite_note-pmid17627671-95" title=""><span>[</span>96<span>]</span></a></sup><sup id="cite_ref-pmid14974077_96-0" class="reference"><a href="#cite_note-pmid14974077-96" title=""><span>[</span>97<span>]</span></a></sup><sup id="cite_ref-pmid11687131_97-0" class="reference"><a href="#cite_note-pmid11687131-97" title=""><span>[</span>98<span>]</span></a></sup><sup id="cite_ref-pmid16235298_98-0" class="reference"><a href="#cite_note-pmid16235298-98" title=""><span>[</span>99<span>]</span></a></sup> Comparisons between immunomodulators (all but mitoxantrone) show that the most effective is natalizumab, both in terms of relapse rate reduction and halting disability progression;<sup id="cite_ref-pmid17350652_99-0" class="reference"><a href="#cite_note-pmid17350652-99" title=""><span>[</span>100<span>]</span></a></sup> it has also been shown to reduce the severity of MS.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100" title=""><span>[</span>101<span>]</span></a></sup> Mitoxantrone may be the most effective of them all;<sup id="cite_ref-101" class="reference"><a href="#cite_note-101" title=""><span>[</span>102<span>]</span></a></sup> however, it is generally not considered as a long-term therapy, as its use is limited by severe <a href="/wiki/Cardiotoxicity" title="Cardiotoxicity">cardiotoxicity</a>.<sup id="cite_ref-pmid16503747_102-0" class="reference"><a href="#cite_note-pmid16503747-102" title=""><span>[</span>103<span>]</span></a></sup></p>
<p>The interferons and glatiramer acetate are delivered by frequent injections, varying from once-per-day for glatiramer acetate to once-per-week (but intra-muscular) for <i><a href="/wiki/Avonex" title="Avonex" class="mw-redirect">Avonex</a></i>. <a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a> and mitoxantrone are given by IV infusion at monthly intervals.</p>
<p>Treatment of progressive MS is more difficult than relapsing-remitting MS. Mitoxantrone has shown positive effects in patients with secondary progressive and progressive relapsing courses. It is moderately effective in reducing the progression of the disease and the frequency of relapses in patients in short-term follow-up.<sup id="cite_ref-pmid16235298_98-1" class="reference"><a href="#cite_note-pmid16235298-98" title=""><span>[</span>99<span>]</span></a></sup> No treatment has been proven to modify the course of primary progressive MS.<sup id="cite_ref-pmid15907149_103-0" class="reference"><a href="#cite_note-pmid15907149-103" title=""><span>[</span>104<span>]</span></a></sup></p>
<p>As with any medical treatment, these treatments have several adverse effects. One of the most common is irritation at the injection site for glatiramer acetate and the interferon treatments. Over time, a visible dent at the injection site, due to the local destruction of fat tissue, known as <a href="/wiki/Lipoatrophy" title="Lipoatrophy">lipoatrophy</a>, may develop. Interferons produce symptoms similar to influenza;<sup id="cite_ref-pmid17131933_104-0" class="reference"><a href="#cite_note-pmid17131933-104" title=""><span>[</span>105<span>]</span></a></sup> some patients taking glatiramer experience a post-injection reaction manifested by flushing, chest tightness, heart palpitations, breathlessness, and anxiety, which usually lasts less than thirty minutes.<sup id="cite_ref-pmid14974077_96-1" class="reference"><a href="#cite_note-pmid14974077-96" title=""><span>[</span>97<span>]</span></a></sup> More dangerous are <a href="/wiki/Hepatotoxicity" title="Hepatotoxicity">liver damage</a> from interferons and mitoxantrone,<sup id="cite_ref-105" class="reference"><a href="#cite_note-105" title=""><span>[</span>106<span>]</span></a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106" title=""><span>[</span>107<span>]</span></a></sup><sup id="cite_ref-107" class="reference"><a href="#cite_note-107" title=""><span>[</span>108<span>]</span></a></sup><sup id="cite_ref-108" class="reference"><a href="#cite_note-108" title=""><span>[</span>109<span>]</span></a></sup><sup id="cite_ref-pmid16750460_109-0" class="reference"><a href="#cite_note-pmid16750460-109" title=""><span>[</span>110<span>]</span></a></sup> the immunosuppressive effects and cardiac toxicity of the latter;<sup id="cite_ref-pmid16750460_109-1" class="reference"><a href="#cite_note-pmid16750460-109" title=""><span>[</span>110<span>]</span></a></sup> and the putative link between natalizumab and some cases of <a href="/wiki/Progressive_multifocal_leukoencephalopathy" title="Progressive multifocal leukoencephalopathy">progressive multifocal leukoencephalopathy</a>.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110" title=""><span>[</span>111<span>]</span></a></sup><sup id="cite_ref-111" class="reference"><a href="#cite_note-111" title=""><span>[</span>112<span>]</span></a></sup><sup id="cite_ref-WSJ08_112-0" class="reference"><a href="#cite_note-WSJ08-112" title=""><span>[</span>113<span>]</span></a></sup></p>
<p><a name="Management_of_the_effects_of_MS" id="Management_of_the_effects_of_MS"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=16" title="Edit section: Management of the effects of MS">edit</a>]</span> <span class="mw-headline">Management of the effects of MS</span></h3>
<p>Disease-modifying treatments reduce the progression rate of the disease, but do not stop it. As multiple sclerosis progresses, the symptomatology tends to increase. The disease is associated with a variety of symptoms and functional deficits that result in a range of progressive impairments and <a href="/wiki/Disability" title="Disability">disability</a>. Management of these deficits is therefore very important. Both drug therapy and <a href="/wiki/Neurorehabilitation" title="Neurorehabilitation">neurorehabilitation</a> have shown to ease the burden of some symptoms, though neither influences disease progression.<sup id="cite_ref-pmid16168933_113-0" class="reference"><a href="#cite_note-pmid16168933-113" title=""><span>[</span>114<span>]</span></a></sup> As for any patient with neurologic deficits, a <a href="/wiki/Multidisciplinary" title="Multidisciplinary" class="mw-redirect">multidisciplinary</a> approach is key to limiting and overcoming disability; however, there are particular difficulties in specifying a ‘core team’ because people with MS may need help from almost any health profession or service at some point.<sup id="cite_ref-isbn_.3D_1_86016_182_0_114-0" class="reference"><a href="#cite_note-isbn_.3D_1_86016_182_0-114" title=""><span>[</span>115<span>]</span></a></sup> Similarly, for each symptom there are different treatment options. Treatments should therefore be individualized depending both on the patient and the physician.</p>
<p><a name="Alternative_treatments" id="Alternative_treatments"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=17" title="Edit section: Alternative treatments">edit</a>]</span> <span class="mw-headline">Alternative treatments</span></h3>
<p>As with most chronic diseases, alternative treatments are pursued by some patients, despite the shortage of supporting, comparable, replicated scientific study. Examples are <a href="/wiki/Diet_(Multiple_Sclerosis)" title="Diet (Multiple Sclerosis)" class="mw-redirect">dietary</a> regimens,<sup id="cite_ref-pmid17253500_115-0" class="reference"><a href="#cite_note-pmid17253500-115" title=""><span>[</span>116<span>]</span></a></sup> <a href="/wiki/Herbal_medicine" title="Herbal medicine" class="mw-redirect">herbal medicine</a>, including the use of <a href="/wiki/Medical_cannabis" title="Medical cannabis">medical cannabis</a> to help alleviate symptoms,<sup id="cite_ref-116" class="reference"><a href="#cite_note-116" title=""><span>[</span>117<span>]</span></a></sup><sup id="cite_ref-117" class="reference"><a href="#cite_note-117" title=""><span>[</span>118<span>]</span></a></sup> and <a href="/wiki/Hyperbaric_oxygenation" title="Hyperbaric oxygenation" class="mw-redirect">hyperbaric oxygenation</a>.<sup id="cite_ref-pmid14974004_118-0" class="reference"><a href="#cite_note-pmid14974004-118" title=""><span>[</span>119<span>]</span></a></sup> The <a href="/wiki/Martial_arts_therapy" title="Martial arts therapy">therapeutic practice of martial arts</a> such as <a href="/wiki/Tai_chi" title="Tai chi" class="mw-redirect">tai chi</a>, relaxation disciplines such as <a href="/wiki/Yoga" title="Yoga">yoga</a>, or general exercise seems to mitigate fatigue, but has no effect on cognitive function.<sup id="cite_ref-pmid15184614_119-0" class="reference"><a href="#cite_note-pmid15184614-119" title=""><span>[</span>120<span>]</span></a></sup></p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=18" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>The <a href="/wiki/Prognosis" title="Prognosis">prognosis</a> (the expected future course of the disease) for a person with multiple sclerosis depends on the subtype of the disease; the individual's sex, age, and initial symptoms; and the degree of <a href="/wiki/Disability" title="Disability">disability</a> the person experiences.<sup id="cite_ref-pmid8017890_6-2" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup> Female sex, relapsing-remitting subtype, optic neuritis or sensory symptoms at onset, few attacks in the initial years and especially early age at onset, are associated with a better course.<sup id="cite_ref-pmid8017890_6-3" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-pmid3495637_120-0" class="reference"><a href="#cite_note-pmid3495637-120" title=""><span>[</span>121<span>]</span></a></sup></p>
<p>The <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> of people with MS, at least for earlier years, is nearly the same as that of unaffected people.<sup id="cite_ref-pmid8017890_6-4" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup> Almost 40% of patients reach the seventh decade of life.<sup id="cite_ref-pmid3495637_120-1" class="reference"><a href="#cite_note-pmid3495637-120" title=""><span>[</span>121<span>]</span></a></sup> Nevertheless, half of the deaths in people with MS are directly related to the consequences of the disease, while 15% more are due to <a href="/wiki/Suicide" title="Suicide">suicide</a>, a percentage much higher than in the healthy population.<sup id="cite_ref-pmid8017890_6-5" class="reference"><a href="#cite_note-pmid8017890-6" title=""><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-pmid15561552_121-0" class="reference"><a href="#cite_note-pmid15561552-121" title=""><span>[</span>122<span>]</span></a></sup></p>
<p>Although most patients lose the ability to walk prior to death, 90% are still capable of independent walking at 10 years from onset, and 75% at 15 years.<sup id="cite_ref-pmid3495637_120-2" class="reference"><a href="#cite_note-pmid3495637-120" title=""><span>[</span>121<span>]</span></a></sup><sup id="cite_ref-pmid11321195_122-0" class="reference"><a href="#cite_note-pmid11321195-122" title=""><span>[</span>123<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=19" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p><a name="Medical_discovery" id="Medical_discovery"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=20" title="Edit section: Medical discovery">edit</a>]</span> <span class="mw-headline">Medical discovery</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Carswell-Multiple_Sclerosis2.jpg" class="image" title="Detail of drawing from Carswell book depicting multiple sclerosis lesions in the brain stem and spinal cord (1838)"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Carswell-Multiple_Sclerosis2.jpg/180px-Carswell-Multiple_Sclerosis2.jpg" width="180" height="253" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Carswell-Multiple_Sclerosis2.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Detail of drawing from Carswell book depicting multiple sclerosis lesions in the <a href="/wiki/Brain_stem" title="Brain stem">brain stem</a> and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> (1838)</div>
</div>
</div>
<p>The French <a href="/wiki/Neurologist" title="Neurologist" class="mw-redirect">neurologist</a> <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a> (1825–1893) was the first person to recognize multiple sclerosis as a distinct disease in 1868. Summarizing previous reports and adding his own clinical and pathological observations, Charcot called the disease <i>sclerose en plaques</i>. The three signs of MS now known as <a href="/wiki/Charcot%27s_triad_1" title="Charcot's triad 1">Charcot's triad 1</a> are <a href="/wiki/Pathologic_nystagmus" title="Pathologic nystagmus">nystagmus</a>, <a href="/wiki/Intention_tremor" title="Intention tremor">intention tremor</a>, and <a href="/wiki/Telegraphic_speech" title="Telegraphic speech">telegraphic speech</a>, though these are not unique to MS. Charcot also observed cognition changes, describing his patients as having a "marked enfeeblement of the memory" and "conceptions that formed slowly".<sup id="cite_ref-Charcot1_3-2" class="reference"><a href="#cite_note-Charcot1-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>Prior to Charcot, Robert Carswell (1793–1857), a British professor of <a href="/wiki/Pathology" title="Pathology">pathology</a>, and <a href="/wiki/Jean_Cruveilhier" title="Jean Cruveilhier">Jean Cruveilhier</a> (1791–1873), a French professor of pathologic anatomy, had described and illustrated many of the disease's clinical details, but did not identify it as a separate disease.<sup id="cite_ref-pmid3066846_123-0" class="reference"><a href="#cite_note-pmid3066846-123" title=""><span>[</span>124<span>]</span></a></sup></p>
<p>After Charcot's description, <a href="/wiki/Eug%C3%A8ne_Devic" title="Eugène Devic">Eugène Devic</a> (1858–1930), <a href="/w/index.php?title=Jozsef_Balo&amp;action=edit&amp;redlink=1" class="new" title="Jozsef Balo (page does not exist)">Jozsef Balo</a> (1895–1979), <a href="/wiki/Paul_Ferdinand_Schilder" title="Paul Ferdinand Schilder">Paul Ferdinand Schilder</a> (1886–1940), and <a href="/wiki/Otto_Marburg" title="Otto Marburg">Otto Marburg</a> (1874–1948) described special cases of the disease.</p>
<p><a name="Historical_cases" id="Historical_cases"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=21" title="Edit section: Historical cases">edit</a>]</span> <span class="mw-headline">Historical cases</span></h3>
<p>There are several historical accounts of people who lived before or shortly after the disease was described by Charcot and probably had MS.</p>
<p>A young woman called Halldora, who lived in <a href="/wiki/Iceland" title="Iceland">Iceland</a> around the year 1200, suddenly lost her vision and mobility, but after praying to the saints, recovered them seven days after. <a href="/wiki/Saint_Lidwina" title="Saint Lidwina" class="mw-redirect">Saint Lidwina</a> of <a href="/wiki/Schiedam" title="Schiedam">Schiedam</a> (1380–1433), a <a href="/wiki/Netherlands" title="Netherlands">Dutch</a> <a href="/wiki/Nun" title="Nun">nun</a>, may be one of the first clearly identifiable MS patients. From the age of 16 until her death at 53, she suffered intermittent pain, weakness of the legs, and vision loss—symptoms typical of MS.<sup id="cite_ref-pmid390966_124-0" class="reference"><a href="#cite_note-pmid390966-124" title=""><span>[</span>125<span>]</span></a></sup> Both cases have led to the proposal of a 'Viking gene' hypothesis for the dissemination of the disease.<sup id="cite_ref-pmid16479124_125-0" class="reference"><a href="#cite_note-pmid16479124-125" title=""><span>[</span>126<span>]</span></a></sup></p>
<p><a href="/wiki/Augustus_d%27Este" title="Augustus d'Este">Augustus Frederick d'Este</a> (1794–1848), an illegitimate grandson of <a href="/wiki/George_III_of_the_United_Kingdom" title="George III of the United Kingdom">King George III of Great Britain</a>, almost certainly suffered from MS. D'Este left a detailed diary describing his 22&#160;years living with the disease. His diary began in 1822 and ended in 1846, although it remained unknown until 1948. His symptoms began at age&#160;28 with a sudden transient visual loss after the funeral of a friend. During the course of his disease, he developed weakness of the legs, clumsiness of the hands, numbness, dizziness, bladder disturbances, and <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. In 1844, he began to use a wheelchair. Despite his illness, he kept an optimistic view of life.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126" title=""><span>[</span>127<span>]</span></a></sup><sup id="cite_ref-pmid16103678_127-0" class="reference"><a href="#cite_note-pmid16103678-127" title=""><span>[</span>128<span>]</span></a></sup></p>
<p>Another early account of MS was kept by the British diarist <a href="/wiki/W._N._P._Barbellion" title="W. N. P. Barbellion">W. N. P. Barbellion</a>, <a href="/wiki/Nom-de-plume" title="Nom-de-plume" class="mw-redirect">nom-de-plume</a> of Bruce Frederick Cummings (1889–1919), who maintained a detailed log of his diagnosis and struggle with MS.<sup id="cite_ref-pmid16103678_127-1" class="reference"><a href="#cite_note-pmid16103678-127" title=""><span>[</span>128<span>]</span></a></sup> His diary was published in 1919 as <i>The Journal of a Disappointed Man</i>.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128" title=""><span>[</span>129<span>]</span></a></sup></p>
<p><a name="Research_directions" id="Research_directions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=22" title="Edit section: Research directions">edit</a>]</span> <span class="mw-headline">Research directions</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Therapies_under_investigation_for_multiple_sclerosis" title="Therapies under investigation for multiple sclerosis">Therapies under investigation for multiple sclerosis</a></div>
<div class="thumb tleft">
<div class="thumbinner" style="width:142px;"><a href="/wiki/File:Alemtuzumab_Fab_1CE1.png" class="image" title="Chemical structure of alemtuzumab."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/32/Alemtuzumab_Fab_1CE1.png/140px-Alemtuzumab_Fab_1CE1.png" width="140" height="190" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Alemtuzumab_Fab_1CE1.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Chemical structure of <a href="/wiki/Alemtuzumab" title="Alemtuzumab">alemtuzumab</a>.</div>
</div>
</div>
<p>A number of treatments that may curtail attacks or improve function are under investigation. Some of these treatments involve the combination of drugs that are already in use for multiple sclerosis, such as the joint administration of <a href="/wiki/Mitoxantrone" title="Mitoxantrone">mitoxantrone</a> and <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">glatiramer acetate</a> (<i>Copaxone</i>).<sup id="cite_ref-129" class="reference"><a href="#cite_note-129" title=""><span>[</span>130<span>]</span></a></sup> However, most treatments already in clinical trials involve drugs that are used in other diseases. These are <a href="/wiki/Alemtuzumab" title="Alemtuzumab">alemtuzumab</a> (trade name <i>Campath</i>),<sup id="cite_ref-130" class="reference"><a href="#cite_note-130" title=""><span>[</span>131<span>]</span></a></sup> <a href="/wiki/Daclizumab" title="Daclizumab">daclizumab</a> (trade name <i>Zenapax</i>),<sup id="cite_ref-131" class="reference"><a href="#cite_note-131" title=""><span>[</span>132<span>]</span></a></sup> <a href="/wiki/Inosine" title="Inosine">inosine</a>,<sup id="cite_ref-132" class="reference"><a href="#cite_note-132" title=""><span>[</span>133<span>]</span></a></sup> <a href="/w/index.php?title=BG00012&amp;action=edit&amp;redlink=1" class="new" title="BG00012 (page does not exist)">BG00012</a>,<sup id="cite_ref-133" class="reference"><a href="#cite_note-133" title=""><span>[</span>134<span>]</span></a></sup> <a href="/wiki/Fingolimod" title="Fingolimod">fingolimod</a>,<sup id="cite_ref-134" class="reference"><a href="#cite_note-134" title=""><span>[</span>135<span>]</span></a></sup> and <a href="/wiki/Teriflunomide" title="Teriflunomide">teriflunomide</a>, the active metabolite of the <a href="/wiki/DMARD" title="DMARD" class="mw-redirect">DMARD</a> <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>. Alemtuzumab performed better than interferon beta-1a in relapsing-remitting MS reducing disability, imaging abnormalities and frequence of relapses, at the cost of increased <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a> problems. These included three cases of <a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura" class="mw-redirect">thrombocytopenic purpura</a> which led to the suspension of the therapy.<sup id="cite_ref-pmid1234567_135-0" class="reference"><a href="#cite_note-pmid1234567-135" title=""><span>[</span>136<span>]</span></a></sup> Other drugs in clinical trials have been designed specifically for MS, such as <a href="/wiki/Laquinimod" title="Laquinimod">laquinimod</a>,<sup id="cite_ref-pmid15781813_136-0" class="reference"><a href="#cite_note-pmid15781813-136" title=""><span>[</span>137<span>]</span></a></sup> and <i><a href="/wiki/Neurovax" title="Neurovax">Neurovax</a></i>.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137" title=""><span>[</span>138<span>]</span></a></sup></p>
<p><a href="/wiki/Low_dose_naltrexone" title="Low dose naltrexone">Low dose naltrexone</a> has been prescribed off-label for certain autoimmune disorders, including MS, and there is anecdotal evidence of benefit,<sup id="cite_ref-138" class="reference"><a href="#cite_note-138" title=""><span>[</span>139<span>]</span></a></sup><sup id="cite_ref-139" class="reference"><a href="#cite_note-139" title=""><span>[</span>140<span>]</span></a></sup> but only two small clinical trials have been conducted (as on December 2008), one in San Francisco, USA,<sup id="cite_ref-140" class="reference"><a href="#cite_note-140" title=""><span>[</span>141<span>]</span></a></sup> the other for the primary progressive variety in Milan, Italy.<sup id="cite_ref-pmid18728058_141-0" class="reference"><a href="#cite_note-pmid18728058-141" title=""><span>[</span>142<span>]</span></a></sup></p>
<p>New diagnostic and evolution evaluation methods are also being investigated. The measurement of <a href="/wiki/Antibody" title="Antibody">antibodies</a> against myelin <a href="/wiki/Protein" title="Protein">proteins</a> such as <a href="/wiki/Myelin_oligodendrocyte_glycoprotein" title="Myelin oligodendrocyte glycoprotein">myelin oligodendrocyte glycoprotein</a> and <a href="/wiki/Myelin_basic_protein" title="Myelin basic protein">myelin basic protein</a> could be useful for diagnosis. <a href="/wiki/Optical_coherence_tomography" title="Optical coherence tomography">Optical coherence tomography</a> of the eye's <a href="/wiki/Retina" title="Retina">retina</a> could be used as a measure of response to medication, axonal degeneration and brain atrophy.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142" title=""><span>[</span>143<span>]</span></a></sup><sup id="cite_ref-143" class="reference"><a href="#cite_note-143" title=""><span>[</span>144<span>]</span></a></sup> Currently there are no clinically established <a href="/wiki/Laboratory_investigation" title="Laboratory investigation" class="mw-redirect">laboratory investigations</a> available that can predict prognosis. However, several promising approaches have been proposed, such as the measurement of a <a href="/wiki/Lipid" title="Lipid">lipid</a>-specific <a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">immunoglobulin M</a> as predictor of long-term outcomes.<sup id="cite_ref-pmid18755821_144-0" class="reference"><a href="#cite_note-pmid18755821-144" title=""><span>[</span>145<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=23" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/List_of_multiple_sclerosis_organizations" title="List of multiple sclerosis organizations">List of multiple sclerosis organizations</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=24" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-pmid11955556-0">^ <a href="#cite_ref-pmid11955556_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-11" title=""><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-12" title=""><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-13" title=""><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-14" title=""><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-15" title=""><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid11955556_0-16" title=""><sup><i><b>q</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFCompston_A.2C_Coles_A2002">Compston A, Coles A (April 2002). "Multiple sclerosis". <i>Lancet</i> <b>359</b> (9313): 1221–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2802%2908220-X" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2802%2908220-X" rel="nofollow">10.1016/S0140-6736(02)08220-X</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11955556" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11955556">PMID 11955556</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multiple+sclerosis&amp;rft.jtitle=Lancet&amp;rft.aulast=Compston+A%2C+Coles+A&amp;rft.au=Compston+A%2C+Coles+A&amp;rft.date=April+2002&amp;rft.volume=359&amp;rft.issue=9313&amp;rft.pages=1221%E2%80%9331&amp;rft_id=info:doi/10.1016%2FS0140-6736%2802%2908220-X&amp;rft_id=info:pmid/11955556&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18637953-1">^ <a href="#cite_ref-pmid18637953_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18637953_1-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFDebouverie_M.2C_Pittion-Vouyovitch_S.2C_Louis_S.2C_Guillemin_F2008">Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F (July 2008). "Natural history of multiple sclerosis in a population-based cohort". <i>Eur. J. Neurol.</i> <b>15</b>: 916. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1468-1331.2008.02241.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1468-1331.2008.02241.x" rel="nofollow">10.1111/j.1468-1331.2008.02241.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18637953" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18637953">PMID 18637953</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Natural+history+of+multiple+sclerosis+in+a+population-based+cohort&amp;rft.jtitle=Eur.+J.+Neurol.&amp;rft.aulast=Debouverie+M%2C+Pittion-Vouyovitch+S%2C+Louis+S%2C+Guillemin+F&amp;rft.au=Debouverie+M%2C+Pittion-Vouyovitch+S%2C+Louis+S%2C+Guillemin+F&amp;rft.date=July+2008&amp;rft.volume=15&amp;rft.pages=916&amp;rft_id=info:doi/10.1111%2Fj.1468-1331.2008.02241.x&amp;rft_id=info:pmid/18637953&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11603614-2">^ <a href="#cite_ref-pmid11603614_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11603614_2-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRosati_G2001">Rosati G (April 2001). "The prevalence of multiple sclerosis in the world: an update". <i>Neurol. Sci.</i> <b>22</b> (2): 117–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs100720170011" class="external text" title="http://dx.doi.org/10.1007%2Fs100720170011" rel="nofollow">10.1007/s100720170011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11603614" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11603614">PMID 11603614</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+prevalence+of+multiple+sclerosis+in+the+world%3A+an+update&amp;rft.jtitle=Neurol.+Sci.&amp;rft.aulast=Rosati+G&amp;rft.au=Rosati+G&amp;rft.date=April+2001&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=117%E2%80%9339&amp;rft_id=info:doi/10.1007%2Fs100720170011&amp;rft_id=info:pmid/11603614&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Charcot1-3">^ <a href="#cite_ref-Charcot1_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Charcot1_3-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Charcot1_3-2" title=""><sup><i><b>c</b></i></sup></a> Charcot, J. <i>Histologie de la sclerose en plaques.</i> Gazette des hopitaux, Paris, 1868; 41: 554–555.</li>
<li id="cite_note-pmid17444504-4">^ <a href="#cite_ref-pmid17444504_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid17444504_4-8" title=""><sup><i><b>i</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAscherio_A.2C_Munger_KL2007">Ascherio A, Munger KL (April 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". <i>Ann. Neurol.</i> <b>61</b> (4): 288–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.21117" class="external text" title="http://dx.doi.org/10.1002%2Fana.21117" rel="nofollow">10.1002/ana.21117</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17444504" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17444504">PMID 17444504</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+risk+factors+for+multiple+sclerosis.+Part+I%3A+the+role+of+infection&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Ascherio+A%2C+Munger+KL&amp;rft.au=Ascherio+A%2C+Munger+KL&amp;rft.date=April+2007&amp;rft.volume=61&amp;rft.issue=4&amp;rft.pages=288%E2%80%9399&amp;rft_id=info:doi/10.1002%2Fana.21117&amp;rft_id=info:pmid/17444504&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8780061-5">^ <a href="#cite_ref-pmid8780061_5-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid8780061_5-8" title=""><sup><i><b>i</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFLublin_FD.2C_Reingold_SC1996">Lublin FD, Reingold SC (April 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". <i>Neurology</i> <b>46</b> (4): 907–11. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8780061" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8780061">PMID 8780061</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Defining+the+clinical+course+of+multiple+sclerosis%3A+results+of+an+international+survey.+National+Multiple+Sclerosis+Society+%28USA%29+Advisory+Committee+on+Clinical+Trials+of+New+Agents+in+Multiple+Sclerosis&amp;rft.jtitle=Neurology&amp;rft.aulast=Lublin+FD%2C+Reingold+SC&amp;rft.au=Lublin+FD%2C+Reingold+SC&amp;rft.date=April+1996&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=907%E2%80%9311&amp;rft_id=info:pmid/8780061&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8017890-6">^ <a href="#cite_ref-pmid8017890_6-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8017890_6-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8017890_6-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8017890_6-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid8017890_6-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid8017890_6-5" title=""><sup><i><b>f</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWeinshenker_BG1994">Weinshenker BG (1994). "Natural history of multiple sclerosis". <i>Ann. Neurol.</i> <b>36 Suppl</b>: S6–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.410360704" class="external text" title="http://dx.doi.org/10.1002%2Fana.410360704" rel="nofollow">10.1002/ana.410360704</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8017890" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8017890">PMID 8017890</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Natural+history+of+multiple+sclerosis&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Weinshenker+BG&amp;rft.au=Weinshenker+BG&amp;rft.date=1994&amp;rft.volume=36+Suppl&amp;rft.pages=S6%E2%80%9311&amp;rft_id=info:doi/10.1002%2Fana.410360704&amp;rft_id=info:pmid/8017890&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15847841-7">^ <a href="#cite_ref-pmid15847841_7-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15847841_7-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMiller_D.2C_Barkhof_F.2C_Montalban_X.2C_Thompson_A.2C_Filippi_M2005">Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". <i>Lancet Neurol</i> <b>4</b> (5): 281–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2805%2970071-5" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2805%2970071-5" rel="nofollow">10.1016/S1474-4422(05)70071-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15847841" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15847841">PMID 15847841</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinically+isolated+syndromes+suggestive+of+multiple+sclerosis%2C+part+I%3A+natural+history%2C+pathogenesis%2C+diagnosis%2C+and+prognosis&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Miller+D%2C+Barkhof+F%2C+Montalban+X%2C+Thompson+A%2C+Filippi+M&amp;rft.au=Miller+D%2C+Barkhof+F%2C+Montalban+X%2C+Thompson+A%2C+Filippi+M&amp;rft.date=May+2005&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=281%E2%80%938&amp;rft_id=info:doi/10.1016%2FS1474-4422%2805%2970071-5&amp;rft_id=info:pmid/15847841&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17952303-8">^ <a href="#cite_ref-pmid17952303_8-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17952303_8-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFSantos_EC.2C_Yokota_M.2C_Dias_NF2007">Santos EC, Yokota M, Dias NF (September 2007). "<a href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0004-282X2007000500032&amp;lng=en&amp;nrm=iso&amp;tlng=en" class="external text" title="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0004-282X2007000500032&amp;lng=en&amp;nrm=iso&amp;tlng=en" rel="nofollow">[Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary of State for Health</a>]" (in Portuguese). <i>Arq Neuropsiquiatr</i> <b>65</b> (3B): 885–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17952303" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17952303">PMID 17952303</a><span class="printonly">. <a href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0004-282X2007000500032&amp;lng=en&amp;nrm=iso&amp;tlng=en" class="external free" title="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0004-282X2007000500032&amp;lng=en&amp;nrm=iso&amp;tlng=en" rel="nofollow">http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0004-282X2007000500032&amp;lng=en&amp;nrm=iso&amp;tlng=en</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BMultiple+sclerosis%3A+study+of+patients+with+relapsing-remitting+form+registered+at+Minas+Gerais+Secretary+of+State+for+Health%5D&amp;rft.jtitle=Arq+Neuropsiquiatr&amp;rft.aulast=Santos+EC%2C+Yokota+M%2C+Dias+NF&amp;rft.au=Santos+EC%2C+Yokota+M%2C+Dias+NF&amp;rft.date=September+2007&amp;rft.volume=65&amp;rft.issue=3B&amp;rft.pages=885%E2%80%938&amp;rft_id=info:pmid/17952303&amp;rft_id=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0004-282X2007000500032%26lng%3Den%26nrm%3Diso%26tlng%3Den&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16288423-9"><b><a href="#cite_ref-pmid16288423_9-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNavarro_S.2C_Mond.C3.A9jar-Mar.C3.ADn_B.2C_Pedrosa-Guerrero_A.2C_P.C3.A9rez-Molina_I.2C_Garrido-Robres_JA.2C_Alvarez-Tejerina_A2005">Navarro S, Mondéjar-Marín B, Pedrosa-Guerrero A, Pérez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A (2005). "<a href="http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&amp;Revista=RevNeurol" class="external text" title="http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&amp;Revista=RevNeurol" rel="nofollow">[Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions</a>]" (in Spanish; Castilian). <i>Rev Neurol</i> <b>41</b> (10): 601–3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16288423" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16288423">PMID 16288423</a><span class="printonly">. <a href="http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&amp;Revista=RevNeurol" class="external free" title="http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&amp;Revista=RevNeurol" rel="nofollow">http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&amp;Revista=RevNeurol</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BAphasia+and+parietal+syndrome+as+the+presenting+symptoms+of+a+demyelinating+disease+with+pseudotumoral+lesions%5D&amp;rft.jtitle=Rev+Neurol&amp;rft.aulast=Navarro+S%2C+Mond%C3%A9jar-Mar%C3%ADn+B%2C+Pedrosa-Guerrero+A%2C+P%C3%A9rez-Molina+I%2C+Garrido-Robres+JA%2C+Alvarez-Tejerina+A&amp;rft.au=Navarro+S%2C+Mond%C3%A9jar-Mar%C3%ADn+B%2C+Pedrosa-Guerrero+A%2C+P%C3%A9rez-Molina+I%2C+Garrido-Robres+JA%2C+Alvarez-Tejerina+A&amp;rft.date=2005&amp;rft.volume=41&amp;rft.issue=10&amp;rft.pages=601%E2%80%933&amp;rft_id=info:pmid/16288423&amp;rft_id=http%3A%2F%2Fwww.revneurol.com%2FLinkOut%2FformMedLine.asp%3FRefer%3D2005523%26Revista%3DRevNeurol&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16631798-10"><b><a href="#cite_ref-pmid16631798_10-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJongen_PJ2006">Jongen PJ (June 2006). "Psychiatric onset of multiple sclerosis". <i>J. Neurol. Sci.</i> <b>245</b> (1-2): 59–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jns.2005.09.014" class="external text" title="http://dx.doi.org/10.1016%2Fj.jns.2005.09.014" rel="nofollow">10.1016/j.jns.2005.09.014</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16631798" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16631798">PMID 16631798</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Psychiatric+onset+of+multiple+sclerosis&amp;rft.jtitle=J.+Neurol.+Sci.&amp;rft.aulast=Jongen+PJ&amp;rft.au=Jongen+PJ&amp;rft.date=June+2006&amp;rft.volume=245&amp;rft.issue=1-2&amp;rft.pages=59%E2%80%9362&amp;rft_id=info:doi/10.1016%2Fj.jns.2005.09.014&amp;rft_id=info:pmid/16631798&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18677330-11"><b><a href="#cite_ref-pmid18677330_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYetimalar_Y.2C_Se.C3.A7il_Y.2C_Inceoglu_AK.2C_Eren_S.2C_Ba.C5.9Fo.C4.9Flu_M2008">Yetimalar Y, Seçil Y, Inceoglu AK, Eren S, Başoğlu M (July 2008). "Unusual primary manifestations of multiple sclerosis". <i>N. Z. Med. J.</i> <b>121</b> (1277): 47–59. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18677330" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18677330">PMID 18677330</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Unusual+primary+manifestations+of+multiple+sclerosis&amp;rft.jtitle=N.+Z.+Med.+J.&amp;rft.aulast=Yetimalar+Y%2C+Se%C3%A7il+Y%2C+Inceoglu+AK%2C+Eren+S%2C+Ba%C5%9Fo%C4%9Flu+M&amp;rft.au=Yetimalar+Y%2C+Se%C3%A7il+Y%2C+Inceoglu+AK%2C+Eren+S%2C+Ba%C5%9Fo%C4%9Flu+M&amp;rft.date=July+2008&amp;rft.volume=121&amp;rft.issue=1277&amp;rft.pages=47%E2%80%9359&amp;rft_id=info:pmid/18677330&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18507677-12"><b><a href="#cite_ref-pmid18507677_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHakiki_B.2C_Goretti_B.2C_Portaccio_E.2C_Zipoli_V.2C_Amato_MP2008">Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (August 2008). "'Subclinical MS': follow-up of four cases". <i>Eur. J. Neurol.</i> <b>15</b> (8): 858–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1468-1331.2008.02155.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1468-1331.2008.02155.x" rel="nofollow">10.1111/j.1468-1331.2008.02155.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18507677" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18507677">PMID 18507677</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27Subclinical+MS%27%3A+follow-up+of+four+cases&amp;rft.jtitle=Eur.+J.+Neurol.&amp;rft.aulast=Hakiki+B%2C+Goretti+B%2C+Portaccio+E%2C+Zipoli+V%2C+Amato+MP&amp;rft.au=Hakiki+B%2C+Goretti+B%2C+Portaccio+E%2C+Zipoli+V%2C+Amato+MP&amp;rft.date=August+2008&amp;rft.volume=15&amp;rft.issue=8&amp;rft.pages=858%E2%80%9361&amp;rft_id=info:doi/10.1111%2Fj.1468-1331.2008.02155.x&amp;rft_id=info:pmid/18507677&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18202208-13"><b><a href="#cite_ref-pmid18202208_13-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLebrun_C.2C_Bensa_C.2C_Debouverie_M.2C_.27.27et_al.27.272008">Lebrun C, Bensa C, Debouverie M, <i>et al</i> (February 2008). "Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>79</b> (2): 195–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.2006.108274" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.2006.108274" rel="nofollow">10.1136/jnnp.2006.108274</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18202208" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18202208">PMID 18202208</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Unexpected+multiple+sclerosis%3A+follow-up+of+30+patients+with+magnetic+resonance+imaging+and+clinical+conversion+profile&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Lebrun+C%2C+Bensa+C%2C+Debouverie+M%2C+%27%27et+al%27%27&amp;rft.au=Lebrun+C%2C+Bensa+C%2C+Debouverie+M%2C+%27%27et+al%27%27&amp;rft.date=February+2008&amp;rft.volume=79&amp;rft.issue=2&amp;rft.pages=195%E2%80%938&amp;rft_id=info:doi/10.1136%2Fjnnp.2006.108274&amp;rft_id=info:pmid/18202208&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11374088-14">^ <a href="#cite_ref-pmid11374088_14-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11374088_14-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFreeman_JA2001">Freeman JA (April 2001). "<a href="http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm" class="external text" title="http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm" rel="nofollow">Improving mobility and functional independence in persons with multiple sclerosis</a>". <i>J. Neurol.</i> <b>248</b> (4): 255–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs004150170198" class="external text" title="http://dx.doi.org/10.1007%2Fs004150170198" rel="nofollow">10.1007/s004150170198</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11374088" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11374088">PMID 11374088</a><span class="printonly">. <a href="http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm" class="external free" title="http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm" rel="nofollow">http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Improving+mobility+and+functional+independence+in+persons+with+multiple+sclerosis&amp;rft.jtitle=J.+Neurol.&amp;rft.aulast=Freeman+JA&amp;rft.au=Freeman+JA&amp;rft.date=April+2001&amp;rft.volume=248&amp;rft.issue=4&amp;rft.pages=255%E2%80%939&amp;rft_id=info:doi/10.1007%2Fs004150170198&amp;rft_id=info:pmid/11374088&amp;rft_id=http%3A%2F%2Flink.springer.de%2Flink%2Fservice%2Fjournals%2F00415%2Fbibs%2F1248004%2F12480255.htm&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9894114-15"><b><a href="#cite_ref-pmid9894114_15-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMerson_RM.2C_Rolnick_MI1998">Merson RM, Rolnick MI (August 1998). "Speech-language pathology and dysphagia in multiple sclerosis". <i>Phys Med Rehabil Clin N Am</i> <b>9</b> (3): 631–41. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9894114" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9894114">PMID 9894114</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Speech-language+pathology+and+dysphagia+in+multiple+sclerosis&amp;rft.jtitle=Phys+Med+Rehabil+Clin+N+Am&amp;rft.aulast=Merson+RM%2C+Rolnick+MI&amp;rft.au=Merson+RM%2C+Rolnick+MI&amp;rft.date=August+1998&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=631%E2%80%9341&amp;rft_id=info:pmid/9894114&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17531862-16"><b><a href="#cite_ref-pmid17531862_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKaur_P.2C_Bennett_JL2007">Kaur P, Bennett JL (2007). "Optic neuritis and the neuro-ophthalmology of multiple sclerosis". <i>Int. Rev. Neurobiol.</i> <b>79</b>: 633–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0074-7742%2807%2979028-1" class="external text" title="http://dx.doi.org/10.1016%2FS0074-7742%2807%2979028-1" rel="nofollow">10.1016/S0074-7742(07)79028-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17531862" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17531862">PMID 17531862</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Optic+neuritis+and+the+neuro-ophthalmology+of+multiple+sclerosis&amp;rft.jtitle=Int.+Rev.+Neurobiol.&amp;rft.aulast=Kaur+P%2C+Bennett+JL&amp;rft.au=Kaur+P%2C+Bennett+JL&amp;rft.date=2007&amp;rft.volume=79&amp;rft.pages=633%E2%80%9363&amp;rft_id=info:doi/10.1016%2FS0074-7742%2807%2979028-1&amp;rft_id=info:pmid/17531862&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18336059-17"><b><a href="#cite_ref-pmid18336059_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFP.C3.B6llmann_W.2C_Feneberg_W2008">Pöllmann W, Feneberg W (2008). "Current management of pain associated with multiple sclerosis". <i>CNS Drugs</i> <b>22</b> (4): 291–324. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00023210-200822040-00003" class="external text" title="http://dx.doi.org/10.2165%2F00023210-200822040-00003" rel="nofollow">10.2165/00023210-200822040-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18336059" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18336059">PMID 18336059</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Current+management+of+pain+associated+with+multiple+sclerosis&amp;rft.jtitle=CNS+Drugs&amp;rft.aulast=P%C3%B6llmann+W%2C+Feneberg+W&amp;rft.au=P%C3%B6llmann+W%2C+Feneberg+W&amp;rft.date=2008&amp;rft.volume=22&amp;rft.issue=4&amp;rft.pages=291%E2%80%93324&amp;rft_id=info:doi/10.2165%2F00023210-200822040-00003&amp;rft_id=info:pmid/18336059&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16417816-18">^ <a href="#cite_ref-pmid16417816_18-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16417816_18-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHenze_T2005">Henze T (August 2005). "<a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf" class="external text" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf" rel="nofollow">Managing specific symptoms in people with multiple sclerosis</a>" (PDF). <i>Int MS J</i> <b>12</b> (2): 60–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16417816" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16417816">PMID 16417816</a><span class="printonly">. <a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf" class="external free" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf" rel="nofollow">http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Managing+specific+symptoms+in+people+with+multiple+sclerosis&amp;rft.jtitle=Int+MS+J&amp;rft.aulast=Henze+T&amp;rft.au=Henze+T&amp;rft.date=August+2005&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=60%E2%80%938&amp;rft_id=info:pmid/16417816&amp;rft_id=http%3A%2F%2Fwww.msforumonline.net%2Fjournal%2Fdownload%2Fdefault.aspx%3Fpdf%3D20051260.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9413302-19"><b><a href="#cite_ref-pmid9413302_19-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAndrews_KL.2C_Husmann_DA1997">Andrews KL, Husmann DA (December 1997). "Bladder dysfunction and management in multiple sclerosis". <i>Mayo Clin. Proc.</i> <b>72</b> (12): 1176–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.4065%2F72.12.1176" class="external text" title="http://dx.doi.org/10.4065%2F72.12.1176" rel="nofollow">10.4065/72.12.1176</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9413302" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9413302">PMID 9413302</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bladder+dysfunction+and+management+in+multiple+sclerosis&amp;rft.jtitle=Mayo+Clin.+Proc.&amp;rft.aulast=Andrews+KL%2C+Husmann+DA&amp;rft.au=Andrews+KL%2C+Husmann+DA&amp;rft.date=December+1997&amp;rft.volume=72&amp;rft.issue=12&amp;rft.pages=1176%E2%80%9383&amp;rft_id=info:doi/10.4065%2F72.12.1176&amp;rft_id=info:pmid/9413302&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12858063-20"><b><a href="#cite_ref-pmid12858063_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBobholz_JA.2C_Rao_SM2003">Bobholz JA, Rao SM (June 2003). "Cognitive dysfunction in multiple sclerosis: a review of recent developments". <i>Curr. Opin. Neurol.</i> <b>16</b> (3): 283–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.1097/01.wco.0000073928.19076.84 (inactive 2009-04-04). <a href="http://www.ncbi.nlm.nih.gov/pubmed/12858063" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12858063">PMID 12858063</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognitive+dysfunction+in+multiple+sclerosis%3A+a+review+of+recent+developments&amp;rft.jtitle=Curr.+Opin.+Neurol.&amp;rft.aulast=Bobholz+JA%2C+Rao+SM&amp;rft.au=Bobholz+JA%2C+Rao+SM&amp;rft.date=June+2003&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=283%E2%80%938&amp;rft_id=info:doi/10.1097%2F01.wco.0000073928.19076.84&amp;rft_id=info:pmid/12858063&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17101907-21"><b><a href="#cite_ref-pmid17101907_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFde_Seze_J.2C_Zephir_H.2C_Hautecoeur_P.2C_Mackowiak_A.2C_Cabaret_M.2C_Vermersch_P2006">de Seze J, Zephir H, Hautecoeur P, Mackowiak A, Cabaret M, Vermersch P (November 2006). "Pathologic laughing and intractable hiccups can occur early in multiple sclerosis". <i>Neurology</i> <b>67</b> (9): 1684–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000242625.75753.69" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000242625.75753.69" rel="nofollow">10.1212/01.wnl.0000242625.75753.69</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17101907" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17101907">PMID 17101907</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pathologic+laughing+and+intractable+hiccups+can+occur+early+in+multiple+sclerosis&amp;rft.jtitle=Neurology&amp;rft.aulast=de+Seze+J%2C+Zephir+H%2C+Hautecoeur+P%2C+Mackowiak+A%2C+Cabaret+M%2C+Vermersch+P&amp;rft.au=de+Seze+J%2C+Zephir+H%2C+Hautecoeur+P%2C+Mackowiak+A%2C+Cabaret+M%2C+Vermersch+P&amp;rft.date=November+2006&amp;rft.volume=67&amp;rft.issue=9&amp;rft.pages=1684%E2%80%936&amp;rft_id=info:doi/10.1212%2F01.wnl.0000242625.75753.69&amp;rft_id=info:pmid/17101907&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKurtzke_JF1983">Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". <i>Neurology</i> <b>33</b> (11): 1444–52. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6685237" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6685237">PMID 6685237</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rating+neurologic+impairment+in+multiple+sclerosis%3A+an+expanded+disability+status+scale+%28EDSS%29&amp;rft.jtitle=Neurology&amp;rft.aulast=Kurtzke+JF&amp;rft.au=Kurtzke+JF&amp;rft.date=1983&amp;rft.volume=33&amp;rft.issue=11&amp;rft.pages=1444%E2%80%9352&amp;rft_id=info:pmid/6685237&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16804331-23">^ <a href="#cite_ref-pmid16804331_23-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16804331_23-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFTataru_N.2C_Vidal_C.2C_Decavel_P.2C_Berger_E.2C_Rumbach_L2006">Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". <i>Neuroepidemiology</i> <b>27</b> (1): 28–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000094233" class="external text" title="http://dx.doi.org/10.1159%2F000094233" rel="nofollow">10.1159/000094233</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16804331" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16804331">PMID 16804331</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Limited+impact+of+the+summer+heat+wave+in+France+%282003%29+on+hospital+admissions+and+relapses+for+multiple+sclerosis&amp;rft.jtitle=Neuroepidemiology&amp;rft.aulast=Tataru+N%2C+Vidal+C%2C+Decavel+P%2C+Berger+E%2C+Rumbach+L&amp;rft.au=Tataru+N%2C+Vidal+C%2C+Decavel+P%2C+Berger+E%2C+Rumbach+L&amp;rft.date=2006&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=28%E2%80%9332&amp;rft_id=info:doi/10.1159%2F000094233&amp;rft_id=info:pmid/16804331&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11960883-24"><b><a href="#cite_ref-pmid11960883_24-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConfavreux_C2002">Confavreux C (May 2002). "<a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960883" class="external text" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960883" rel="nofollow">Infections and the risk of relapse in multiple sclerosis</a>". <i>Brain</i> <b>125</b> (Pt 5): 933–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fbrain%2Fawf146" class="external text" title="http://dx.doi.org/10.1093%2Fbrain%2Fawf146" rel="nofollow">10.1093/brain/awf146</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11960883" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11960883">PMID 11960883</a><span class="printonly">. <a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960883" class="external free" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960883" rel="nofollow">http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960883</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Infections+and+the+risk+of+relapse+in+multiple+sclerosis&amp;rft.jtitle=Brain&amp;rft.aulast=Confavreux+C&amp;rft.au=Confavreux+C&amp;rft.date=May+2002&amp;rft.volume=125&amp;rft.issue=Pt+5&amp;rft.pages=933%E2%80%934&amp;rft_id=info:doi/10.1093%2Fbrain%2Fawf146&amp;rft_id=info:pmid/11960883&amp;rft_id=http%3A%2F%2Fbrain.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11960883&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11960885-25"><b><a href="#cite_ref-pmid11960885_25-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBuljevac_D.2C_Flach_HZ.2C_Hop_WC.2C_.27.27et_al.27.272002">Buljevac D, Flach HZ, Hop WC, <i>et al</i> (May 2002). "<a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960885" class="external text" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960885" rel="nofollow">Prospective study on the relationship between infections and multiple sclerosis exacerbations</a>". <i>Brain</i> <b>125</b> (Pt 5): 952–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fbrain%2Fawf098" class="external text" title="http://dx.doi.org/10.1093%2Fbrain%2Fawf098" rel="nofollow">10.1093/brain/awf098</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11960885" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11960885">PMID 11960885</a><span class="printonly">. <a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960885" class="external free" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960885" rel="nofollow">http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=11960885</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prospective+study+on+the+relationship+between+infections+and+multiple+sclerosis+exacerbations&amp;rft.jtitle=Brain&amp;rft.aulast=Buljevac+D%2C+Flach+HZ%2C+Hop+WC%2C+%27%27et+al%27%27&amp;rft.au=Buljevac+D%2C+Flach+HZ%2C+Hop+WC%2C+%27%27et+al%27%27&amp;rft.date=May+2002&amp;rft.volume=125&amp;rft.issue=Pt+5&amp;rft.pages=952%E2%80%9360&amp;rft_id=info:doi/10.1093%2Fbrain%2Fawf098&amp;rft_id=info:pmid/11960885&amp;rft_id=http%3A%2F%2Fbrain.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11960885&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14500435-26"><b><a href="#cite_ref-pmid14500435_26-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBuljevac_D.2C_Hop_WC.2C_Reedeker_W.2C_.27.27et_al.27.272003">Buljevac D, Hop WC, Reedeker W, <i>et al</i> (September 2003). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=196389" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=196389" rel="nofollow">Self reported stressful life events and exacerbations in multiple sclerosis: prospective study</a>". <i>BMJ</i> <b>327</b> (7416): 646. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.327.7416.646" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.327.7416.646" rel="nofollow">10.1136/bmj.327.7416.646</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14500435" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14500435">PMID 14500435</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Self+reported+stressful+life+events+and+exacerbations+in+multiple+sclerosis%3A+prospective+study&amp;rft.jtitle=BMJ&amp;rft.aulast=Buljevac+D%2C+Hop+WC%2C+Reedeker+W%2C+%27%27et+al%27%27&amp;rft.au=Buljevac+D%2C+Hop+WC%2C+Reedeker+W%2C+%27%27et+al%27%27&amp;rft.date=September+2003&amp;rft.volume=327&amp;rft.issue=7416&amp;rft.pages=646&amp;rft_id=info:doi/10.1136%2Fbmj.327.7416.646&amp;rft_id=info:pmid/14500435&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16900759-27"><b><a href="#cite_ref-pmid16900759_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrown_RF.2C_Tennant_CC.2C_Sharrock_M.2C_Hodgkinson_S.2C_Dunn_SM.2C_Pollard_JD2006">Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "<a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900759" class="external text" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900759" rel="nofollow">Relationship between stress and relapse in multiple sclerosis: Part I. Important features</a>". <i>Mult. Scler.</i> <b>12</b> (4): 453–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1191%2F1352458506ms1295oa" class="external text" title="http://dx.doi.org/10.1191%2F1352458506ms1295oa" rel="nofollow">10.1191/1352458506ms1295oa</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16900759" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16900759">PMID 16900759</a><span class="printonly">. <a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900759" class="external free" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900759" rel="nofollow">http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900759</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Relationship+between+stress+and+relapse+in+multiple+sclerosis%3A+Part+I.+Important+features&amp;rft.jtitle=Mult.+Scler.&amp;rft.aulast=Brown+RF%2C+Tennant+CC%2C+Sharrock+M%2C+Hodgkinson+S%2C+Dunn+SM%2C+Pollard+JD&amp;rft.au=Brown+RF%2C+Tennant+CC%2C+Sharrock+M%2C+Hodgkinson+S%2C+Dunn+SM%2C+Pollard+JD&amp;rft.date=August+2006&amp;rft.volume=12&amp;rft.issue=4&amp;rft.pages=453%E2%80%9364&amp;rft_id=info:doi/10.1191%2F1352458506ms1295oa&amp;rft_id=info:pmid/16900759&amp;rft_id=http%3A%2F%2Fmsj.sagepub.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16900759&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16900760-28"><b><a href="#cite_ref-pmid16900760_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrown_RF.2C_Tennant_CC.2C_Sharrock_M.2C_Hodgkinson_S.2C_Dunn_SM.2C_Pollard_JD2006">Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "<a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900760" class="external text" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900760" rel="nofollow">Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships</a>". <i>Mult. Scler.</i> <b>12</b> (4): 465–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1191%2F1352458506ms1296oa" class="external text" title="http://dx.doi.org/10.1191%2F1352458506ms1296oa" rel="nofollow">10.1191/1352458506ms1296oa</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16900760" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16900760">PMID 16900760</a><span class="printonly">. <a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900760" class="external free" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900760" rel="nofollow">http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=16900760</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Relationship+between+stress+and+relapse+in+multiple+sclerosis%3A+Part+II.+Direct+and+indirect+relationships&amp;rft.jtitle=Mult.+Scler.&amp;rft.aulast=Brown+RF%2C+Tennant+CC%2C+Sharrock+M%2C+Hodgkinson+S%2C+Dunn+SM%2C+Pollard+JD&amp;rft.au=Brown+RF%2C+Tennant+CC%2C+Sharrock+M%2C+Hodgkinson+S%2C+Dunn+SM%2C+Pollard+JD&amp;rft.date=August+2006&amp;rft.volume=12&amp;rft.issue=4&amp;rft.pages=465%E2%80%9375&amp;rft_id=info:doi/10.1191%2F1352458506ms1296oa&amp;rft_id=info:pmid/16900760&amp;rft_id=http%3A%2F%2Fmsj.sagepub.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16900760&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8195822-29"><b><a href="#cite_ref-pmid8195822_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWorthington_J.2C_Jones_R.2C_Crawford_M.2C_Forti_A1994">Worthington J, Jones R, Crawford M, Forti A (February 1994). "Pregnancy and multiple sclerosis--a 3-year prospective study". <i>J. Neurol.</i> <b>241</b> (4): 228–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF00863773" class="external text" title="http://dx.doi.org/10.1007%2FBF00863773" rel="nofollow">10.1007/BF00863773</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8195822" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8195822">PMID 8195822</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pregnancy+and+multiple+sclerosis--a+3-year+prospective+study&amp;rft.jtitle=J.+Neurol.&amp;rft.aulast=Worthington+J%2C+Jones+R%2C+Crawford+M%2C+Forti+A&amp;rft.au=Worthington+J%2C+Jones+R%2C+Crawford+M%2C+Forti+A&amp;rft.date=February+1994&amp;rft.volume=241&amp;rft.issue=4&amp;rft.pages=228%E2%80%9333&amp;rft_id=info:doi/10.1007%2FBF00863773&amp;rft_id=info:pmid/8195822&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11172162-30"><b><a href="#cite_ref-pmid11172162_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConfavreux_C.2C_Suissa_S.2C_Saddier_P.2C_Bourd.C3.A8s_V.2C_Vukusic_S2001">Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "<a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11172162&amp;promo=ONFLNS19" class="external text" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11172162&amp;promo=ONFLNS19" rel="nofollow">Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group</a>". <i>N. Engl. J. Med.</i> <b>344</b> (5): 319–26. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11172162" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11172162">PMID 11172162</a><span class="printonly">. <a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11172162&amp;promo=ONFLNS19" class="external free" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11172162&amp;promo=ONFLNS19" rel="nofollow">http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11172162&amp;promo=ONFLNS19</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Vaccinations+and+the+risk+of+relapse+in+multiple+sclerosis.+Vaccines+in+Multiple+Sclerosis+Study+Group&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Confavreux+C%2C+Suissa+S%2C+Saddier+P%2C+Bourd%C3%A8s+V%2C+Vukusic+S&amp;rft.au=Confavreux+C%2C+Suissa+S%2C+Saddier+P%2C+Bourd%C3%A8s+V%2C+Vukusic+S&amp;rft.date=February+2001&amp;rft.volume=344&amp;rft.issue=5&amp;rft.pages=319%E2%80%9326&amp;rft_id=info:pmid/11172162&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D11172162%26promo%3DONFLNS19&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11205361-31"><b><a href="#cite_ref-pmid11205361_31-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMartinelli_V2000">Martinelli V (2000). "<a href="http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm" class="external text" title="http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm" rel="nofollow">Trauma, stress and multiple sclerosis</a>". <i>Neurol. Sci.</i> <b>21</b> (4 Suppl 2): S849–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs100720070024" class="external text" title="http://dx.doi.org/10.1007%2Fs100720070024" rel="nofollow">10.1007/s100720070024</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11205361" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11205361">PMID 11205361</a><span class="printonly">. <a href="http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm" class="external free" title="http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm" rel="nofollow">http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Trauma%2C+stress+and+multiple+sclerosis&amp;rft.jtitle=Neurol.+Sci.&amp;rft.aulast=Martinelli+V&amp;rft.au=Martinelli+V&amp;rft.date=2000&amp;rft.volume=21&amp;rft.issue=4+Suppl+2&amp;rft.pages=S849%E2%80%9352&amp;rft_id=info:doi/10.1007%2Fs100720070024&amp;rft_id=info:pmid/11205361&amp;rft_id=http%3A%2F%2Flink.springer-ny.com%2Flink%2Fservice%2Fjournals%2F10072%2Fbibs%2F00214%2520Suppl%25202%2F0021S849.htm&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid1895121-32"><b><a href="#cite_ref-pmid1895121_32-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSibley_WA.2C_Bamford_CR.2C_Clark_K.2C_Smith_MS.2C_Laguna_JF1991">Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (July 1991). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1014426" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1014426" rel="nofollow">A prospective study of physical trauma and multiple sclerosis</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>54</b> (7): 584–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.54.7.584" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.54.7.584" rel="nofollow">10.1136/jnnp.54.7.584</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1895121" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1895121">PMID 1895121</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+prospective+study+of+physical+trauma+and+multiple+sclerosis&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Sibley+WA%2C+Bamford+CR%2C+Clark+K%2C+Smith+MS%2C+Laguna+JF&amp;rft.au=Sibley+WA%2C+Bamford+CR%2C+Clark+K%2C+Smith+MS%2C+Laguna+JF&amp;rft.date=July+1991&amp;rft.volume=54&amp;rft.issue=7&amp;rft.pages=584%E2%80%939&amp;rft_id=info:doi/10.1136%2Fjnnp.54.7.584&amp;rft_id=info:pmid/1895121&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10603618-33"><b><a href="#cite_ref-pmid10603618_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSmith_KJ.2C_McDonald_WI1999">Smith KJ, McDonald WI (October 1999). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1692682" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1692682" rel="nofollow">The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease</a>". <i>Philos. Trans. R. Soc. Lond., B, Biol. Sci.</i> <b>354</b> (1390): 1649–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1098%2Frstb.1999.0510" class="external text" title="http://dx.doi.org/10.1098%2Frstb.1999.0510" rel="nofollow">10.1098/rstb.1999.0510</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10603618" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10603618">PMID 10603618</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+pathophysiology+of+multiple+sclerosis%3A+the+mechanisms+underlying+the+production+of+symptoms+and+the+natural+history+of+the+disease&amp;rft.jtitle=Philos.+Trans.+R.+Soc.+Lond.%2C+B%2C+Biol.+Sci.&amp;rft.aulast=Smith+KJ%2C+McDonald+WI&amp;rft.au=Smith+KJ%2C+McDonald+WI&amp;rft.date=October+1999&amp;rft.volume=354&amp;rft.issue=1390&amp;rft.pages=1649%E2%80%9373&amp;rft_id=info:doi/10.1098%2Frstb.1999.0510&amp;rft_id=info:pmid/10603618&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18219812-34"><b><a href="#cite_ref-pmid18219812_34-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPittock_SJ.2C_Rodriguez_M2008">Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". <i>Curr. Top. Microbiol. Immunol.</i> <b>318</b>: 1–17. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2F978-3-540-73677-6_1" class="external text" title="http://dx.doi.org/10.1007%2F978-3-540-73677-6_1" rel="nofollow">10.1007/978-3-540-73677-6_1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18219812" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18219812">PMID 18219812</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Benign+multiple+sclerosis%3A+a+distinct+clinical+entity+with+therapeutic+implications&amp;rft.jtitle=Curr.+Top.+Microbiol.+Immunol.&amp;rft.aulast=Pittock+SJ%2C+Rodriguez+M&amp;rft.au=Pittock+SJ%2C+Rodriguez+M&amp;rft.date=2008&amp;rft.volume=318&amp;rft.pages=1%E2%80%9317&amp;rft_id=info:doi/10.1007%2F978-3-540-73677-6_1&amp;rft_id=info:pmid/18219812&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16545751-35"><b><a href="#cite_ref-pmid16545751_35-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRovaris_M.2C_Confavreux_C.2C_Furlan_R.2C_Kappos_L.2C_Comi_G.2C_Filippi_M2006">Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". <i>Lancet Neurol</i> <b>5</b> (4): 343–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2806%2970410-0" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2806%2970410-0" rel="nofollow">10.1016/S1474-4422(06)70410-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16545751" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16545751">PMID 16545751</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Secondary+progressive+multiple+sclerosis%3A+current+knowledge+and+future+challenges&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Rovaris+M%2C+Confavreux+C%2C+Furlan+R%2C+Kappos+L%2C+Comi+G%2C+Filippi+M&amp;rft.au=Rovaris+M%2C+Confavreux+C%2C+Furlan+R%2C+Kappos+L%2C+Comi+G%2C+Filippi+M&amp;rft.date=April+2006&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=343%E2%80%9354&amp;rft_id=info:doi/10.1016%2FS1474-4422%2806%2970410-0&amp;rft_id=info:pmid/16545751&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17884680-36">^ <a href="#cite_ref-pmid17884680_36-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17884680_36-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17884680_36-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17884680_36-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMiller_DH.2C_Leary_SM2007">Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". <i>Lancet Neurol</i> <b>6</b> (10): 903–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2807%2970243-0" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2807%2970243-0" rel="nofollow">10.1016/S1474-4422(07)70243-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17884680" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17884680">PMID 17884680</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary-progressive+multiple+sclerosis&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Miller+DH%2C+Leary+SM&amp;rft.au=Miller+DH%2C+Leary+SM&amp;rft.date=October+2007&amp;rft.volume=6&amp;rft.issue=10&amp;rft.pages=903%E2%80%9312&amp;rft_id=info:doi/10.1016%2FS1474-4422%2807%2970243-0&amp;rft_id=info:pmid/17884680&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11787357-37"><b><a href="#cite_ref-pmid11787357_37-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFontaine_B2001">Fontaine B (September 2001). "<a href="http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68" class="external text" title="http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68" rel="nofollow">[Borderline forms of multiple sclerosis</a>]" (in French). <i>Rev. Neurol. (Paris)</i> <b>157</b> (8-9 Pt 2): 929–34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11787357" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11787357">PMID 11787357</a><span class="printonly">. <a href="http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68" class="external free" title="http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68" rel="nofollow">http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BBorderline+forms+of+multiple+sclerosis%5D&amp;rft.jtitle=Rev.+Neurol.+%28Paris%29&amp;rft.aulast=Fontaine+B&amp;rft.au=Fontaine+B&amp;rft.date=September+2001&amp;rft.volume=157&amp;rft.issue=8-9+Pt+2&amp;rft.pages=929%E2%80%9334&amp;rft_id=info:pmid/11787357&amp;rft_id=http%3A%2F%2Fwww.masson.fr%2Fmasson%2FMDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15727234-38"><b><a href="#cite_ref-pmid15727234_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCapello_E.2C_Mancardi_GL2004">Capello E, Mancardi GL (November 2004). "Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis". <i>Neurol. Sci.</i> <b>25 Suppl 4</b>: S361–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs10072-004-0341-1" class="external text" title="http://dx.doi.org/10.1007%2Fs10072-004-0341-1" rel="nofollow">10.1007/s10072-004-0341-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15727234" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15727234">PMID 15727234</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Marburg+type+and+Bal%C3%B2%27s+concentric+sclerosis%3A+rare+and+acute+variants+of+multiple+sclerosis&amp;rft.jtitle=Neurol.+Sci.&amp;rft.aulast=Capello+E%2C+Mancardi+GL&amp;rft.au=Capello+E%2C+Mancardi+GL&amp;rft.date=November+2004&amp;rft.volume=25+Suppl+4&amp;rft.pages=S361%E2%80%933&amp;rft_id=info:doi/10.1007%2Fs10072-004-0341-1&amp;rft_id=info:pmid/15727234&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid1343820-39"><b><a href="#cite_ref-pmid1343820_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHainfellner_JA.2C_Schmidbauer_M.2C_Schmutzhard_E.2C_Maier_H.2C_Budka_H1992">Hainfellner JA, Schmidbauer M, Schmutzhard E, Maier H, Budka H (December 1992). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1015338" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1015338" rel="nofollow">Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>55</b> (12): 1194–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.55.12.1194" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.55.12.1194" rel="nofollow">10.1136/jnnp.55.12.1194</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1343820" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1343820">PMID 1343820</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Devic%27s+neuromyelitis+optica+and+Schilder%27s+myelinoclastic+diffuse+sclerosis&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Hainfellner+JA%2C+Schmidbauer+M%2C+Schmutzhard+E%2C+Maier+H%2C+Budka+H&amp;rft.au=Hainfellner+JA%2C+Schmidbauer+M%2C+Schmutzhard+E%2C+Maier+H%2C+Budka+H&amp;rft.date=December+1992&amp;rft.volume=55&amp;rft.issue=12&amp;rft.pages=1194%E2%80%936&amp;rft_id=info:doi/10.1136%2Fjnnp.55.12.1194&amp;rft_id=info:pmid/1343820&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStark_W.2C_Huppke_P.2C_G.C3.A4rtner_J2008">Stark W, Huppke P, Gärtner J (December 2008). "Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence". <i>J. Neurol.</i> <b>255 Suppl 6</b>: 119–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00415-008-6022-x" class="external text" title="http://dx.doi.org/10.1007%2Fs00415-008-6022-x" rel="nofollow">10.1007/s00415-008-6022-x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19300972" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/19300972">PMID 19300972</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Paediatric+multiple+sclerosis%3A+the+experience+of+the+German+Centre+for+Multiple+Sclerosis+in+Childhood+and+Adolescence&amp;rft.jtitle=J.+Neurol.&amp;rft.aulast=Stark+W%2C+Huppke+P%2C+G%C3%A4rtner+J&amp;rft.au=Stark+W%2C+Huppke+P%2C+G%C3%A4rtner+J&amp;rft.date=December+2008&amp;rft.volume=255+Suppl+6&amp;rft.pages=119%E2%80%9322&amp;rft_id=info:doi/10.1007%2Fs00415-008-6022-x&amp;rft_id=info:pmid/19300972&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9229127-41"><b><a href="#cite_ref-pmid9229127_41-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFO.27Riordan_JI1997">O'Riordan JI (June 1997). "Central nervous system white matter diseases other than multiple sclerosis". <i>Curr. Opin. Neurol.</i> <b>10</b> (3): 211–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9229127" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9229127">PMID 9229127</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Central+nervous+system+white+matter+diseases+other+than+multiple+sclerosis&amp;rft.jtitle=Curr.+Opin.+Neurol.&amp;rft.aulast=O%27Riordan+JI&amp;rft.au=O%27Riordan+JI&amp;rft.date=June+1997&amp;rft.volume=10&amp;rft.issue=3&amp;rft.pages=211%E2%80%934&amp;rft_id=info:pmid/9229127&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11794488-42"><b><a href="#cite_ref-pmid11794488_42-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTrojano_M.2C_Paolicelli_D2001">Trojano M, Paolicelli D (November 2001). "<a href="http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm" class="external text" title="http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm" rel="nofollow">The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes</a>". <i>Neurol. Sci.</i> <b>22 Suppl 2</b>: S98–102. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs100720100044" class="external text" title="http://dx.doi.org/10.1007%2Fs100720100044" rel="nofollow">10.1007/s100720100044</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11794488" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11794488">PMID 11794488</a><span class="printonly">. <a href="http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm" class="external free" title="http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm" rel="nofollow">http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+differential+diagnosis+of+multiple+sclerosis%3A+classification+and+clinical+features+of+relapsing+and+progressive+neurological+syndromes&amp;rft.jtitle=Neurol.+Sci.&amp;rft.aulast=Trojano+M%2C+Paolicelli+D&amp;rft.au=Trojano+M%2C+Paolicelli+D&amp;rft.date=November+2001&amp;rft.volume=22+Suppl+2&amp;rft.pages=S98%E2%80%93102&amp;rft_id=info:doi/10.1007%2Fs100720100044&amp;rft_id=info:pmid/11794488&amp;rft_id=http%3A%2F%2Flink.springer-ny.com%2Flink%2Fservice%2Fjournals%2F10072%2Fbibs%2F122%2520Suppl%25202000%2F122%2520Suppl%252020S98.htm&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15177763-43"><b><a href="#cite_ref-pmid15177763_43-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPoser_CM.2C_Brinar_VV2004">Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". <i>Clin Neurol Neurosurg</i> <b>106</b> (3): 147–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.clineuro.2004.02.004" class="external text" title="http://dx.doi.org/10.1016%2Fj.clineuro.2004.02.004" rel="nofollow">10.1016/j.clineuro.2004.02.004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15177763" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15177763">PMID 15177763</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diagnostic+criteria+for+multiple+sclerosis%3A+an+historical+review&amp;rft.jtitle=Clin+Neurol+Neurosurg&amp;rft.aulast=Poser+CM%2C+Brinar+VV&amp;rft.au=Poser+CM%2C+Brinar+VV&amp;rft.date=June+2004&amp;rft.volume=106&amp;rft.issue=3&amp;rft.pages=147%E2%80%9358&amp;rft_id=info:doi/10.1016%2Fj.clineuro.2004.02.004&amp;rft_id=info:pmid/15177763&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11456302-44">^ <a href="#cite_ref-pmid11456302_44-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11456302_44-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11456302_44-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid11456302_44-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMcDonald_WI.2C_Compston_A.2C_Edan_G.2C_.27.27et_al.27.272001">McDonald WI, Compston A, Edan G, <i>et al</i> (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". <i>Ann. Neurol.</i> <b>50</b> (1): 121–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.1032" class="external text" title="http://dx.doi.org/10.1002%2Fana.1032" rel="nofollow">10.1002/ana.1032</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11456302" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11456302">PMID 11456302</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Recommended+diagnostic+criteria+for+multiple+sclerosis%3A+guidelines+from+the+International+Panel+on+the+diagnosis+of+multiple+sclerosis&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=McDonald+WI%2C+Compston+A%2C+Edan+G%2C+%27%27et+al%27%27&amp;rft.au=McDonald+WI%2C+Compston+A%2C+Edan+G%2C+%27%27et+al%27%27&amp;rft.date=July+2001&amp;rft.volume=50&amp;rft.issue=1&amp;rft.pages=121%E2%80%937&amp;rft_id=info:doi/10.1002%2Fana.1032&amp;rft_id=info:pmid/11456302&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18256986-45"><b><a href="#cite_ref-pmid18256986_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRashid_W.2C_Miller_DH2008">Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". <i>Semin Neurol</i> <b>28</b> (1): 46–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1055%2Fs-2007-1019127" class="external text" title="http://dx.doi.org/10.1055%2Fs-2007-1019127" rel="nofollow">10.1055/s-2007-1019127</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18256986" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18256986">PMID 18256986</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Recent+advances+in+neuroimaging+of+multiple+sclerosis&amp;rft.jtitle=Semin+Neurol&amp;rft.aulast=Rashid+W%2C+Miller+DH&amp;rft.au=Rashid+W%2C+Miller+DH&amp;rft.date=February+2008&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=46%E2%80%9355&amp;rft_id=info:doi/10.1055%2Fs-2007-1019127&amp;rft_id=info:pmid/18256986&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16945427-46"><b><a href="#cite_ref-pmid16945427_46-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLink_H.2C_Huang_YM2006">Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". <i>J. Neuroimmunol.</i> <b>180</b> (1-2): 17–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jneuroim.2006.07.006" class="external text" title="http://dx.doi.org/10.1016%2Fj.jneuroim.2006.07.006" rel="nofollow">10.1016/j.jneuroim.2006.07.006</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16945427" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16945427">PMID 16945427</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oligoclonal+bands+in+multiple+sclerosis+cerebrospinal+fluid%3A+an+update+on+methodology+and+clinical+usefulness&amp;rft.jtitle=J.+Neuroimmunol.&amp;rft.aulast=Link+H%2C+Huang+YM&amp;rft.au=Link+H%2C+Huang+YM&amp;rft.date=November+2006&amp;rft.volume=180&amp;rft.issue=1-2&amp;rft.pages=17%E2%80%9328&amp;rft_id=info:doi/10.1016%2Fj.jneuroim.2006.07.006&amp;rft_id=info:pmid/16945427&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10802774-47"><b><a href="#cite_ref-pmid10802774_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGronseth_GS.2C_Ashman_EJ2000">Gronseth GS, Ashman EJ (May 2000). "<a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=10802774" class="external text" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=10802774" rel="nofollow">Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology</a>". <i>Neurology</i> <b>54</b> (9): 1720–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10802774" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10802774">PMID 10802774</a><span class="printonly">. <a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=10802774" class="external free" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=10802774" rel="nofollow">http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=10802774</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Practice+parameter%3A+the+usefulness+of+evoked+potentials+in+identifying+clinically+silent+lesions+in+patients+with+suspected+multiple+sclerosis+%28an+evidence-based+review%29%3A+Report+of+the+Quality+Standards+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.jtitle=Neurology&amp;rft.aulast=Gronseth+GS%2C+Ashman+EJ&amp;rft.au=Gronseth+GS%2C+Ashman+EJ&amp;rft.date=May+2000&amp;rft.volume=54&amp;rft.issue=9&amp;rft.pages=1720%E2%80%935&amp;rft_id=info:pmid/10802774&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10802774&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17606882-48"><b><a href="#cite_ref-pmid17606882_48-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPascual_AM.2C_Mart.C3.ADnez-Bisbal_MC.2C_Bosc.C3.A1_I.2C_.27.27et_al.27.272007">Pascual AM, Martínez-Bisbal MC, Boscá I, <i>et al</i> (July 2007). "Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis". <i>Neurology</i> <b>69</b> (1): 63–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000265054.08610.12" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000265054.08610.12" rel="nofollow">10.1212/01.wnl.0000265054.08610.12</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17606882" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17606882">PMID 17606882</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Axonal+loss+is+progressive+and+partly+dissociated+from+lesion+load+in+early+multiple+sclerosis&amp;rft.jtitle=Neurology&amp;rft.aulast=Pascual+AM%2C+Mart%C3%ADnez-Bisbal+MC%2C+Bosc%C3%A1+I%2C+%27%27et+al%27%27&amp;rft.au=Pascual+AM%2C+Mart%C3%ADnez-Bisbal+MC%2C+Bosc%C3%A1+I%2C+%27%27et+al%27%27&amp;rft.date=July+2007&amp;rft.volume=69&amp;rft.issue=1&amp;rft.pages=63%E2%80%937&amp;rft_id=info:doi/10.1212%2F01.wnl.0000265054.08610.12&amp;rft_id=info:pmid/17606882&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17531860-49">^ <a href="#cite_ref-pmid17531860_49-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17531860_49-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFChari_DM2007">Chari DM (2007). "Remyelination in multiple sclerosis". <i>Int. Rev. Neurobiol.</i> <b>79</b>: 589–620. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0074-7742%2807%2979026-8" class="external text" title="http://dx.doi.org/10.1016%2FS0074-7742%2807%2979026-8" rel="nofollow">10.1016/S0074-7742(07)79026-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17531860" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17531860">PMID 17531860</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Remyelination+in+multiple+sclerosis&amp;rft.jtitle=Int.+Rev.+Neurobiol.&amp;rft.aulast=Chari+DM&amp;rft.au=Chari+DM&amp;rft.date=2007&amp;rft.volume=79&amp;rft.pages=589%E2%80%93620&amp;rft_id=info:doi/10.1016%2FS0074-7742%2807%2979026-8&amp;rft_id=info:pmid/17531860&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10852536-50"><b><a href="#cite_ref-pmid10852536_50-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLucchinetti_C.2C_Br.C3.BCck_W.2C_Parisi_J.2C_Scheithauer_B.2C_Rodriguez_M.2C_Lassmann_H2000">Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (June 2000). "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination". <i>Ann. Neurol.</i> <b>47</b> (6): 707–17. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F1531-8249%28200006%2947%3A6%3C707%3A%3AAID-ANA3%3E3.0.CO%3B2-Q" class="external text" title="http://dx.doi.org/10.1002%2F1531-8249%28200006%2947%3A6%3C707%3A%3AAID-ANA3%3E3.0.CO%3B2-Q" rel="nofollow">10.1002/1531-8249(200006)47:6&lt;707::AID-ANA3&gt;3.0.CO;2-Q</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10852536" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10852536">PMID 10852536</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Heterogeneity+of+multiple+sclerosis+lesions%3A+implications+for+the+pathogenesis+of+demyelination&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Lucchinetti+C%2C+Br%C3%BCck+W%2C+Parisi+J%2C+Scheithauer+B%2C+Rodriguez+M%2C+Lassmann+H&amp;rft.au=Lucchinetti+C%2C+Br%C3%BCck+W%2C+Parisi+J%2C+Scheithauer+B%2C+Rodriguez+M%2C+Lassmann+H&amp;rft.date=June+2000&amp;rft.volume=47&amp;rft.issue=6&amp;rft.pages=707%E2%80%9317&amp;rft_id=info:doi/10.1002%2F1531-8249%28200006%2947%3A6%3C707%3A%3AAID-ANA3%3E3.0.CO%3B2-Q&amp;rft_id=info:pmid/10852536&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8269393-51">^ <a href="#cite_ref-pmid8269393_51-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8269393_51-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8269393_51-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8269393_51-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKurtzke_JF1993">Kurtzke JF (October 1993). "<a href="http://cmr.asm.org/cgi/pmidlookup?view=long&amp;pmid=8269393" class="external text" title="http://cmr.asm.org/cgi/pmidlookup?view=long&amp;pmid=8269393" rel="nofollow">Epidemiologic evidence for multiple sclerosis as an infection</a>". <i>Clin. Microbiol. Rev.</i> <b>6</b> (4): 382–427. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8269393" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8269393">PMID 8269393</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=358295" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=358295" rel="nofollow">358295</a><span class="printonly">. <a href="http://cmr.asm.org/cgi/pmidlookup?view=long&amp;pmid=8269393" class="external free" title="http://cmr.asm.org/cgi/pmidlookup?view=long&amp;pmid=8269393" rel="nofollow">http://cmr.asm.org/cgi/pmidlookup?view=long&amp;pmid=8269393</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemiologic+evidence+for+multiple+sclerosis+as+an+infection&amp;rft.jtitle=Clin.+Microbiol.+Rev.&amp;rft.aulast=Kurtzke+JF&amp;rft.au=Kurtzke+JF&amp;rft.date=October+1993&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=382%E2%80%93427&amp;rft_id=info:pmid/8269393&amp;rft_id=http%3A%2F%2Fcmr.asm.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D8269393&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15556803-52">^ <a href="#cite_ref-pmid15556803_52-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid15556803_52-7" title=""><sup><i><b>h</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMarrie_RA2004">Marrie RA (December 2004). "Environmental risk factors in multiple sclerosis aetiology". <i>Lancet Neurol</i> <b>3</b> (12): 709–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2804%2900933-0" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2804%2900933-0" rel="nofollow">10.1016/S1474-4422(04)00933-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15556803" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15556803">PMID 15556803</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+risk+factors+in+multiple+sclerosis+aetiology&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Marrie+RA&amp;rft.au=Marrie+RA&amp;rft.date=December+2004&amp;rft.volume=3&amp;rft.issue=12&amp;rft.pages=709%E2%80%9318&amp;rft_id=info:doi/10.1016%2FS1474-4422%2804%2900933-0&amp;rft_id=info:pmid/15556803&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17492755-53">^ <a href="#cite_ref-pmid17492755_53-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17492755_53-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17492755_53-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17492755_53-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17492755_53-4" title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAscherio_A.2C_Munger_KL2007">Ascherio A, Munger KL (June 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". <i>Ann. Neurol.</i> <b>61</b> (6): 504–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.21141" class="external text" title="http://dx.doi.org/10.1002%2Fana.21141" rel="nofollow">10.1002/ana.21141</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17492755" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17492755">PMID 17492755</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+risk+factors+for+multiple+sclerosis.+Part+II%3A+Noninfectious+factors&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Ascherio+A%2C+Munger+KL&amp;rft.au=Ascherio+A%2C+Munger+KL&amp;rft.date=June+2007&amp;rft.volume=61&amp;rft.issue=6&amp;rft.pages=504%E2%80%9313&amp;rft_id=info:doi/10.1002%2Fana.21141&amp;rft_id=info:pmid/17492755&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11582940-54">^ <a href="#cite_ref-pmid11582940_54-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11582940_54-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBrissaud_O.2C_Palin_K.2C_Chateil_JF.2C_Pedespan_JM2001">Brissaud O, Palin K, Chateil JF, Pedespan JM (September 2001). "Multiple sclerosis: pathogenesis and manifestations in children" (in French). <i>Arch Pediatr</i> <b>8</b> (9): 969–78. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0929-693X%2801%2900564-4" class="external text" title="http://dx.doi.org/10.1016%2FS0929-693X%2801%2900564-4" rel="nofollow">10.1016/S0929-693X(01)00564-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11582940" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11582940">PMID 11582940</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multiple+sclerosis%3A+pathogenesis+and+manifestations+in+children&amp;rft.jtitle=Arch+Pediatr&amp;rft.aulast=Brissaud+O%2C+Palin+K%2C+Chateil+JF%2C+Pedespan+JM&amp;rft.au=Brissaud+O%2C+Palin+K%2C+Chateil+JF%2C+Pedespan+JM&amp;rft.date=September+2001&amp;rft.volume=8&amp;rft.issue=9&amp;rft.pages=969%E2%80%9378&amp;rft_id=info:doi/10.1016%2FS0929-693X%2801%2900564-4&amp;rft_id=info:pmid/11582940&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18606967-55">^ <a href="#cite_ref-pmid18606967_55-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18606967_55-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18606967_55-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAlonso_A.2C_Hern.C3.A1n_MA2008">Alonso A, Hernán MA (July 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". <i>Neurology</i> <b>71</b> (2): 129–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000316802.35974.34" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000316802.35974.34" rel="nofollow">10.1212/01.wnl.0000316802.35974.34</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18606967" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18606967">PMID 18606967</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Temporal+trends+in+the+incidence+of+multiple+sclerosis%3A+a+systematic+review&amp;rft.jtitle=Neurology&amp;rft.aulast=Alonso+A%2C+Hern%C3%A1n+MA&amp;rft.au=Alonso+A%2C+Hern%C3%A1n+MA&amp;rft.date=July+2008&amp;rft.volume=71&amp;rft.issue=2&amp;rft.pages=129%E2%80%9335&amp;rft_id=info:doi/10.1212%2F01.wnl.0000316802.35974.34&amp;rft_id=info:pmid/18606967&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15459512-56"><b><a href="#cite_ref-pmid15459512_56-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAladro_Y.2C_Alemany_MJ.2C_P.C3.A9rez-Vieitez_MC.2C_.27.27et_al.27.272005">Aladro Y, Alemany MJ, Pérez-Vieitez MC, <i>et al</i> (2005). "Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain". <i>Neuroepidemiology</i> <b>24</b> (1-2): 70–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000081052" class="external text" title="http://dx.doi.org/10.1159%2F000081052" rel="nofollow">10.1159/000081052</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15459512" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15459512">PMID 15459512</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+and+incidence+of+multiple+sclerosis+in+Las+Palmas%2C+Canary+Islands%2C+Spain&amp;rft.jtitle=Neuroepidemiology&amp;rft.aulast=Aladro+Y%2C+Alemany+MJ%2C+P%C3%A9rez-Vieitez+MC%2C+%27%27et+al%27%27&amp;rft.au=Aladro+Y%2C+Alemany+MJ%2C+P%C3%A9rez-Vieitez+MC%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=24&amp;rft.issue=1-2&amp;rft.pages=70%E2%80%935&amp;rft_id=info:doi/10.1159%2F000081052&amp;rft_id=info:pmid/15459512&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11603620-57">^ <a href="#cite_ref-pmid11603620_57-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11603620_57-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPugliatti_M.2C_Sotgiu_S.2C_Solinas_G.2C_Castiglia_P.2C_Rosati_G2001">Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Rosati G (April 2001). "<a href="http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm" class="external text" title="http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm" rel="nofollow">Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory</a>". <i>Neurol. Sci.</i> <b>22</b> (2): 163–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs100720170017" class="external text" title="http://dx.doi.org/10.1007%2Fs100720170017" rel="nofollow">10.1007/s100720170017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11603620" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11603620">PMID 11603620</a><span class="printonly">. <a href="http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm" class="external free" title="http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm" rel="nofollow">http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multiple+sclerosis+prevalence+among+Sardinians%3A+further+evidence+against+the+latitude+gradient+theory&amp;rft.jtitle=Neurol.+Sci.&amp;rft.aulast=Pugliatti+M%2C+Sotgiu+S%2C+Solinas+G%2C+Castiglia+P%2C+Rosati+G&amp;rft.au=Pugliatti+M%2C+Sotgiu+S%2C+Solinas+G%2C+Castiglia+P%2C+Rosati+G&amp;rft.date=April+2001&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=163%E2%80%935&amp;rft_id=info:doi/10.1007%2Fs100720170017&amp;rft_id=info:pmid/11603620&amp;rft_id=http%3A%2F%2Flink.springer-ny.com%2Flink%2Fservice%2Fjournals%2F10072%2Fbibs%2F1022002%2F10220163.htm&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10775541-58"><b><a href="#cite_ref-pmid10775541_58-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHammond_SR.2C_English_DR.2C_McLeod_JG2000">Hammond SR, English DR, McLeod JG (May 2000). "<a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10775541" class="external text" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10775541" rel="nofollow">The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia</a>". <i>Brain</i> <b>123 (Pt 5)</b>: 968–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fbrain%2F123.5.968" class="external text" title="http://dx.doi.org/10.1093%2Fbrain%2F123.5.968" rel="nofollow">10.1093/brain/123.5.968</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10775541" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10775541">PMID 10775541</a><span class="printonly">. <a href="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10775541" class="external free" title="http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10775541" rel="nofollow">http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10775541</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+age-range+of+risk+of+developing+multiple+sclerosis%3A+evidence+from+a+migrant+population+in+Australia&amp;rft.jtitle=Brain&amp;rft.aulast=Hammond+SR%2C+English+DR%2C+McLeod+JG&amp;rft.au=Hammond+SR%2C+English+DR%2C+McLeod+JG&amp;rft.date=May+2000&amp;rft.volume=123+%28Pt+5%29&amp;rft.pages=968%E2%80%9374&amp;rft_id=info:doi/10.1093%2Fbrain%2F123.5.968&amp;rft_id=info:pmid/10775541&amp;rft_id=http%3A%2F%2Fbrain.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10775541&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRothwell_PM.2C_Charlton_D1998">Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>64</b> (6): 730–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.64.6.730" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.64.6.730" rel="nofollow">10.1136/jnnp.64.6.730</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9647300" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9647300">PMID 9647300</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=High+incidence+and+prevalence+of+multiple+sclerosis+in+south+east+Scotland%3A+evidence+of+a+genetic+predisposition&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Rothwell+PM%2C+Charlton+D&amp;rft.au=Rothwell+PM%2C+Charlton+D&amp;rft.date=1998&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=730%E2%80%935&amp;rft_id=info:doi/10.1136%2Fjnnp.64.6.730&amp;rft_id=info:pmid/9647300&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14747002-60"><b><a href="#cite_ref-pmid14747002_60-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDyment_DA.2C_Ebers_GC.2C_Sadovnick_AD2004">Dyment DA, Ebers GC, Sadovnick AD (Feb 2004). "Genetics of multiple sclerosis". <i>Lancet Neurol</i> <b>3</b> (92): 104–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2803%2900663-X" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2803%2900663-X" rel="nofollow">10.1016/S1474-4422(03)00663-X</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14747002" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14747002">PMID 14747002</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genetics+of+multiple+sclerosis&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Dyment+DA%2C+Ebers+GC%2C+Sadovnick+AD&amp;rft.au=Dyment+DA%2C+Ebers+GC%2C+Sadovnick+AD&amp;rft.date=Feb+2004&amp;rft.volume=3&amp;rft.issue=92&amp;rft.pages=104%E2%80%9310&amp;rft_id=info:doi/10.1016%2FS1474-4422%2803%2900663-X&amp;rft_id=info:pmid/14747002&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8656905-61"><b><a href="#cite_ref-pmid8656905_61-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSadovnick_AD.2C_Ebers_GC.2C_Dyment_DA.2C_Risch_NJ1996">Sadovnick AD, Ebers GC, Dyment DA, Risch NJ (June 1996). "Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group". <i>Lancet</i> <b>347</b> (9017): 1728–30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8656905" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8656905">PMID 8656905</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Evidence+for+genetic+basis+of+multiple+sclerosis.+The+Canadian+Collaborative+Study+Group&amp;rft.jtitle=Lancet&amp;rft.aulast=Sadovnick+AD%2C+Ebers+GC%2C+Dyment+DA%2C+Risch+NJ&amp;rft.au=Sadovnick+AD%2C+Ebers+GC%2C+Dyment+DA%2C+Risch+NJ&amp;rft.date=June+1996&amp;rft.volume=347&amp;rft.issue=9017&amp;rft.pages=1728%E2%80%9330&amp;rft_id=info:pmid/8656905&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18461312-62">^ <a href="#cite_ref-pmid18461312_62-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18461312_62-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFSvejgaard_A2008">Svejgaard A (June 2008). "The immunogenetics of multiple sclerosis". <i>Immunogenetics</i> <b>60</b> (6): 275–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00251-008-0295-1" class="external text" title="http://dx.doi.org/10.1007%2Fs00251-008-0295-1" rel="nofollow">10.1007/s00251-008-0295-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18461312" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18461312">PMID 18461312</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+immunogenetics+of+multiple+sclerosis&amp;rft.jtitle=Immunogenetics&amp;rft.aulast=Svejgaard+A&amp;rft.au=Svejgaard+A&amp;rft.date=June+2008&amp;rft.volume=60&amp;rft.issue=6&amp;rft.pages=275%E2%80%9386&amp;rft_id=info:doi/10.1007%2Fs00251-008-0295-1&amp;rft_id=info:pmid/18461312&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17660530-63"><b><a href="#cite_ref-pmid17660530_63-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHafler_DA.2C_Compston_A.2C_Sawcer_S.2C_.27.27et_al.27.272007">Hafler DA, Compston A, Sawcer S, <i>et al</i> (August 2007). "Risk alleles for multiple sclerosis identified by a genomewide study". <i>N. Engl. J. Med.</i> <b>357</b> (9): 851–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa073493" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa073493" rel="nofollow">10.1056/NEJMoa073493</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17660530" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17660530">PMID 17660530</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Risk+alleles+for+multiple+sclerosis+identified+by+a+genomewide+study&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Hafler+DA%2C+Compston+A%2C+Sawcer+S%2C+%27%27et+al%27%27&amp;rft.au=Hafler+DA%2C+Compston+A%2C+Sawcer+S%2C+%27%27et+al%27%27&amp;rft.date=August+2007&amp;rft.volume=357&amp;rft.issue=9&amp;rft.pages=851%E2%80%9362&amp;rft_id=info:doi/10.1056%2FNEJMoa073493&amp;rft_id=info:pmid/17660530&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18354419-64"><b><a href="#cite_ref-pmid18354419_64-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWeber_F.2C_Fontaine_B.2C_Cournu-Rebeix_I.2C_.27.27et_al.27.272008">Weber F, Fontaine B, Cournu-Rebeix I, <i>et al</i> (April 2008). "IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations". <i>Genes Immun.</i> <b>9</b> (3): 259–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fgene.2008.14" class="external text" title="http://dx.doi.org/10.1038%2Fgene.2008.14" rel="nofollow">10.1038/gene.2008.14</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18354419" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18354419">PMID 18354419</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=IL2RA+and+IL7RA+genes+confer+susceptibility+for+multiple+sclerosis+in+two+independent+European+populations&amp;rft.jtitle=Genes+Immun.&amp;rft.aulast=Weber+F%2C+Fontaine+B%2C+Cournu-Rebeix+I%2C+%27%27et+al%27%27&amp;rft.au=Weber+F%2C+Fontaine+B%2C+Cournu-Rebeix+I%2C+%27%27et+al%27%27&amp;rft.date=April+2008&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=259%E2%80%9363&amp;rft_id=info:doi/10.1038%2Fgene.2008.14&amp;rft_id=info:pmid/18354419&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17162361-65"><b><a href="#cite_ref-pmid17162361_65-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAnaya_JM.2C_G.C3.B3mez_L.2C_Castiblanco_J2006">Anaya JM, Gómez L, Castiblanco J (2006). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2270753" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2270753" rel="nofollow">Is there a common genetic basis for autoimmune diseases?</a>". <i>Clin. Dev. Immunol.</i> <b>13</b> (2-4): 185–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F17402520600876762" class="external text" title="http://dx.doi.org/10.1080%2F17402520600876762" rel="nofollow">10.1080/17402520600876762</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17162361" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17162361">PMID 17162361</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Is+there+a+common+genetic+basis+for+autoimmune+diseases%3F&amp;rft.jtitle=Clin.+Dev.+Immunol.&amp;rft.aulast=Anaya+JM%2C+G%C3%B3mez+L%2C+Castiblanco+J&amp;rft.au=Anaya+JM%2C+G%C3%B3mez+L%2C+Castiblanco+J&amp;rft.date=2006&amp;rft.volume=13&amp;rft.issue=2-4&amp;rft.pages=185%E2%80%9395&amp;rft_id=info:doi/10.1080%2F17402520600876762&amp;rft_id=info:pmid/17162361&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18779574-66"><b><a href="#cite_ref-pmid18779574_66-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSpolski_R.2C_Kashyap_M.2C_Robinson_C.2C_Yu_Z.2C_Leonard_WJ2008">Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ (September 2008). "IL-21 signaling is critical for the development of type I diabetes in the NOD mouse". <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>105</b>: 14028. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1073%2Fpnas.0804358105" class="external text" title="http://dx.doi.org/10.1073%2Fpnas.0804358105" rel="nofollow">10.1073/pnas.0804358105</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18779574" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18779574">PMID 18779574</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=IL-21+signaling+is+critical+for+the+development+of+type+I+diabetes+in+the+NOD+mouse&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.aulast=Spolski+R%2C+Kashyap+M%2C+Robinson+C%2C+Yu+Z%2C+Leonard+WJ&amp;rft.au=Spolski+R%2C+Kashyap+M%2C+Robinson+C%2C+Yu+Z%2C+Leonard+WJ&amp;rft.date=September+2008&amp;rft.volume=105&amp;rft.pages=14028&amp;rft_id=info:doi/10.1073%2Fpnas.0804358105&amp;rft_id=info:pmid/18779574&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-67"><b><a href="#cite_ref-67" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAulchenko_YS.2C_Hoppenbrouwers_IA.2C_Ramagopalan_SV.2C_.27.27et_al.27.272008">Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, <i>et al</i> (December 2008). "Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis". <i>Nat. Genet.</i> <b>40</b> (12): 1402–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fng.251" class="external text" title="http://dx.doi.org/10.1038%2Fng.251" rel="nofollow">10.1038/ng.251</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18997785" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18997785">PMID 18997785</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genetic+variation+in+the+KIF1B+locus+influences+susceptibility+to+multiple+sclerosis&amp;rft.jtitle=Nat.+Genet.&amp;rft.aulast=Aulchenko+YS%2C+Hoppenbrouwers+IA%2C+Ramagopalan+SV%2C+%27%27et+al%27%27&amp;rft.au=Aulchenko+YS%2C+Hoppenbrouwers+IA%2C+Ramagopalan+SV%2C+%27%27et+al%27%27&amp;rft.date=December+2008&amp;rft.volume=40&amp;rft.issue=12&amp;rft.pages=1402%E2%80%933&amp;rft_id=info:doi/10.1038%2Fng.251&amp;rft_id=info:pmid/18997785&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16099057-68"><b><a href="#cite_ref-pmid16099057_68-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPalacios_R.2C_Aguirrezabal_I.2C_Fernandez-Diez_B.2C_Brieva_L.2C_Villoslada_P2005">Palacios R, Aguirrezabal I, Fernandez-Diez B, Brieva L, Villoslada P (October 2005). "Chromosome 5 and multiple sclerosis". <i>J. Neuroimmunol.</i> <b>167</b> (1-2): 1–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jneuroim.2005.06.023" class="external text" title="http://dx.doi.org/10.1016%2Fj.jneuroim.2005.06.023" rel="nofollow">10.1016/j.jneuroim.2005.06.023</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16099057" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16099057">PMID 16099057</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chromosome+5+and+multiple+sclerosis&amp;rft.jtitle=J.+Neuroimmunol.&amp;rft.aulast=Palacios+R%2C+Aguirrezabal+I%2C+Fernandez-Diez+B%2C+Brieva+L%2C+Villoslada+P&amp;rft.au=Palacios+R%2C+Aguirrezabal+I%2C+Fernandez-Diez+B%2C+Brieva+L%2C+Villoslada+P&amp;rft.date=October+2005&amp;rft.volume=167&amp;rft.issue=1-2&amp;rft.pages=1%E2%80%933&amp;rft_id=info:doi/10.1016%2Fj.jneuroim.2005.06.023&amp;rft_id=info:pmid/16099057&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid5910580-69"><b><a href="#cite_ref-pmid5910580_69-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLeibowitz_U.2C_Antonovsky_A.2C_Medalie_JM.2C_Smith_HA.2C_Halpern_L.2C_Alter_M1966">Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (February 1966). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=495985" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=495985" rel="nofollow">Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>29</b> (1): 60–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.29.1.60" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.29.1.60" rel="nofollow">10.1136/jnnp.29.1.60</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/5910580" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/5910580">PMID 5910580</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemiological+study+of+multiple+sclerosis+in+Israel.+II.+Multiple+sclerosis+and+level+of+sanitation&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Leibowitz+U%2C+Antonovsky+A%2C+Medalie+JM%2C+Smith+HA%2C+Halpern+L%2C+Alter+M&amp;rft.au=Leibowitz+U%2C+Antonovsky+A%2C+Medalie+JM%2C+Smith+HA%2C+Halpern+L%2C+Alter+M&amp;rft.date=February+1966&amp;rft.volume=29&amp;rft.issue=1&amp;rft.pages=60%E2%80%938&amp;rft_id=info:doi/10.1136%2Fjnnp.29.1.60&amp;rft_id=info:pmid/5910580&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17315205-70"><b><a href="#cite_ref-pmid17315205_70-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFleming_J.2C_Fabry_Z2007">Fleming J, Fabry Z (February 2007). "The hygiene hypothesis and multiple sclerosis". <i>Ann. Neurol.</i> <b>61</b> (2): 85–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.21092" class="external text" title="http://dx.doi.org/10.1002%2Fana.21092" rel="nofollow">10.1002/ana.21092</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17315205" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17315205">PMID 17315205</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+hygiene+hypothesis+and+multiple+sclerosis&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Fleming+J%2C+Fabry+Z&amp;rft.au=Fleming+J%2C+Fabry+Z&amp;rft.date=February+2007&amp;rft.volume=61&amp;rft.issue=2&amp;rft.pages=85%E2%80%939&amp;rft_id=info:doi/10.1002%2Fana.21092&amp;rft_id=info:pmid/17315205&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15721830-71"><b><a href="#cite_ref-pmid15721830_71-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGilden_DH2005">Gilden DH (March 2005). "Infectious causes of multiple sclerosis". <i>Lancet Neurol</i> <b>4</b> (3): 195–202. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2805%2901017-3" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2805%2901017-3" rel="nofollow">10.1016/S1474-4422(05)01017-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15721830" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15721830">PMID 15721830</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Infectious+causes+of+multiple+sclerosis&amp;rft.jtitle=Lancet+Neurol&amp;rft.aulast=Gilden+DH&amp;rft.au=Gilden+DH&amp;rft.date=March+2005&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=195%E2%80%93202&amp;rft_id=info:doi/10.1016%2FS1474-4422%2805%2901017-3&amp;rft_id=info:pmid/15721830&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17686342-72"><b><a href="#cite_ref-pmid17686342_72-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChristensen_T2007">Christensen T (June 2007). "<a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf" class="external text" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf" rel="nofollow">Human herpesviruses in MS</a>" (PDF). <i>Int MS J</i> <b>14</b> (2): 41–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17686342" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17686342">PMID 17686342</a><span class="printonly">. <a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf" class="external free" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf" rel="nofollow">http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Human+herpesviruses+in+MS&amp;rft.jtitle=Int+MS+J&amp;rft.aulast=Christensen+T&amp;rft.au=Christensen+T&amp;rft.date=June+2007&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=41%E2%80%937&amp;rft_id=info:pmid/17686342&amp;rft_id=http%3A%2F%2Fwww.msforumonline.net%2Fjournal%2Fdownload%2Fdefault.aspx%3Fpdf%3D20071441.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18306233-73"><b><a href="#cite_ref-pmid18306233_73-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSotelo_J.2C_Mart.C3.ADnez-Palomo_A.2C_Ordo.C3.B1ez_G.2C_Pineda_B2008">Sotelo J, Martínez-Palomo A, Ordoñez G, Pineda B (March 2008). "Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis". <i>Ann. Neurol.</i> <b>63</b> (3): 303–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.21316" class="external text" title="http://dx.doi.org/10.1002%2Fana.21316" rel="nofollow">10.1002/ana.21316</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18306233" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18306233">PMID 18306233</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Varicella-zoster+virus+in+cerebrospinal+fluid+at+relapses+of+multiple+sclerosis&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Sotelo+J%2C+Mart%C3%ADnez-Palomo+A%2C+Ordo%C3%B1ez+G%2C+Pineda+B&amp;rft.au=Sotelo+J%2C+Mart%C3%ADnez-Palomo+A%2C+Ordo%C3%B1ez+G%2C+Pineda+B&amp;rft.date=March+2008&amp;rft.volume=63&amp;rft.issue=3&amp;rft.pages=303%E2%80%9311&amp;rft_id=info:doi/10.1002%2Fana.21316&amp;rft_id=info:pmid/18306233&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17459939-74"><b><a href="#cite_ref-pmid17459939_74-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFL.C3.BCnemann_JD.2C_Kamradt_T.2C_Martin_R.2C_M.C3.BCnz_C2007">Lünemann JD, Kamradt T, Martin R, Münz C (July 2007). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1933281" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1933281" rel="nofollow">Epstein-barr virus: environmental trigger of multiple sclerosis?</a>". <i>J. Virol.</i> <b>81</b> (13): 6777–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1128%2FJVI.00153-07" class="external text" title="http://dx.doi.org/10.1128%2FJVI.00153-07" rel="nofollow">10.1128/JVI.00153-07</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17459939" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17459939">PMID 17459939</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epstein-barr+virus%3A+environmental+trigger+of+multiple+sclerosis%3F&amp;rft.jtitle=J.+Virol.&amp;rft.aulast=L%C3%BCnemann+JD%2C+Kamradt+T%2C+Martin+R%2C+M%C3%BCnz+C&amp;rft.au=L%C3%BCnemann+JD%2C+Kamradt+T%2C+Martin+R%2C+M%C3%BCnz+C&amp;rft.date=July+2007&amp;rft.volume=81&amp;rft.issue=13&amp;rft.pages=6777%E2%80%9384&amp;rft_id=info:doi/10.1128%2FJVI.00153-07&amp;rft_id=info:pmid/17459939&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11601494-75"><b><a href="#cite_ref-pmid11601494_75-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnston_JB.2C_Silva_C.2C_Holden_J.2C_Warren_KG.2C_Clark_AW.2C_Power_C2001">Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (October 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". <i>Ann. Neurol.</i> <b>50</b> (4): 434–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.1131" class="external text" title="http://dx.doi.org/10.1002%2Fana.1131" rel="nofollow">10.1002/ana.1131</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11601494" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11601494">PMID 11601494</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Monocyte+activation+and+differentiation+augment+human+endogenous+retrovirus+expression%3A+implications+for+inflammatory+brain+diseases&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Johnston+JB%2C+Silva+C%2C+Holden+J%2C+Warren+KG%2C+Clark+AW%2C+Power+C&amp;rft.au=Johnston+JB%2C+Silva+C%2C+Holden+J%2C+Warren+KG%2C+Clark+AW%2C+Power+C&amp;rft.date=October+2001&amp;rft.volume=50&amp;rft.issue=4&amp;rft.pages=434%E2%80%9342&amp;rft_id=info:doi/10.1002%2Fana.1131&amp;rft_id=info:pmid/11601494&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16635422-76"><b><a href="#cite_ref-pmid16635422_76-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChristensen_T2006">Christensen T (May 2006). "<a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf" class="external text" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf" rel="nofollow">The role of EBV in MS pathogenesis</a>" (PDF). <i>Int MS J</i> <b>13</b> (2): 52–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16635422" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16635422">PMID 16635422</a><span class="printonly">. <a href="http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf" class="external free" title="http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf" rel="nofollow">http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+role+of+EBV+in+MS+pathogenesis&amp;rft.jtitle=Int+MS+J&amp;rft.aulast=Christensen+T&amp;rft.au=Christensen+T&amp;rft.date=May+2006&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=52%E2%80%937&amp;rft_id=info:pmid/16635422&amp;rft_id=http%3A%2F%2Fwww.msforumonline.net%2Fjournal%2Fdownload%2Fdefault.aspx%3Fpdf%3D20061352.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11342681-77"><b><a href="#cite_ref-pmid11342681_77-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYao_SY.2C_Stratton_CW.2C_Mitchell_WM.2C_Sriram_S2001">Yao SY, Stratton CW, Mitchell WM, Sriram S (May 2001). "<a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11342681" class="external text" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11342681" rel="nofollow">CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens</a>". <i>Neurology</i> <b>56</b> (9): 1168–76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11342681" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11342681">PMID 11342681</a><span class="printonly">. <a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11342681" class="external free" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11342681" rel="nofollow">http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11342681</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=CSF+oligoclonal+bands+in+MS+include+antibodies+against+Chlamydophila+antigens&amp;rft.jtitle=Neurology&amp;rft.aulast=Yao+SY%2C+Stratton+CW%2C+Mitchell+WM%2C+Sriram+S&amp;rft.au=Yao+SY%2C+Stratton+CW%2C+Mitchell+WM%2C+Sriram+S&amp;rft.date=May+2001&amp;rft.volume=56&amp;rft.issue=9&amp;rft.pages=1168%E2%80%9376&amp;rft_id=info:pmid/11342681&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11342681&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17646631-78"><b><a href="#cite_ref-pmid17646631_78-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIslam_T.2C_Gauderman_WJ.2C_Cozen_W.2C_Mack_TM2007">Islam T, Gauderman WJ, Cozen W, Mack TM (July 2007). "Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins". <i>Neurology</i> <b>69</b> (4): 381–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000268266.50850.48" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000268266.50850.48" rel="nofollow">10.1212/01.wnl.0000268266.50850.48</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17646631" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17646631">PMID 17646631</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Childhood+sun+exposure+influences+risk+of+multiple+sclerosis+in+monozygotic+twins&amp;rft.jtitle=Neurology&amp;rft.aulast=Islam+T%2C+Gauderman+WJ%2C+Cozen+W%2C+Mack+TM&amp;rft.au=Islam+T%2C+Gauderman+WJ%2C+Cozen+W%2C+Mack+TM&amp;rft.date=July+2007&amp;rft.volume=69&amp;rft.issue=4&amp;rft.pages=381%E2%80%938&amp;rft_id=info:doi/10.1212%2F01.wnl.0000268266.50850.48&amp;rft_id=info:pmid/17646631&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12907484-79"><b><a href="#cite_ref-pmid12907484_79-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_der_Mei_IA.2C_Ponsonby_AL.2C_Dwyer_T.2C_.27.27et_al.27.272003">van der Mei IA, Ponsonby AL, Dwyer T, <i>et al</i> (August 2003). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=169645" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=169645" rel="nofollow">Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study</a>". <i>BMJ</i> <b>327</b> (7410): 316. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.327.7410.316" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.327.7410.316" rel="nofollow">10.1136/bmj.327.7410.316</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12907484" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12907484">PMID 12907484</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Past+exposure+to+sun%2C+skin+phenotype%2C+and+risk+of+multiple+sclerosis%3A+case-control+study&amp;rft.jtitle=BMJ&amp;rft.aulast=van+der+Mei+IA%2C+Ponsonby+AL%2C+Dwyer+T%2C+%27%27et+al%27%27&amp;rft.au=van+der+Mei+IA%2C+Ponsonby+AL%2C+Dwyer+T%2C+%27%27et+al%27%27&amp;rft.date=August+2003&amp;rft.volume=327&amp;rft.issue=7410&amp;rft.pages=316&amp;rft_id=info:doi/10.1136%2Fbmj.327.7410.316&amp;rft_id=info:pmid/12907484&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17179460-80"><b><a href="#cite_ref-pmid17179460_80-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMunger_KL.2C_Levin_LI.2C_Hollis_BW.2C_Howard_NS.2C_Ascherio_A2006">Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (December 2006). "Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis". <i>JAMA</i> <b>296</b> (23): 2832–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.1001/jama.296.23.2832 (inactive 2009-04-04). <a href="http://www.ncbi.nlm.nih.gov/pubmed/17179460" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17179460">PMID 17179460</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Serum+25-hydroxyvitamin+D+levels+and+risk+of+multiple+sclerosis&amp;rft.jtitle=JAMA&amp;rft.aulast=Munger+KL%2C+Levin+LI%2C+Hollis+BW%2C+Howard+NS%2C+Ascherio+A&amp;rft.au=Munger+KL%2C+Levin+LI%2C+Hollis+BW%2C+Howard+NS%2C+Ascherio+A&amp;rft.date=December+2006&amp;rft.volume=296&amp;rft.issue=23&amp;rft.pages=2832%E2%80%938&amp;rft_id=info:doi/10.1001%2Fjama.296.23.2832&amp;rft_id=info:pmid/17179460&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15007121-81"><b><a href="#cite_ref-pmid15007121_81-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLi_J.2C_Johansen_C.2C_Br.C3.B8nnum-Hansen_H.2C_Stenager_E.2C_Koch-Henriksen_N.2C_Olsen_J2004">Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J (March 2004). "<a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=15007121" class="external text" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=15007121" rel="nofollow">The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark</a>". <i>Neurology</i> <b>62</b> (5): 726–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15007121" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15007121">PMID 15007121</a><span class="printonly">. <a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=15007121" class="external free" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=15007121" rel="nofollow">http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=15007121</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+risk+of+multiple+sclerosis+in+bereaved+parents%3A+A+nationwide+cohort+study+in+Denmark&amp;rft.jtitle=Neurology&amp;rft.aulast=Li+J%2C+Johansen+C%2C+Br%C3%B8nnum-Hansen+H%2C+Stenager+E%2C+Koch-Henriksen+N%2C+Olsen+J&amp;rft.au=Li+J%2C+Johansen+C%2C+Br%C3%B8nnum-Hansen+H%2C+Stenager+E%2C+Koch-Henriksen+N%2C+Olsen+J&amp;rft.date=March+2004&amp;rft.volume=62&amp;rft.issue=5&amp;rft.pages=726%E2%80%939&amp;rft_id=info:pmid/15007121&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D15007121&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14581658-82"><b><a href="#cite_ref-pmid14581658_82-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFranklin_GM.2C_Nelson_L2003">Franklin GM, Nelson L (October 2003). "<a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=14581658" class="external text" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=14581658" rel="nofollow">Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy</a>". <i>Neurology</i> <b>61</b> (8): 1032–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14581658" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14581658">PMID 14581658</a><span class="printonly">. <a href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=14581658" class="external free" title="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=14581658" rel="nofollow">http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=14581658</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+risk+factors+in+multiple+sclerosis%3A+causes%2C+triggers%2C+and+patient+autonomy&amp;rft.jtitle=Neurology&amp;rft.aulast=Franklin+GM%2C+Nelson+L&amp;rft.au=Franklin+GM%2C+Nelson+L&amp;rft.date=October+2003&amp;rft.volume=61&amp;rft.issue=8&amp;rft.pages=1032%E2%80%934&amp;rft_id=info:pmid/14581658&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D14581658&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16687059-83"><b><a href="#cite_ref-pmid16687059_83-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKoch_M.2C_De_Keyser_J2006">Koch M, De Keyser J (April 2006). "Uric acid in multiple sclerosis". <i>Neurol. Res.</i> <b>28</b> (3): 316–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1179%2F016164106X98215" class="external text" title="http://dx.doi.org/10.1179%2F016164106X98215" rel="nofollow">10.1179/016164106X98215</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16687059" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16687059">PMID 16687059</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Uric+acid+in+multiple+sclerosis&amp;rft.jtitle=Neurol.+Res.&amp;rft.aulast=Koch+M%2C+De+Keyser+J&amp;rft.au=Koch+M%2C+De+Keyser+J&amp;rft.date=April+2006&amp;rft.volume=28&amp;rft.issue=3&amp;rft.pages=316%E2%80%939&amp;rft_id=info:doi/10.1179%2F016164106X98215&amp;rft_id=info:pmid/16687059&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18219824-84"><b><a href="#cite_ref-pmid18219824_84-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSpitsin_S.2C_Koprowski_H2008">Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". <i>Curr. Top. Microbiol. Immunol.</i> <b>318</b>: 325–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2F978-3-540-73677-6_13" class="external text" title="http://dx.doi.org/10.1007%2F978-3-540-73677-6_13" rel="nofollow">10.1007/978-3-540-73677-6_13</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18219824" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18219824">PMID 18219824</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Role+of+uric+acid+in+multiple+sclerosis&amp;rft.jtitle=Curr.+Top.+Microbiol.+Immunol.&amp;rft.aulast=Spitsin+S%2C+Koprowski+H&amp;rft.au=Spitsin+S%2C+Koprowski+H&amp;rft.date=2008&amp;rft.volume=318&amp;rft.pages=325%E2%80%9342&amp;rft_id=info:doi/10.1007%2F978-3-540-73677-6_13&amp;rft_id=info:pmid/18219824&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15493114-85"><b><a href="#cite_ref-pmid15493114_85-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMattle_HP.2C_Lienert_C.2C_Greeve_I2004">Mattle HP, Lienert C, Greeve I (September 2004). "[Uric acid and multiple sclerosis]" (in German). <i>Ther Umsch</i> <b>61</b> (9): 553–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15493114" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15493114">PMID 15493114</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BUric+acid+and+multiple+sclerosis%5D&amp;rft.jtitle=Ther+Umsch&amp;rft.aulast=Mattle+HP%2C+Lienert+C%2C+Greeve+I&amp;rft.au=Mattle+HP%2C+Lienert+C%2C+Greeve+I&amp;rft.date=September+2004&amp;rft.volume=61&amp;rft.issue=9&amp;rft.pages=553%E2%80%935&amp;rft_id=info:pmid/15493114&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18256984-86"><b><a href="#cite_ref-pmid18256984_86-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAscherio_A.2C_Munger_K2008">Ascherio A, Munger K (February 2008). "Epidemiology of multiple sclerosis: from risk factors to prevention". <i>Semin Neurol</i> <b>28</b> (1): 17–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1055%2Fs-2007-1019126" class="external text" title="http://dx.doi.org/10.1055%2Fs-2007-1019126" rel="nofollow">10.1055/s-2007-1019126</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18256984" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18256984">PMID 18256984</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemiology+of+multiple+sclerosis%3A+from+risk+factors+to+prevention&amp;rft.jtitle=Semin+Neurol&amp;rft.aulast=Ascherio+A%2C+Munger+K&amp;rft.au=Ascherio+A%2C+Munger+K&amp;rft.date=February+2008&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=17%E2%80%9328&amp;rft_id=info:doi/10.1055%2Fs-2007-1019126&amp;rft_id=info:pmid/18256984&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-87"><b><a href="#cite_ref-87" title="">^</a></b> <a href="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682795.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682795.html" rel="nofollow">Methylprednisolone Oral.</a> US National Library of Medicine (Medline) (<span class="mw-formatted-date" title="2003-04-01"><a href="/wiki/2003" title="2003">2003</a>-<a href="/wiki/April_1" title="April 1">04-01</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-01"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_1" title="September 1">09-01</a></span>.</li>
<li id="cite_note-88"><b><a href="#cite_ref-88" title="">^</a></b> <a href="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601157.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601157.html" rel="nofollow">Methylprednisolone Sodium Succinate Injection.</a> US National Library of Medicine (Medline) (2003-04-01). Retrieved on 2007-09-01.</li>
<li id="cite_note-89"><b><a href="#cite_ref-89" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrusaferri_F.2C_Candelise_L2000">Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". <i>J. Neurol.</i> <b>247</b> (6): 435–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs004150070172" class="external text" title="http://dx.doi.org/10.1007%2Fs004150070172" rel="nofollow">10.1007/s004150070172</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10929272" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10929272">PMID 10929272</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Steroids+for+multiple+sclerosis+and+optic+neuritis%3A+a+meta-analysis+of+randomized+controlled+clinical+trials&amp;rft.jtitle=J.+Neurol.&amp;rft.aulast=Brusaferri+F%2C+Candelise+L&amp;rft.au=Brusaferri+F%2C+Candelise+L&amp;rft.date=2000&amp;rft.volume=247&amp;rft.issue=6&amp;rft.pages=435%E2%80%9342&amp;rft_id=info:doi/10.1007%2Fs004150070172&amp;rft_id=info:pmid/10929272&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-90"><b><a href="#cite_ref-90" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDovio_A.2C_Perazzolo_L.2C_Osella_G.2C_.27.27et_al.27.272004">Dovio A, Perazzolo L, Osella G, <i>et al</i> (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". <i>J. Clin. Endocrinol. Metab.</i> <b>89</b> (10): 4923–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1210%2Fjc.2004-0164" class="external text" title="http://dx.doi.org/10.1210%2Fjc.2004-0164" rel="nofollow">10.1210/jc.2004-0164</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15472186" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15472186">PMID 15472186</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Immediate+fall+of+bone+formation+and+transient+increase+of+bone+resorption+in+the+course+of+high-dose%2C+short-term+glucocorticoid+therapy+in+young+patients+with+multiple+sclerosis&amp;rft.jtitle=J.+Clin.+Endocrinol.+Metab.&amp;rft.aulast=Dovio+A%2C+Perazzolo+L%2C+Osella+G%2C+%27%27et+al%27%27&amp;rft.au=Dovio+A%2C+Perazzolo+L%2C+Osella+G%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.volume=89&amp;rft.issue=10&amp;rft.pages=4923%E2%80%938&amp;rft_id=info:doi/10.1210%2Fjc.2004-0164&amp;rft_id=info:pmid/15472186&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-91"><b><a href="#cite_ref-91" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUttner_I.2C_M.C3.BCller_S.2C_Zinser_C.2C_.27.27et_al.27.272005">Uttner I, Müller S, Zinser C, <i>et al</i> (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". <i>Neurology</i> <b>64</b> (11): 1971–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.WNL.0000163804.94163.91" class="external text" title="http://dx.doi.org/10.1212%2F01.WNL.0000163804.94163.91" rel="nofollow">10.1212/01.WNL.0000163804.94163.91</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15955958" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15955958">PMID 15955958</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reversible+impaired+memory+induced+by+pulsed+methylprednisolone+in+patients+with+MS&amp;rft.jtitle=Neurology&amp;rft.aulast=Uttner+I%2C+M%C3%BCller+S%2C+Zinser+C%2C+%27%27et+al%27%27&amp;rft.au=Uttner+I%2C+M%C3%BCller+S%2C+Zinser+C%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=64&amp;rft.issue=11&amp;rft.pages=1971%E2%80%933&amp;rft_id=info:doi/10.1212%2F01.WNL.0000163804.94163.91&amp;rft_id=info:pmid/15955958&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-92"><b><a href="#cite_ref-92" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJacobs_LD.2C_Beck_RW.2C_Simon_JH.2C_.27.27et_al..27.272000">Jacobs LD, Beck RW, Simon JH, <i>et al.</i> (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". <i><a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine">N Engl J Med</a></i> <b>343</b> (13): 898–904. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM200009283431301" class="external text" title="http://dx.doi.org/10.1056%2FNEJM200009283431301" rel="nofollow">10.1056/NEJM200009283431301</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11006365" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11006365">PMID 11006365</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Intramuscular+interferon+beta-1a+therapy+initiated+during+a+first+demyelinating+event+in+multiple+sclerosis.+CHAMPS+Study+Group&amp;rft.jtitle=%5B%5BNew+England+Journal+of+Medicine%7CN+Engl+J+Med%5D%5D&amp;rft.aulast=Jacobs+LD%2C+Beck+RW%2C+Simon+JH%2C+%27%27et+al.%27%27&amp;rft.au=Jacobs+LD%2C+Beck+RW%2C+Simon+JH%2C+%27%27et+al.%27%27&amp;rft.date=2000&amp;rft.volume=343&amp;rft.issue=13&amp;rft.pages=898%E2%80%93904&amp;rft_id=info:doi/10.1056%2FNEJM200009283431301&amp;rft_id=info:pmid/11006365&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-93"><b><a href="#cite_ref-93" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFComi_G.2C_Filippi_M.2C_Barkhof_F.2C_.27.27et_al..27.272001">Comi G, Filippi M, Barkhof F, <i>et al.</i> (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". <i><a href="/wiki/Lancet_(journal)" title="Lancet (journal)" class="mw-redirect">Lancet</a></i> <b>357</b> (9268): 1576–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2800%2904725-5" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2800%2904725-5" rel="nofollow">10.1016/S0140-6736(00)04725-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11377645" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11377645">PMID 11377645</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+early+interferon+treatment+on+conversion+to+definite+multiple+sclerosis%3A+a+randomised+study&amp;rft.jtitle=%5B%5BLancet+%28journal%29%7CLancet%5D%5D&amp;rft.aulast=Comi+G%2C+Filippi+M%2C+Barkhof+F%2C+%27%27et+al.%27%27&amp;rft.au=Comi+G%2C+Filippi+M%2C+Barkhof+F%2C+%27%27et+al.%27%27&amp;rft.date=2001&amp;rft.volume=357&amp;rft.issue=9268&amp;rft.pages=1576%E2%80%9382&amp;rft_id=info:doi/10.1016%2FS0140-6736%2800%2904725-5&amp;rft_id=info:pmid/11377645&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17679016-94"><b><a href="#cite_ref-pmid17679016_94-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKappos_L.2C_Freedman_MS.2C_Polman_CH.2C_.27.27et_al..27.272007">Kappos L, Freedman MS, Polman CH, <i>et al.</i> (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". <i>Lancet</i> <b>370</b> (9585): 389–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961194-5" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961194-5" rel="nofollow">10.1016/S0140-6736(07)61194-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17679016" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17679016">PMID 17679016</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+early+versus+delayed+interferon+beta-1b+treatment+on+disability+after+a+first+clinical+event+suggestive+of+multiple+sclerosis%3A+a+3-year+follow-up+analysis+of+the+BENEFIT+study&amp;rft.jtitle=Lancet&amp;rft.aulast=Kappos+L%2C+Freedman+MS%2C+Polman+CH%2C+%27%27et+al.%27%27&amp;rft.au=Kappos+L%2C+Freedman+MS%2C+Polman+CH%2C+%27%27et+al.%27%27&amp;rft.date=2007&amp;rft.volume=370&amp;rft.issue=9585&amp;rft.pages=389%E2%80%9397&amp;rft_id=info:doi/10.1016%2FS0140-6736%2807%2961194-5&amp;rft_id=info:pmid/17679016&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17627671-95"><b><a href="#cite_ref-pmid17627671_95-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRuggieri_M.2C_Avolio_C.2C_Livrea_P.2C_Trojano_M2007">Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". <i>CNS Drug Rev</i> <b>13</b> (2): 178–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1527-3458.2007.00010.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1527-3458.2007.00010.x" rel="nofollow">10.1111/j.1527-3458.2007.00010.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17627671" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17627671">PMID 17627671</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Glatiramer+acetate+in+multiple+sclerosis%3A+a+review&amp;rft.jtitle=CNS+Drug+Rev&amp;rft.aulast=Ruggieri+M%2C+Avolio+C%2C+Livrea+P%2C+Trojano+M&amp;rft.au=Ruggieri+M%2C+Avolio+C%2C+Livrea+P%2C+Trojano+M&amp;rft.date=2007&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=178%E2%80%9391&amp;rft_id=info:doi/10.1111%2Fj.1527-3458.2007.00010.x&amp;rft_id=info:pmid/17627671&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14974077-96">^ <a href="#cite_ref-pmid14974077_96-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid14974077_96-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMunari_L.2C_Lovati_R.2C_Boiko_A2004">Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". <i>Cochrane Database Syst Rev</i> (1): CD004678. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD004678" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD004678" rel="nofollow">10.1002/14651858.CD004678</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14974077" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14974077">PMID 14974077</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Therapy+with+glatiramer+acetate+for+multiple+sclerosis&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Munari+L%2C+Lovati+R%2C+Boiko+A&amp;rft.au=Munari+L%2C+Lovati+R%2C+Boiko+A&amp;rft.date=2004&amp;rft.issue=1&amp;rft.pages=CD004678&amp;rft_id=info:doi/10.1002%2F14651858.CD004678&amp;rft_id=info:pmid/14974077&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11687131-97"><b><a href="#cite_ref-pmid11687131_97-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRice_GP.2C_Incorvaia_B.2C_Munari_L.2C_.27.27et_al.27.272001">Rice GP, Incorvaia B, Munari L, <i>et al</i> (2001). "Interferon in relapsing-remitting multiple sclerosis". <i>Cochrane Database Syst Rev</i> (4): CD002002. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD002002" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD002002" rel="nofollow">10.1002/14651858.CD002002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11687131" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11687131">PMID 11687131</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Interferon+in+relapsing-remitting+multiple+sclerosis&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Rice+GP%2C+Incorvaia+B%2C+Munari+L%2C+%27%27et+al%27%27&amp;rft.au=Rice+GP%2C+Incorvaia+B%2C+Munari+L%2C+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.issue=4&amp;rft.pages=CD002002&amp;rft_id=info:doi/10.1002%2F14651858.CD002002&amp;rft_id=info:pmid/11687131&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16235298-98">^ <a href="#cite_ref-pmid16235298_98-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16235298_98-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMartinelli_Boneschi_F.2C_Rovaris_M.2C_Capra_R.2C_Comi_G2005">Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". <i>Cochrane Database Syst Rev</i> (4): CD002127. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD002127.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD002127.pub2" rel="nofollow">10.1002/14651858.CD002127.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16235298" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16235298">PMID 16235298</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mitoxantrone+for+multiple+sclerosis&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Martinelli+Boneschi+F%2C+Rovaris+M%2C+Capra+R%2C+Comi+G&amp;rft.au=Martinelli+Boneschi+F%2C+Rovaris+M%2C+Capra+R%2C+Comi+G&amp;rft.date=2005&amp;rft.issue=4&amp;rft.pages=CD002127&amp;rft_id=info:doi/10.1002%2F14651858.CD002127.pub2&amp;rft_id=info:pmid/16235298&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17350652-99"><b><a href="#cite_ref-pmid17350652_99-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnson_KP2007">Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". <i>J. Neurol. Sci.</i> <b>256 Suppl 1</b>: S23–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jns.2007.01.060" class="external text" title="http://dx.doi.org/10.1016%2Fj.jns.2007.01.060" rel="nofollow">10.1016/j.jns.2007.01.060</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17350652" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17350652">PMID 17350652</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Control+of+multiple+sclerosis+relapses+with+immunomodulating+agents&amp;rft.jtitle=J.+Neurol.+Sci.&amp;rft.aulast=Johnson+KP&amp;rft.au=Johnson+KP&amp;rft.date=2007&amp;rft.volume=256+Suppl+1&amp;rft.pages=S23%E2%80%938&amp;rft_id=info:doi/10.1016%2Fj.jns.2007.01.060&amp;rft_id=info:pmid/17350652&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-100"><b><a href="#cite_ref-100" title="">^</a></b> Natalizumab reduces MS severity - <a href="http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169" class="external free" title="http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169" rel="nofollow">http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169</a></li>
<li id="cite_note-101"><b><a href="#cite_ref-101" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGonsette_RE2007">Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". <i>Expert opinion on pharmacotherapy</i> <b>8</b> (8): 1103–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1517%2F14656566.8.8.1103" class="external text" title="http://dx.doi.org/10.1517%2F14656566.8.8.1103" rel="nofollow">10.1517/14656566.8.8.1103</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17516874" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17516874">PMID 17516874</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Compared+benefit+of+approved+and+experimental+immunosuppressive+therapeutic+approaches+in+multiple+sclerosis&amp;rft.jtitle=Expert+opinion+on+pharmacotherapy&amp;rft.aulast=Gonsette+RE&amp;rft.au=Gonsette+RE&amp;rft.date=2007&amp;rft.volume=8&amp;rft.issue=8&amp;rft.pages=1103%E2%80%9316&amp;rft_id=info:doi/10.1517%2F14656566.8.8.1103&amp;rft_id=info:pmid/17516874&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16503747-102"><b><a href="#cite_ref-pmid16503747_102-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMurray_TJ2006">Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". <i>Expert opinion on drug safety</i> <b>5</b> (2): 265–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1517%2F14740338.5.2.265" class="external text" title="http://dx.doi.org/10.1517%2F14740338.5.2.265" rel="nofollow">10.1517/14740338.5.2.265</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16503747" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16503747">PMID 16503747</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+cardiac+effects+of+mitoxantrone%3A+do+the+benefits+in+multiple+sclerosis+outweigh+the+risks%3F&amp;rft.jtitle=Expert+opinion+on+drug+safety&amp;rft.aulast=Murray+TJ&amp;rft.au=Murray+TJ&amp;rft.date=2006&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=265%E2%80%9374&amp;rft_id=info:doi/10.1517%2F14740338.5.2.265&amp;rft_id=info:pmid/16503747&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15907149-103"><b><a href="#cite_ref-pmid15907149_103-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLeary_SM.2C_Thompson_AJ2005">Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". <i>CNS drugs</i> <b>19</b> (5): 369–76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15907149" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15907149">PMID 15907149</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary+progressive+multiple+sclerosis%3A+current+and+future+treatment+options&amp;rft.jtitle=CNS+drugs&amp;rft.aulast=Leary+SM%2C+Thompson+AJ&amp;rft.au=Leary+SM%2C+Thompson+AJ&amp;rft.date=2005&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=369%E2%80%9376&amp;rft_id=info:pmid/15907149&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17131933-104"><b><a href="#cite_ref-pmid17131933_104-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSl.C3.A1dkov.C3.A1_T.2C_Kostolansk.C3.BD_F2006">Sládková T, Kostolanský F (2006). "The role of cytokines in the immune response to influenza A virus infection". <i>Acta Virol.</i> <b>50</b> (3): 151–62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17131933" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17131933">PMID 17131933</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+role+of+cytokines+in+the+immune+response+to+influenza+A+virus+infection&amp;rft.jtitle=Acta+Virol.&amp;rft.aulast=Sl%C3%A1dkov%C3%A1+T%2C+Kostolansk%C3%BD+F&amp;rft.au=Sl%C3%A1dkov%C3%A1+T%2C+Kostolansk%C3%BD+F&amp;rft.date=2006&amp;rft.volume=50&amp;rft.issue=3&amp;rft.pages=151%E2%80%9362&amp;rft_id=info:pmid/17131933&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-105"><b><a href="#cite_ref-105" title="">^</a></b> Primetherapeutics - serious liver damage per FDA - <a href="http://www.primetherapeutics.com/DrugNews/flash/Avonex.pdf" class="external free" title="http://www.primetherapeutics.com/DrugNews/flash/Avonex.pdf" rel="nofollow">http://www.primetherapeutics.com/DrugNews/flash/Avonex.pdf</a> Primetherapeutics]</li>
<li id="cite_note-106"><b><a href="#cite_ref-106" title="">^</a></b> Betaseron [package insert]. Montville, NJ: Berlex Inc; 2003</li>
<li id="cite_note-107"><b><a href="#cite_ref-107" title="">^</a></b> Rebif [package insert]. Rockland, MA: Serono Inc; 2005.</li>
<li id="cite_note-108"><b><a href="#cite_ref-108" title="">^</a></b> Avonex [package insert]. Cambridge, MA: Biogen Inc; 2003</li>
<li id="cite_note-pmid16750460-109">^ <a href="#cite_ref-pmid16750460_109-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16750460_109-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFox_EJ2006">Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". <i>Clinical therapeutics</i> <b>28</b> (4): 461–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.clinthera.2006.04.013" class="external text" title="http://dx.doi.org/10.1016%2Fj.clinthera.2006.04.013" rel="nofollow">10.1016/j.clinthera.2006.04.013</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16750460" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16750460">PMID 16750460</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Management+of+worsening+multiple+sclerosis+with+mitoxantrone%3A+a+review&amp;rft.jtitle=Clinical+therapeutics&amp;rft.aulast=Fox+EJ&amp;rft.au=Fox+EJ&amp;rft.date=2006&amp;rft.volume=28&amp;rft.issue=4&amp;rft.pages=461%E2%80%9374&amp;rft_id=info:doi/10.1016%2Fj.clinthera.2006.04.013&amp;rft_id=info:pmid/16750460&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-110"><b><a href="#cite_ref-110" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKleinschmidt-DeMasters_BK.2C_Tyler_KL2005">Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". <i>N Engl J Med</i> <b>353</b> (4): 369–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa051782" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa051782" rel="nofollow">10.1056/NEJMoa051782</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15947079" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15947079">PMID 15947079</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Progressive+multifocal+leukoencephalopathy+complicating+treatment+with+natalizumab+and+interferon+beta-1a+for+multiple+sclerosis&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Kleinschmidt-DeMasters+BK%2C+Tyler+KL&amp;rft.au=Kleinschmidt-DeMasters+BK%2C+Tyler+KL&amp;rft.date=2005&amp;rft.volume=353&amp;rft.issue=4&amp;rft.pages=369%E2%80%9374&amp;rft_id=info:doi/10.1056%2FNEJMoa051782&amp;rft_id=info:pmid/15947079&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span> <a href="http://content.nejm.org/cgi/content/abstract/353/4/369" class="external text" title="http://content.nejm.org/cgi/content/abstract/353/4/369" rel="nofollow">Free full text with registration</a></li>
<li id="cite_note-111"><b><a href="#cite_ref-111" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLanger-Gould_A.2C_Atlas_SW.2C_Green_AJ.2C_Bollen_AW.2C_Pelletier_D2005">Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". <i>N Engl J Med</i> <b>353</b> (4): 375–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa051847" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa051847" rel="nofollow">10.1056/NEJMoa051847</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15947078" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15947078">PMID 15947078</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Progressive+multifocal+leukoencephalopathy+in+a+patient+treated+with+natalizumab&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Langer-Gould+A%2C+Atlas+SW%2C+Green+AJ%2C+Bollen+AW%2C+Pelletier+D&amp;rft.au=Langer-Gould+A%2C+Atlas+SW%2C+Green+AJ%2C+Bollen+AW%2C+Pelletier+D&amp;rft.date=2005&amp;rft.volume=353&amp;rft.issue=4&amp;rft.pages=375%E2%80%9381&amp;rft_id=info:doi/10.1056%2FNEJMoa051847&amp;rft_id=info:pmid/15947078&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span> <a href="http://content.nejm.org/cgi/content/abstract/353/4/375" class="external text" title="http://content.nejm.org/cgi/content/abstract/353/4/375" rel="nofollow">Free full text with registration</a></li>
<li id="cite_note-WSJ08-112"><b><a href="#cite_ref-WSJ08_112-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri" class="external text" title="http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri" rel="nofollow">"Brain Infections Return for Multiple Sclerosis Drug Tysabri"</a>. 2008-08-01<span class="printonly">. <a href="http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri" class="external free" title="http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri" rel="nofollow">http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri</a></span><span class="reference-accessdate">. Retrieved on 2008-08-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Brain+Infections+Return+for+Multiple+Sclerosis+Drug+Tysabri&amp;rft.atitle=&amp;rft.date=2008-08-01&amp;rft_id=http%3A%2F%2Fblogs.wsj.com%2Fhealth%2F2008%2F08%2F01%2Fbrain-infections-return-for-multiple-sclerosis-drug-tysabri&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16168933-113"><b><a href="#cite_ref-pmid16168933_113-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKesselring_J.2C_Beer_S2005">Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". <i>Lancet neurology</i> <b>4</b> (10): 643–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1474-4422%2805%2970193-9" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2805%2970193-9" rel="nofollow">10.1016/S1474-4422(05)70193-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16168933" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16168933">PMID 16168933</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Symptomatic+therapy+and+neurorehabilitation+in+multiple+sclerosis&amp;rft.jtitle=Lancet+neurology&amp;rft.aulast=Kesselring+J%2C+Beer+S&amp;rft.au=Kesselring+J%2C+Beer+S&amp;rft.date=2005&amp;rft.volume=4&amp;rft.issue=10&amp;rft.pages=643%E2%80%9352&amp;rft_id=info:doi/10.1016%2FS1474-4422%2805%2970193-9&amp;rft_id=info:pmid/16168933&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-isbn_.3D_1_86016_182_0-114"><b><a href="#cite_ref-isbn_.3D_1_86016_182_0_114-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFThe_Royal_College_of_Physicians2004">The Royal College of Physicians (2004). <i>Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care</i>. Salisbury, Wiltshire: Sarum ColourView Group. <a href="/wiki/Special:BookSources/1860161820" class="internal">ISBN 1 86016 182 0</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Multiple+Sclerosis.+National+clinical+guideline+for+diagnosis+and+management+in+primary+and+secondary+care&amp;rft.aulast=The+Royal+College+of+Physicians&amp;rft.au=The+Royal+College+of+Physicians&amp;rft.date=2004&amp;rft.place=Salisbury%2C+Wiltshire&amp;rft.pub=Sarum+ColourView+Group&amp;rft.isbn=1+86016+182+0&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span><a href="http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf" class="external text" title="http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf" rel="nofollow">Free full text</a> (<span class="mw-formatted-date" title="2004-08-13"><a href="/wiki/2004" title="2004">2004</a>-<a href="/wiki/August_13" title="August 13">08-13</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-10-01"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/October_1" title="October 1">10-01</a></span>.</li>
<li id="cite_note-pmid17253500-115"><b><a href="#cite_ref-pmid17253500_115-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFarinotti_M.2C_Simi_S.2C_Di_Pietrantonj_C.2C_.27.27et_al..27.272007">Farinotti M, Simi S, Di Pietrantonj C, <i>et al.</i> (2007). "Dietary interventions for multiple sclerosis". <i>Cochrane database of systematic reviews (Online)</i> (1): CD004192. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD004192.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD004192.pub2" rel="nofollow">10.1002/14651858.CD004192.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17253500" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17253500">PMID 17253500</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dietary+interventions+for+multiple+sclerosis&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.aulast=Farinotti+M%2C+Simi+S%2C+Di+Pietrantonj+C%2C+%27%27et+al.%27%27&amp;rft.au=Farinotti+M%2C+Simi+S%2C+Di+Pietrantonj+C%2C+%27%27et+al.%27%27&amp;rft.date=2007&amp;rft.issue=1&amp;rft.pages=CD004192&amp;rft_id=info:doi/10.1002%2F14651858.CD004192.pub2&amp;rft_id=info:pmid/17253500&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-116"><b><a href="#cite_ref-116" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChong_MS.2C_Wolff_K.2C_Wise_K.2C_Tanton_C.2C_Winstock_A.2C_Silber_E2006">Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". <i>Mult. Scler.</i> <b>12</b> (5): 646–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1177%2F1352458506070947" class="external text" title="http://dx.doi.org/10.1177%2F1352458506070947" rel="nofollow">10.1177/1352458506070947</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17086912" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17086912">PMID 17086912</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cannabis+use+in+patients+with+multiple+sclerosis&amp;rft.jtitle=Mult.+Scler.&amp;rft.aulast=Chong+MS%2C+Wolff+K%2C+Wise+K%2C+Tanton+C%2C+Winstock+A%2C+Silber+E&amp;rft.au=Chong+MS%2C+Wolff+K%2C+Wise+K%2C+Tanton+C%2C+Winstock+A%2C+Silber+E&amp;rft.date=2006&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=646%E2%80%9351&amp;rft_id=info:doi/10.1177%2F1352458506070947&amp;rft_id=info:pmid/17086912&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-117"><b><a href="#cite_ref-117" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZajicek_JP.2C_Sanders_HP.2C_Wright_DE.2C_Vickery_PJ.2C_Ingram_WM.2C_Reilly_SM.2C_Nunn_AJ.2C_Teare_LJ.2C_Fox_PJ.2C_Thompson_AJ2005">Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>76</b> (12): 1664–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.2005.070136" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.2005.070136" rel="nofollow">10.1136/jnnp.2005.070136</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16291891" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16291891">PMID 16291891</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cannabinoids+in+multiple+sclerosis+%28CAMS%29+study%3A+safety+and+efficacy+data+for+12+months+follow+up&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Zajicek+JP%2C+Sanders+HP%2C+Wright+DE%2C+Vickery+PJ%2C+Ingram+WM%2C+Reilly+SM%2C+Nunn+AJ%2C+Teare+LJ%2C+Fox+PJ%2C+Thompson+AJ&amp;rft.au=Zajicek+JP%2C+Sanders+HP%2C+Wright+DE%2C+Vickery+PJ%2C+Ingram+WM%2C+Reilly+SM%2C+Nunn+AJ%2C+Teare+LJ%2C+Fox+PJ%2C+Thompson+AJ&amp;rft.date=2005&amp;rft.volume=76&amp;rft.issue=12&amp;rft.pages=1664%E2%80%939&amp;rft_id=info:doi/10.1136%2Fjnnp.2005.070136&amp;rft_id=info:pmid/16291891&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14974004-118"><b><a href="#cite_ref-pmid14974004_118-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBennett_M.2C_Heard_R2004">Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". <i>Cochrane database of systematic reviews (Online)</i> (1): CD003057. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD003057.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD003057.pub2" rel="nofollow">10.1002/14651858.CD003057.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14974004" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14974004">PMID 14974004</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Hyperbaric+oxygen+therapy+for+multiple+sclerosis&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.aulast=Bennett+M%2C+Heard+R&amp;rft.au=Bennett+M%2C+Heard+R&amp;rft.date=2004&amp;rft.issue=1&amp;rft.pages=CD003057&amp;rft_id=info:doi/10.1002%2F14651858.CD003057.pub2&amp;rft_id=info:pmid/14974004&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15184614-119"><b><a href="#cite_ref-pmid15184614_119-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOken_BS.2C_Kishiyama_S.2C_Zajdel_D.2C_.27.27et_al..27.272004">Oken BS, Kishiyama S, Zajdel D, <i>et al.</i> (2004). "Randomized controlled trial of yoga and exercise in multiple sclerosis". <i>Neurology</i> <b>62</b> (11): 2058–64. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15184614" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15184614">PMID 15184614</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Randomized+controlled+trial+of+yoga+and+exercise+in+multiple+sclerosis&amp;rft.jtitle=Neurology&amp;rft.aulast=Oken+BS%2C+Kishiyama+S%2C+Zajdel+D%2C+%27%27et+al.%27%27&amp;rft.au=Oken+BS%2C+Kishiyama+S%2C+Zajdel+D%2C+%27%27et+al.%27%27&amp;rft.date=2004&amp;rft.volume=62&amp;rft.issue=11&amp;rft.pages=2058%E2%80%9364&amp;rft_id=info:pmid/15184614&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid3495637-120">^ <a href="#cite_ref-pmid3495637_120-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid3495637_120-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid3495637_120-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPhadke_JG1987">Phadke JG (May 1987). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1031962" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1031962" rel="nofollow">Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>50</b> (5): 523–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.50.5.523" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.50.5.523" rel="nofollow">10.1136/jnnp.50.5.523</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3495637" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3495637">PMID 3495637</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Survival+pattern+and+cause+of+death+in+patients+with+multiple+sclerosis%3A+results+from+an+epidemiological+survey+in+north+east+Scotland&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Phadke+JG&amp;rft.au=Phadke+JG&amp;rft.date=May+1987&amp;rft.volume=50&amp;rft.issue=5&amp;rft.pages=523%E2%80%9331&amp;rft_id=info:doi/10.1136%2Fjnnp.50.5.523&amp;rft_id=info:pmid/3495637&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15561552-121"><b><a href="#cite_ref-pmid15561552_121-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStern_M2005">Stern M (February 2005). "Aging with multiple sclerosis". <i>Phys Med Rehabil Clin N Am</i> <b>16</b> (1): 219–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pmr.2004.06.010" class="external text" title="http://dx.doi.org/10.1016%2Fj.pmr.2004.06.010" rel="nofollow">10.1016/j.pmr.2004.06.010</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15561552" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15561552">PMID 15561552</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Aging+with+multiple+sclerosis&amp;rft.jtitle=Phys+Med+Rehabil+Clin+N+Am&amp;rft.aulast=Stern+M&amp;rft.au=Stern+M&amp;rft.date=February+2005&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=219%E2%80%9334&amp;rft_id=info:doi/10.1016%2Fj.pmr.2004.06.010&amp;rft_id=info:pmid/15561552&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11321195-122"><b><a href="#cite_ref-pmid11321195_122-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMyhr_KM.2C_Riise_T.2C_Vedeler_C.2C_.27.27et_al.27.272001">Myhr KM, Riise T, Vedeler C, <i>et al</i> (February 2001). "<a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=11321195" class="external text" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=11321195" rel="nofollow">Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension</a>". <i>Mult. Scler.</i> <b>7</b> (1): 59–65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11321195" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11321195">PMID 11321195</a><span class="printonly">. <a href="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=11321195" class="external free" title="http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=11321195" rel="nofollow">http://msj.sagepub.com/cgi/pmidlookup?view=long&amp;pmid=11321195</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Disability+and+prognosis+in+multiple+sclerosis%3A+demographic+and+clinical+variables+important+for+the+ability+to+walk+and+awarding+of+disability+pension&amp;rft.jtitle=Mult.+Scler.&amp;rft.aulast=Myhr+KM%2C+Riise+T%2C+Vedeler+C%2C+%27%27et+al%27%27&amp;rft.au=Myhr+KM%2C+Riise+T%2C+Vedeler+C%2C+%27%27et+al%27%27&amp;rft.date=February+2001&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=59%E2%80%9365&amp;rft_id=info:pmid/11321195&amp;rft_id=http%3A%2F%2Fmsj.sagepub.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11321195&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid3066846-123"><b><a href="#cite_ref-pmid3066846_123-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCompston_A1988">Compston A (October 1988). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1032909" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1032909" rel="nofollow">The 150th anniversary of the first depiction of the lesions of multiple sclerosis</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>51</b> (10): 1249–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.51.10.1249" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.51.10.1249" rel="nofollow">10.1136/jnnp.51.10.1249</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3066846" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3066846">PMID 3066846</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+150th+anniversary+of+the+first+depiction+of+the+lesions+of+multiple+sclerosis&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Compston+A&amp;rft.au=Compston+A&amp;rft.date=October+1988&amp;rft.volume=51&amp;rft.issue=10&amp;rft.pages=1249%E2%80%9352&amp;rft_id=info:doi/10.1136%2Fjnnp.51.10.1249&amp;rft_id=info:pmid/3066846&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid390966-124"><b><a href="#cite_ref-pmid390966_124-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMedaer_R1979">Medaer R (September 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". <i>Acta Neurol. Scand.</i> <b>60</b> (3): 189–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/390966" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/390966">PMID 390966</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Does+the+history+of+multiple+sclerosis+go+back+as+far+as+the+14th+century%3F&amp;rft.jtitle=Acta+Neurol.+Scand.&amp;rft.aulast=Medaer+R&amp;rft.au=Medaer+R&amp;rft.date=September+1979&amp;rft.volume=60&amp;rft.issue=3&amp;rft.pages=189%E2%80%9392&amp;rft_id=info:pmid/390966&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16479124-125"><b><a href="#cite_ref-pmid16479124_125-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHolm.C3.B8y_T2006">Holmøy T (2006). "A Norse contribution to the history of neurological diseases". <i>Eur. Neurol.</i> <b>55</b> (1): 57–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000091431" class="external text" title="http://dx.doi.org/10.1159%2F000091431" rel="nofollow">10.1159/000091431</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16479124" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16479124">PMID 16479124</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Norse+contribution+to+the+history+of+neurological+diseases&amp;rft.jtitle=Eur.+Neurol.&amp;rft.aulast=Holm%C3%B8y+T&amp;rft.au=Holm%C3%B8y+T&amp;rft.date=2006&amp;rft.volume=55&amp;rft.issue=1&amp;rft.pages=57%E2%80%938&amp;rft_id=info:doi/10.1159%2F000091431&amp;rft_id=info:pmid/16479124&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-126"><b><a href="#cite_ref-126" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFFirth1948">Firth, D (1948). <i>The Case of August D`Esté</i>. Cambridge: Cambridge University Press.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Case+of+August+D%60Est%C3%A9&amp;rft.aulast=Firth&amp;rft.aufirst=D&amp;rft.au=Firth%2C+D&amp;rft.date=1948&amp;rft.place=Cambridge&amp;rft.pub=Cambridge+University+Press&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16103678-127">^ <a href="#cite_ref-pmid16103678_127-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16103678_127-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPearce_JM2005">Pearce JM (2005). "Historical descriptions of multiple sclerosis". <i>Eur. Neurol.</i> <b>54</b> (1): 49–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000087387" class="external text" title="http://dx.doi.org/10.1159%2F000087387" rel="nofollow">10.1159/000087387</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16103678" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16103678">PMID 16103678</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Historical+descriptions+of+multiple+sclerosis&amp;rft.jtitle=Eur.+Neurol.&amp;rft.aulast=Pearce+JM&amp;rft.au=Pearce+JM&amp;rft.date=2005&amp;rft.volume=54&amp;rft.issue=1&amp;rft.pages=49%E2%80%9353&amp;rft_id=info:doi/10.1159%2F000087387&amp;rft_id=info:pmid/16103678&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-128"><b><a href="#cite_ref-128" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFBarbellion1919">Barbellion, Wilhelm Nero Pilate (1919). <i>The Journal of a Disappointed Man</i>. New York: George H. Doran.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Journal+of+a+Disappointed+Man&amp;rft.aulast=Barbellion&amp;rft.aufirst=Wilhelm+Nero+Pilate&amp;rft.au=Barbellion%2C+Wilhelm+Nero+Pilate&amp;rft.date=1919&amp;rft.place=New+York&amp;rft.pub=George+H.+Doran&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-129"><b><a href="#cite_ref-129" title="">^</a></b> <a href="http://www.mxga-mstrial.co.uk" class="external text" title="http://www.mxga-mstrial.co.uk" rel="nofollow">United Kingdom early Mitoxantrone Copaxone trial.</a> Onyx Healthcare (<span class="mw-formatted-date" title="2006-01-01"><a href="/wiki/2006" title="2006">2006</a>-<a href="/wiki/January_1" title="January 1">01-01</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-02"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_2" title="September 2">09-02</a></span>.</li>
<li id="cite_note-130"><b><a href="#cite_ref-130" title="">^</a></b> <a href="http://www.genzyme.com/corp/media/GENZ%20PR-050207.asp" class="external text" title="http://www.genzyme.com/corp/media/GENZ%20PR-050207.asp" rel="nofollow">Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN.</a> Genzyme (<span class="mw-formatted-date" title="2007-02-01"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/February_1" title="February 1">02-01</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-02"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_2" title="September 2">09-02</a></span>.</li>
<li id="cite_note-131"><b><a href="#cite_ref-131" title="">^</a></b> <a href="http://www.pdl.com/index.cfm?navId=49" class="external text" title="http://www.pdl.com/index.cfm?navId=49" rel="nofollow">Daclizumab.</a> PDL Biopharma (<span class="mw-formatted-date" title="2006-01-01"><a href="/wiki/2006" title="2006">2006</a>-<a href="/wiki/January_1" title="January 1">01-01</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-02"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_2" title="September 2">09-02</a></span>.</li>
<li id="cite_note-132"><b><a href="#cite_ref-132" title="">^</a></b> <a href="http://www.clinicaltrials.gov/ct/show/NCT00067327" class="external text" title="http://www.clinicaltrials.gov/ct/show/NCT00067327" rel="nofollow">Treatment of Multiple Sclerosis Using Over the Counter Inosine.</a> ClinicalTrials.gov (<span class="mw-formatted-date" title="2006-03-16"><a href="/wiki/2006" title="2006">2006</a>-<a href="/wiki/March_16" title="March 16">03-16</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-02"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_2" title="September 2">09-02</a></span>.</li>
<li id="cite_note-133"><b><a href="#cite_ref-133" title="">^</a></b> <a href="http://www.clinicaltrials.gov/ct2/show/NCT00420212?term=biogen&amp;recr=Open&amp;rank=12" class="external text" title="http://www.clinicaltrials.gov/ct2/show/NCT00420212?term=biogen&amp;recr=Open&amp;rank=12" rel="nofollow">Efficacy and Safety of BG00012 in Relapsing-Remitting Multiple Sclerosis.</a> ClinicalTrials.gov (<span class="mw-formatted-date" title="2007-09-01"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_1" title="September 1">09-01</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-11-12"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/November_12" title="November 12">11-12</a></span>.</li>
<li id="cite_note-134"><b><a href="#cite_ref-134" title="">^</a></b> <a href="http://www.clinicaltrials.gov/ct/show/NCT00289978" class="external text" title="http://www.clinicaltrials.gov/ct/show/NCT00289978" rel="nofollow">Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis.</a> ClinicalTrials.gov (<span class="mw-formatted-date" title="2006-02-09"><a href="/wiki/2006" title="2006">2006</a>-<a href="/wiki/February_9" title="February 9">02-09</a></span>). Retrieved on <span class="mw-formatted-date" title="2007-09-02"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/September_2" title="September 2">09-02</a></span>.</li>
<li id="cite_note-pmid1234567-135"><b><a href="#cite_ref-pmid1234567_135-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThe_CAMMS223_Trial_Investigators2008">The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". <i>N Engl J Med</i> <b>359</b> (17): 1786–1801. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa0802670" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa0802670" rel="nofollow">10.1056/NEJMoa0802670</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946064" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18946064">PMID 18946064</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Alemtuzumab+vs.+Interferon+Beta-1a+in+Early+Multiple+Sclerosis&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=The+CAMMS223+Trial+Investigators&amp;rft.au=The+CAMMS223+Trial+Investigators&amp;rft.date=2008&amp;rft.volume=359&amp;rft.issue=17&amp;rft.pages=1786%E2%80%931801&amp;rft_id=info:doi/10.1056%2FNEJMoa0802670&amp;rft_id=info:pmid/18946064&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15781813-136"><b><a href="#cite_ref-pmid15781813_136-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPolman_C.2C_Barkhof_F.2C_Sandberg-Wollheim_M.2C_Linde_A.2C_Nordle_O.2C_Nederman_T2005">Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005). "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS". <i>Neurology</i> <b>64</b> (6): 987–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.1212/01.WNL.0000154520.48391.69 (inactive 2009-04-04). <a href="http://www.ncbi.nlm.nih.gov/pubmed/15781813" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15781813">PMID 15781813</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+with+laquinimod+reduces+development+of+active+MRI+lesions+in+relapsing+MS&amp;rft.jtitle=Neurology&amp;rft.aulast=Polman+C%2C+Barkhof+F%2C+Sandberg-Wollheim+M%2C+Linde+A%2C+Nordle+O%2C+Nederman+T&amp;rft.au=Polman+C%2C+Barkhof+F%2C+Sandberg-Wollheim+M%2C+Linde+A%2C+Nordle+O%2C+Nederman+T&amp;rft.date=2005&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=987%E2%80%9391&amp;rft_id=info:doi/10.1212%2F01.WNL.0000154520.48391.69&amp;rft_id=info:pmid/15781813&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-137"><b><a href="#cite_ref-137" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDarlington_CL2005">Darlington CL (2005). "Technology evaluation: NeuroVax, Immune Response Corp". <i>Curr. Opin. Mol. Ther.</i> <b>7</b> (6): 598–603. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16370383" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16370383">PMID 16370383</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Technology+evaluation%3A+NeuroVax%2C+Immune+Response+Corp&amp;rft.jtitle=Curr.+Opin.+Mol.+Ther.&amp;rft.aulast=Darlington+CL&amp;rft.au=Darlington+CL&amp;rft.date=2005&amp;rft.volume=7&amp;rft.issue=6&amp;rft.pages=598%E2%80%93603&amp;rft_id=info:pmid/16370383&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-138"><b><a href="#cite_ref-138" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAgrawal_YP2005">Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". <i>Med. Hypotheses</i> <b>64</b> (4): 721–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.mehy.2004.09.024" class="external text" title="http://dx.doi.org/10.1016%2Fj.mehy.2004.09.024" rel="nofollow">10.1016/j.mehy.2004.09.024</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15694688" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15694688">PMID 15694688</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Low+dose+naltrexone+therapy+in+multiple+sclerosis&amp;rft.jtitle=Med.+Hypotheses&amp;rft.aulast=Agrawal+YP&amp;rft.au=Agrawal+YP&amp;rft.date=2005&amp;rft.volume=64&amp;rft.issue=4&amp;rft.pages=721%E2%80%934&amp;rft_id=info:doi/10.1016%2Fj.mehy.2004.09.024&amp;rft_id=info:pmid/15694688&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-139"><b><a href="#cite_ref-139" title="">^</a></b> <a href="http://clinicaltrials.gov/ct2/results?term=Low+dose+naltrexone+Multiple+Sclerosis" class="external text" title="http://clinicaltrials.gov/ct2/results?term=Low+dose+naltrexone+Multiple+Sclerosis" rel="nofollow">search of clinicaltrials.gov data-base for Low dose naltrexone Multiple Sclerosis</a></li>
<li id="cite_note-140"><b><a href="#cite_ref-140" title="">^</a></b> <a href="http://clinicaltrials.gov/ct2/show/NCT00501696?term=Low+dose+naltrexone+Multiple+Sclerosis&amp;rank=1" class="external text" title="http://clinicaltrials.gov/ct2/show/NCT00501696?term=Low+dose+naltrexone+Multiple+Sclerosis&amp;rank=1" rel="nofollow">2007 clinical trial using LDN</a></li>
<li id="cite_note-pmid18728058-141"><b><a href="#cite_ref-pmid18728058_141-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGironi_M.2C_Martinelli-Boneschi_F.2C_Sacerdote_P.2C_Solaro_C.2C_Zaffaroni_M.2C_Cavarretta_R.2C_Moiola_L.2C_Bucello_S.2C_Radaelli_M.2C_Pilato_V.2C_Rodegher_M.2C_Cursi_M.2C_Franchi_S.2C_Martinelli_V.2C_Nemni_R.2C_Comi_G.2C_Martino_G2008">Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.". <i>Multiple Sclerosis</i> <b>14</b> (8): 1076–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1177%2F1352458508095828" class="external text" title="http://dx.doi.org/10.1177%2F1352458508095828" rel="nofollow">10.1177/1352458508095828</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18728058" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18728058">PMID 18728058</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+pilot+trial+of+low-dose+naltrexone+in+primary+progressive+multiple+sclerosis.&amp;rft.jtitle=Multiple+Sclerosis&amp;rft.aulast=Gironi+M%2C+Martinelli-Boneschi+F%2C+Sacerdote+P%2C+Solaro+C%2C+Zaffaroni+M%2C+Cavarretta+R%2C+Moiola+L%2C+Bucello+S%2C+Radaelli+M%2C+Pilato+V%2C+Rodegher+M%2C+Cursi+M%2C+Franchi+S%2C+Martinelli+V%2C+Nemni+R%2C+Comi+G%2C+Martino+G&amp;rft.au=Gironi+M%2C+Martinelli-Boneschi+F%2C+Sacerdote+P%2C+Solaro+C%2C+Zaffaroni+M%2C+Cavarretta+R%2C+Moiola+L%2C+Bucello+S%2C+Radaelli+M%2C+Pilato+V%2C+Rodegher+M%2C+Cursi+M%2C+Franchi+S%2C+Martinelli+V%2C+Nemni+R%2C+Comi+G%2C+Martino+G&amp;rft.date=2008&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=1076%E2%80%9383&amp;rft_id=info:doi/10.1177%2F1352458508095828&amp;rft_id=info:pmid/18728058&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-142"><b><a href="#cite_ref-142" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlbrecht_P.2C_Fr.C3.B6hlich_R.2C_Hartung_HP.2C_Kieseier_BC.2C_Methner_A2007">Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". <i>J Neurol</i> <b>Online</b>: 1595. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00415-007-0538-3" class="external text" title="http://dx.doi.org/10.1007%2Fs00415-007-0538-3" rel="nofollow">10.1007/s00415-007-0538-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17987252" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17987252">PMID 17987252</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Optical+coherence+tomography+measures+axonal+loss+in+multiple+sclerosis+independently+of+optic+neuritis&amp;rft.jtitle=J+Neurol&amp;rft.aulast=Albrecht+P%2C+Fr%C3%B6hlich+R%2C+Hartung+HP%2C+Kieseier+BC%2C+Methner+A&amp;rft.au=Albrecht+P%2C+Fr%C3%B6hlich+R%2C+Hartung+HP%2C+Kieseier+BC%2C+Methner+A&amp;rft.date=2007&amp;rft.volume=Online&amp;rft.pages=1595&amp;rft_id=info:doi/10.1007%2Fs00415-007-0538-3&amp;rft_id=info:pmid/17987252&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-143"><b><a href="#cite_ref-143" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGordon-Lipkin_E.2C_Chodkowski_B.2C_Reich_DS_.27.27et_al.27.272007">Gordon-Lipkin E, Chodkowski B, Reich DS <i>et al</i> (October 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". <i>Neurology</i> <b>69</b> (16): 1603–09. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000295995.46586.ae" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000295995.46586.ae" rel="nofollow">10.1212/01.wnl.0000295995.46586.ae</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17938370" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17938370">PMID 17938370</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Retinal+nerve+fiber+layer+is+associated+with+brain+atrophy+in+multiple+sclerosis&amp;rft.jtitle=Neurology&amp;rft.aulast=Gordon-Lipkin+E%2C+Chodkowski+B%2C+Reich+DS+%27%27et+al%27%27&amp;rft.au=Gordon-Lipkin+E%2C+Chodkowski+B%2C+Reich+DS+%27%27et+al%27%27&amp;rft.date=October+2007&amp;rft.volume=69&amp;rft.issue=16&amp;rft.pages=1603%E2%80%9309&amp;rft_id=info:doi/10.1212%2F01.wnl.0000295995.46586.ae&amp;rft_id=info:pmid/17938370&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18755821-144"><b><a href="#cite_ref-pmid18755821_144-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThangarajh_M.2C_Gomez-Rial_J.2C_Hedstr.C3.B6m_AK.2C_.27.27et_al.27.272008">Thangarajh M, Gomez-Rial J, Hedström AK, <i>et al</i> (August 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". <i>Mult. Scler.</i> <b>14</b>: 1208. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1177%2F1352458508095729" class="external text" title="http://dx.doi.org/10.1177%2F1352458508095729" rel="nofollow">10.1177/1352458508095729</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18755821" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18755821">PMID 18755821</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lipid-specific+immunoglobulin+M+in+CSF+predicts+adverse+long-term+outcome+in+multiple+sclerosis&amp;rft.jtitle=Mult.+Scler.&amp;rft.aulast=Thangarajh+M%2C+Gomez-Rial+J%2C+Hedstr%C3%B6m+AK%2C+%27%27et+al%27%27&amp;rft.au=Thangarajh+M%2C+Gomez-Rial+J%2C+Hedstr%C3%B6m+AK%2C+%27%27et+al%27%27&amp;rft.date=August+2008&amp;rft.volume=14&amp;rft.pages=1208&amp;rft_id=info:doi/10.1177%2F1352458508095729&amp;rft_id=info:pmid/18755821&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_sclerosis"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=25" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h2>
<ul>
<li>Langgartner M, Langgartner I, Drlicek M. <i><a href="http://bmj.bmjjournals.com/cgi/content/full/330/7496/885" class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/330/7496/885" rel="nofollow">The patient's journey: multiple sclerosis</a></i>. <a href="/wiki/British_Medical_Journal" title="British Medical Journal" class="mw-redirect">BMJ</a>. 2005 Apr 16;330(7496):885-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15831874" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15831874">PMID 15831874</a>.</li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit&amp;section=26" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.dmoz.org/Health/Conditions_and_Diseases/Neurological_Disorders/Demyelinating_Diseases/Multiple_Sclerosis//" class="external text" title="http://www.dmoz.org/Health/Conditions_and_Diseases/Neurological_Disorders/Demyelinating_Diseases/Multiple_Sclerosis//" rel="nofollow">Multiple sclerosis</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://www.atlasofms.org/" class="external text" title="http://www.atlasofms.org/" rel="nofollow">Database for analysis and comparison of global data on the epidemiology of MS</a></li>
<li><a href="http://clinicaltrials.gov/search/term=Multiple+Sclerosis" class="external text" title="http://clinicaltrials.gov/search/term=Multiple+Sclerosis" rel="nofollow">NIH listing of clinical trials related to MS</a></li>
<li><a href="http://www.cochrane.org/reviews/en/topics/79.html" class="external text" title="http://www.cochrane.org/reviews/en/topics/79.html" rel="nofollow">Abstract index</a> of the <a href="/wiki/Cochrane_Library" title="Cochrane Library">Cochrane Library</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background: Silver;" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background: Silver;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Multiple_sclerosis" title="Template:Multiple sclerosis"><span title="View this template" style=";background: Silver;;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Multiple_sclerosis&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Multiple sclerosis (page does not exist)"><span title="Discussion about this template" style=";background: Silver;;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Multiple_sclerosis&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Multiple_sclerosis&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background: Silver;;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><strong class="selflink">Multiple sclerosis</strong></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Multiple_sclerosis_signs_and_symptoms" title="Multiple sclerosis signs and symptoms">Signs and symptoms</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Ataxia" title="Ataxia">Ataxia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">Depression</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Diplopia" title="Diplopia">Diplopia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dysarthria" title="Dysarthria">Dysarthria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dysphagia" title="Dysphagia">Dysphagia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">Fatigue</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">Incontinence</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Neurological_fatigue" title="Neurological fatigue">Neurological fatigue</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pathologic_nystagmus" title="Pathologic nystagmus">Nystagmus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Optic_neuritis" title="Optic neuritis">Optic neuritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pain" title="Pain">Pain</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Uhthoff%27s_phenomenon" title="Uhthoff's phenomenon">Uhthoff's phenomenon</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Diagnosis and evolution following</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/McDonald_criteria" title="McDonald criteria">McDonald criteria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Expanded_Disability_Status_Scale" title="Expanded Disability Status Scale">EDSS</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Investigation</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pathophysiology_of_multiple_sclerosis" title="Pathophysiology of multiple sclerosis">Pathophysiology</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Experimental_autoimmune_encephalomyelitis" title="Experimental autoimmune encephalomyelitis">Experimental autoimmune encephalomyelitis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Treatment_of_multiple_sclerosis" title="Treatment of multiple sclerosis">Treatment</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Interferon" title="Interferon">Interferon</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Glatiramer_acetate" title="Glatiramer acetate">Glatiramer acetate</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Therapies_under_investigation_for_multiple_sclerosis" title="Therapies under investigation for multiple sclerosis">Therapies under investigation</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Borderline_forms_of_multiple_sclerosis" title="Borderline forms of multiple sclerosis" class="mw-redirect">Borderline forms</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated encephalomyelitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Balo_concentric_sclerosis" title="Balo concentric sclerosis">Balo concentric sclerosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Neuromyelitis_optica" title="Neuromyelitis optica">Neuromyelitis optica</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Guillain-Barr%C3%A9_syndrome" title="Guillain-Barré syndrome">Guillain-Barré syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Marburg_multiple_sclerosis" title="Marburg multiple sclerosis">Marburg multiple sclerosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Schilder%27s_disease" title="Schilder's disease">Schilder's disease</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/List_of_people_with_multiple_sclerosis" title="List of people with multiple sclerosis">List of people with multiple sclerosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/List_of_multiple_sclerosis_organizations" title="List of multiple sclerosis organizations">List of multiple sclerosis organizations</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background: Silver;" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background: Silver;;border:none;; font-size:xx-small;"><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system"><span title="View this template" style=";background: Silver;;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:CNS_diseases_of_the_nervous_system" title="Template talk:CNS diseases of the nervous system"><span title="Discussion about this template" style=";background: Silver;;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:CNS_diseases_of_the_nervous_system&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:CNS_diseases_of_the_nervous_system&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background: Silver;;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Pathology" title="Pathology">Pathology</a> of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a> (<a href="/wiki/ICD-10_Chapter_VI:_Diseases_of_the_nervous_system" title="ICD-10 Chapter VI: Diseases of the nervous system">G00–G47</a>, <a href="/wiki/List_of_ICD-9_codes_320-359:_Diseases_of_the_nervous_system" title="List of ICD-9 codes 320-359: Diseases of the nervous system" class="mw-redirect">320–349</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Brain" title="Brain">Brain</a>/<br />
<a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a> (<a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a>, <a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Systemic <a href="/wiki/Atrophies" title="Atrophies" class="mw-redirect">atrophies</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Huntington%27s_disease" title="Huntington's disease">Huntington's disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">Spinocerebellar ataxia</a> (<a href="/wiki/Friedreich%27s_ataxia" title="Friedreich's ataxia">Friedreich's ataxia</a>, <a href="/wiki/Ataxia_telangiectasia" title="Ataxia telangiectasia">Ataxia telangiectasia</a>, <a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a>)
<p><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">Spinal muscular atrophy</a>: <a href="/wiki/Kennedy_disease" title="Kennedy disease">Kennedy disease</a> <span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Spinal_muscular_atrophies_of_childhood" title="Spinal muscular atrophies of childhood">spinal muscular atrophies of childhood</a></i> (<a href="/wiki/Werdnig-Hoffman_disease" title="Werdnig-Hoffman disease">Werdnig-Hoffman</a>, <a href="/wiki/Kugelberg-Welander_disease" title="Kugelberg-Welander disease">Kugelberg-Welander</a>)</p>
<a href="/wiki/Motor_neurone_disease" title="Motor neurone disease">MND</a> (<a href="/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis">ALS</a>, <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">PMA</a>, <a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">PBP</a>, <a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">PP</a>, <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">PLS</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fazio-Londe_disease" title="Fazio-Londe disease">Fazio-Londe</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Extrapyramidal" title="Extrapyramidal" class="mw-redirect">Extrapyramidal</a> and<br />
<a href="/wiki/Movement_disorder" title="Movement disorder">movement disorders</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>: <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a> (<a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, <a href="/wiki/Postencephalitic_parkinsonism" title="Postencephalitic parkinsonism">Postencephalitic parkinsonism</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">Neuroleptic malignant syndrome</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">Pantothenate kinase-associated neurodegeneration</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">Progressive supranuclear palsy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Striatonigral_degeneration" title="Striatonigral degeneration" class="mw-redirect">Striatonigral degeneration</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a><br />
<p><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>: <a href="/wiki/Dystonia" title="Dystonia">Dystonia</a> (<a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a>, <a href="/wiki/Meige%27s_syndrome" title="Meige's syndrome">Meige's</a>, <a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Chorea_(disease)" title="Chorea (disease)">Chorea</a> (<a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a> (<a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a>)</p>
<a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stiff_person_syndrome" title="Stiff person syndrome">Stiff person</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dementia" title="Dementia">Dementia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's</a> (<a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer's disease">Early-onset</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a> (<a href="/wiki/Pick%27s_disease" title="Pick's disease">Pick's</a>, <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multi-infarct_dementia" title="Multi-infarct dementia">Multi-infarct dementia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Leigh%27s_disease" title="Leigh's disease">Leigh's</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">autoimmune</a></i> (<strong class="selflink">Multiple sclerosis</strong>, <a href="/wiki/Neuromyelitis_optica" title="Neuromyelitis optica">Neuromyelitis optica</a>, <a href="/wiki/Schilder%27s_disease" title="Schilder's disease">Schilder's disease</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Hereditary_CNS_demyelinating_disease" title="Hereditary CNS demyelinating disease">hereditary</a></i> (<a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a>, <a href="/wiki/Alexander_disease" title="Alexander disease">Alexander</a>, <a href="/wiki/Canavan_disease" title="Canavan disease">Canavan</a>, <a href="/wiki/Krabbe_disease" title="Krabbe disease">Krabbe</a>, <a href="/wiki/Metachromatic_leukodystrophy" title="Metachromatic leukodystrophy">ML</a>, <a href="/wiki/Pelizaeus-Merzbacher_disease" title="Pelizaeus-Merzbacher disease">Pelizaeus-Merzbacher</a>, <a href="/wiki/Leukoencephalopathy_with_vanishing_white_matter" title="Leukoencephalopathy with vanishing white matter">VWM</a>, <a href="/wiki/Megalencephalic_leukoencephalopathy_with_subcortical_cysts" title="Megalencephalic leukoencephalopathy with subcortical cysts">MFC</a>, <a href="/wiki/CAMFAK_syndrome" title="CAMFAK syndrome">CAMFAK syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Central_pontine_myelinolysis" title="Central pontine myelinolysis">Central pontine myelinolysis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Marchiafava-Bignami_disease" title="Marchiafava-Bignami disease">Marchiafava-Bignami disease</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alpers%27_disease" title="Alpers' disease">Alpers'</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Episodic/<br />
<a href="/wiki/Paroxysm" title="Paroxysm" class="mw-redirect">paroxysmal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Epileptic_seizure" title="Epileptic seizure" class="mw-redirect">Seizure</a>/<a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Focal_seizures" title="Focal seizures" class="mw-redirect">Focal</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Generalised_epilepsy" title="Generalised epilepsy">Generalised</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Headache" title="Headache">Headache</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Migraine" title="Migraine">Migraine</a> (<a href="/wiki/Familial_hemiplegic_migraine" title="Familial hemiplegic migraine">Familial hemiplegic</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vascular_headache" title="Vascular headache">Vascular</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tension_headache" title="Tension headache">Tension</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">Transient ischemic attack</a> (<a href="/wiki/Amaurosis_fugax" title="Amaurosis fugax">Amaurosis fugax</a>, <a href="/wiki/Transient_global_amnesia" title="Transient global amnesia">Transient global amnesia</a>)<br />
<a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular disease</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stroke" title="Stroke">Stroke</a> (<a href="/wiki/Middle_cerebral_artery_syndrome" title="Middle cerebral artery syndrome">MCA</a>, <a href="/wiki/Anterior_cerebral_artery_syndrome" title="Anterior cerebral artery syndrome">ACA</a>, <a href="/wiki/Posterior_cerebral_artery_syndrome" title="Posterior cerebral artery syndrome">PCA</a>, <a href="/wiki/Foville%27s_syndrome" title="Foville's syndrome">Foville's</a>, <a href="/wiki/Millard-Gubler_syndrome" title="Millard-Gubler syndrome">Millard-Gubler</a>, <a href="/wiki/Lateral_medullary_syndrome" title="Lateral medullary syndrome">Lateral medullary</a>, <a href="/wiki/Weber%27s_syndrome" title="Weber's syndrome">Weber's</a>, <a href="/wiki/Lacunar_stroke" title="Lacunar stroke">Lacunar stroke</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorders</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypersomnia" title="Hypersomnia">Hypersomnia</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sleep_apnea" title="Sleep apnea">Sleep apnea</a> (<a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">Obstructive</a>, <a href="/wiki/Ondine%27s_curse" title="Ondine's curse">Ondine's curse</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Narcolepsy" title="Narcolepsy">Narcolepsy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cataplexy" title="Cataplexy">Cataplexy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Kleine-Levin_syndrome" title="Kleine-Levin syndrome">Kleine-Levin</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Circadian_rhythm_sleep_disorder" title="Circadian rhythm sleep disorder">Circadian rhythm sleep</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Delayed_sleep_phase_syndrome" title="Delayed sleep phase syndrome">Delayed sleep phase</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Advanced_sleep_phase_syndrome" title="Advanced sleep phase syndrome">Advanced sleep phase</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Intracranial_hypertension" title="Intracranial hypertension" class="mw-redirect">Intracranial hypertension</a> (<a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a>/<a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure</a>, <a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Reye%27s_syndrome" title="Reye's syndrome">Reye's</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Spinal_cord" title="Spinal cord">Spinal cord</a>/<br />
<a href="/wiki/Myelopathy" title="Myelopathy">myelopathy</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Myelitis" title="Myelitis">Myelitis</a>: <a href="/wiki/Poliomyelitis" title="Poliomyelitis">Poliomyelitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating disease</a> (<a href="/wiki/Transverse_myelitis" title="Transverse myelitis">Transverse myelitis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tropical_spastic_paraparesis" title="Tropical spastic paraparesis">Tropical spastic paraparesis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Syringomyelia" title="Syringomyelia">Syringomyelia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Syringobulbia" title="Syringobulbia">Syringobulbia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Morvan%27s_syndrome" title="Morvan's syndrome">Morvan's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vascular_myelopathy" title="Vascular myelopathy">Vascular myelopathy</a> (<a href="/wiki/Foix-Alajouanine_syndrome" title="Foix-Alajouanine syndrome">Foix-Alajouanine syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">Spinal cord compression</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Both/either</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a> (<a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a>)<br />
<p><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a>/<a href="/wiki/Arachnoiditis" title="Arachnoiditis">Arachnoiditis</a>: <a href="/wiki/Bacterial_meningitis" title="Bacterial meningitis">Bacterial</a> (<a href="/wiki/Tuberculous_meningitis" title="Tuberculous meningitis">Tuberculous</a>, <a href="/wiki/Haemophilus_meningitis" title="Haemophilus meningitis">Haemophilus</a>, <a href="/wiki/Pneumococcal_infection" title="Pneumococcal infection">Pneumococcal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Viral_meningitis" title="Viral meningitis">Viral</a> (<a href="/wiki/Herpesviral_meningitis" title="Herpesviral meningitis">Herpesviral</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fungal_meningitis" title="Fungal meningitis">Fungal</a> (<a href="/wiki/Cryptococcal_meningitis" title="Cryptococcal meningitis" class="mw-redirect">Cryptococcal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Aseptic_meningitis" title="Aseptic meningitis">Aseptic</a> (<a href="/wiki/Drug-induced_aseptic_meningitis" title="Drug-induced aseptic meningitis">Drug-induced</a>)</p>
<a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">congenital</a>, <a href="/wiki/Template:Central_nervous_system_tumors" title="Template:Central nervous system tumors">tumors</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Hypersensitivity_and_autoimmune_diseases" title="Template talk:Hypersensitivity and autoimmune diseases"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Immune_disorder" title="Immune disorder">Immune disorders</a>: <a href="/wiki/Hypersensitivity" title="Hypersensitivity">Hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br />
(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">Atopic dermatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Urticaria" title="Urticaria">Allergic urticaria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hay_fever" title="Hay fever" class="mw-redirect">Hay fever</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Asthma" title="Asthma">Allergic asthma</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a> (<a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a>, <a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a>, <a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a>, <a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a>, <a href="/wiki/Seafood_allergy" title="Seafood allergy">Seafood</a>, <a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a>, <a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>none</i></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cell-mediated_cytotoxicity" title="Antibody-dependent cell-mediated cytotoxicity">ADCC</a><br />
(<a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a>, <a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgG</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Penicillin_allergy" title="Penicillin allergy" class="mw-redirect">Penicillin allergy</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cytotoxic" title="Cytotoxic" class="mw-redirect">Cytotoxic</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Idiopathic_thrombocytopenic_purpura" title="Idiopathic thrombocytopenic purpura">Idiopathic thrombocytopenic purpura</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Goodpasture%27s_syndrome" title="Goodpasture's syndrome">Goodpasture's syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">"<a href="/wiki/Hypersensitivity#Type_5" title="Hypersensitivity">Type 5</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br />
(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Henoch-Sch%C3%B6nlein_purpura" title="Henoch-Schönlein purpura">Henoch-Schönlein purpura</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypersensitivity_vasculitis" title="Hypersensitivity vasculitis">Hypersensitivity vasculitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">Rheumatoid arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Farmer%27s_lung" title="Farmer's lung">Farmer's lung</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Post-streptococcal_glomerulonephritis" title="Post-streptococcal glomerulonephritis">Post-streptococcal glomerulonephritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br />
(<a href="/wiki/T-cells" title="T-cells" class="mw-redirect">T-cells</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Contact_dermatitis" title="Contact dermatitis">Contact dermatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's thyroiditis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Guillain-Barr%C3%A9_syndrome" title="Guillain-Barré syndrome">Guillain-Barré syndrome</a> <span style="font-weight:bold;">&#160;·</span> <strong class="selflink">Multiple sclerosis</strong> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Giant_cell_arteritis" title="Giant cell arteritis">Giant cell arteritis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Transfusion-associated_graft_versus_host_disease" title="Transfusion-associated graft versus host disease">Transfusion-associated graft versus host disease</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Unknown/<br />
multiple</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a> (<a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a> (<a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a>, <a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_adrenalitis" title="Autoimmune adrenalitis">Autoimmune adrenalitis</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<div style="right:10px; display:none;" class="metadata topicon" id="featured-star">
<div><a href="/wiki/Wikipedia:Featured_articles" title="This is a featured article. Click here for more information."><img alt="Featured article" src="http://upload.wikimedia.org/wikipedia/en/6/60/LinkFA-star.png" width="14" height="14" border="0" /></a></div>
</div>
<p><span id="interwiki-de-fa"></span></p>


<!-- 
NewPP limit report
Preprocessor node count: 72350/1000000
Post-expand include size: 755923/2048000 bytes
Template argument size: 337002/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:50603-0!1!0!default!!en!2 and timestamp 20090405152800 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Multiple_sclerosis">http://en.wikipedia.org/wiki/Multiple_sclerosis</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Neurological_disorders" title="Category:Neurological disorders">Neurological disorders</a></span> | <span dir='ltr'><a href="/wiki/Category:Neurobiological_brain_disorder" title="Category:Neurobiological brain disorder">Neurobiological brain disorder</a></span> | <span dir='ltr'><a href="/wiki/Category:Multiple_sclerosis" title="Category:Multiple sclerosis">Multiple sclerosis</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Pages_with_DOIs_broken_since_2009" title="Category:Pages with DOIs broken since 2009">Pages with DOIs broken since 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Featured_articles" title="Category:Featured articles">Featured articles</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Multiple_sclerosis" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Multiple_sclerosis" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Multiple_sclerosis&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Multiple_sclerosis&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Multiple_sclerosis" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Multiple_sclerosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Multiple_sclerosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Multiple_sclerosis&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Multiple_sclerosis&amp;oldid=281888849" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Multiple_sclerosis&amp;id=281888849">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF">العربية</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%9C%D0%BD%D0%BE%D0%B6%D0%B5%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0">Български</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Esclerosi_m%C3%BAltiple">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Roztrou%C5%A1en%C3%A1_skler%C3%B3za">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Multipel_sklerose">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Multiple_Sklerose">Deutsch</a></li>
				<li class="interwiki-et"><a href="http://et.wikipedia.org/wiki/Multiipelskleroos">Eesti</a></li>
				<li class="interwiki-el"><a href="http://el.wikipedia.org/wiki/%CE%A0%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CE%AE_%CF%83%CE%BA%CE%BB%CE%AE%CF%81%CF%85%CE%BD%CF%83%CE%B7">Ελληνικά</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Esclerosis_m%C3%BAltiple">Español</a></li>
				<li class="interwiki-eo"><a href="http://eo.wikipedia.org/wiki/Multloka_sklerozo">Esperanto</a></li>
				<li class="interwiki-eu"><a href="http://eu.wikipedia.org/wiki/Esklerosi_anizkoitz">Euskara</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D8%A7%D8%B3%DA%A9%D9%84%D8%B1%D9%88%D8%B2_%DA%86%D9%86%D8%AF%DA%AF%D8%A7%D9%86%D9%87">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Scl%C3%A9rose_en_plaques">Français</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Sklerosis_ganda">Bahasa Indonesia</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Sclerosi_multipla">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%98%D7%A8%D7%A9%D7%AA_%D7%A0%D7%A4%D7%95%D7%A6%D7%94">עברית</a></li>
				<li class="interwiki-ku"><a href="http://ku.wikipedia.org/wiki/Skleroza_en%C3%AEfireh">Kurdî / كوردی</a></li>
				<li class="interwiki-lv"><a href="http://lv.wikipedia.org/wiki/Izkais%C4%ABt%C4%81_skleroze">Latviešu</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/I%C5%A1s%C4%97tin%C4%97_skleroz%C4%97">Lietuvių</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Sclerosis_multiplex">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Multiple_sclerose">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E5%A4%9A%E7%99%BA%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Multippel_sklerose">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Stwardnienie_rozsiane">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Esclerose_m%C3%BAltipla">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A0%D0%B0%D1%81%D1%81%D0%B5%D1%8F%D0%BD%D0%BD%D1%8B%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7">Русский</a></li>
				<li class="interwiki-sq"><a href="http://sq.wikipedia.org/wiki/Multiple_skleroza">Shqip</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/Multipla_skleroza">Српски / Srpski</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/MS-tauti">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Multipel_skleros">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Multipl_skleroz">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%A0%D0%BE%D0%B7%D1%81%D1%96%D1%8F%D0%BD%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7">Українська</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E5%A4%9A%E5%8F%91%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 5 April 2009, at 13:06.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv183 in 0.063 secs. --></body></html>
